
<html lang="en"     class="pb-page"  data-request-id="59adbe6d-e680-46a0-a280-7cabc51ba813"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-24;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.9b01070"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Identification of Methionine Aminopeptidase-2 (MetAP-2) Inhibitor M8891: A Clinical Compound for the Treatment of Cancer" /></meta><meta name="dc.Creator" content="Timo  Heinrich" /></meta><meta name="dc.Creator" content="Jeyaprakashnarayanan  Seenisamy" /></meta><meta name="dc.Creator" content="Frank  Becker" /></meta><meta name="dc.Creator" content="Beatrix  Blume" /></meta><meta name="dc.Creator" content="Jörg  Bomke" /></meta><meta name="dc.Creator" content="Melanie  Dietz" /></meta><meta name="dc.Creator" content="Uwe  Eckert" /></meta><meta name="dc.Creator" content="Manja  Friese-Hamim" /></meta><meta name="dc.Creator" content="Jakub  Gunera" /></meta><meta name="dc.Creator" content="Kerrin  Hansen" /></meta><meta name="dc.Creator" content="Birgitta  Leuthner" /></meta><meta name="dc.Creator" content="Djordje  Musil" /></meta><meta name="dc.Creator" content="Jens  Pfalzgraf" /></meta><meta name="dc.Creator" content="Felix  Rohdich" /></meta><meta name="dc.Creator" content="Christian  Siegl" /></meta><meta name="dc.Creator" content="Dieter  Spuck" /></meta><meta name="dc.Creator" content="Ansgar  Wegener" /></meta><meta name="dc.Creator" content="Frank T.  Zenke" /></meta><meta name="dc.Description" content="The recently disclosed next generation of reversible, selective, and potent MetAP-2 inhibitors introduced a cyclic tartronic diamide scaffold. However, the lead compound 1a suffered from enterohepa..." /></meta><meta name="Description" content="The recently disclosed next generation of reversible, selective, and potent MetAP-2 inhibitors introduced a cyclic tartronic diamide scaffold. However, the lead compound 1a suffered from enterohepa..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 14, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01070" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01070" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01070" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01070" /></link>
        
    
    

<title>Identification of Methionine Aminopeptidase-2 (MetAP-2) Inhibitor M8891: A Clinical Compound for the Treatment of Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01070" /></meta><meta property="og:title" content="Identification of Methionine Aminopeptidase-2 (MetAP-2) Inhibitor M8891: A Clinical Compound for the Treatment of Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0013.jpeg" /></meta><meta property="og:description" content="The recently disclosed next generation of reversible, selective, and potent MetAP-2 inhibitors introduced a cyclic tartronic diamide scaffold. However, the lead compound 1a suffered from enterohepatic circulation, preventing further development. Nevertheless, 1a served as a starting point for further optimization. Maintaining potent antiproliferation activity, while improving other compound properties, enabled the generation of an attractive array of new MetAP-2 inhibitors. The most promising derivatives were identified by a multiparameter analysis of the compound properties. Essential for the efficient selection of candidates with in vivo activity was the identification of molecules with a long residence time on the target protein, high permeability, and low efflux ratio not only in Caco-2 but also in the MDR-MDCK cell line. Orally bioavailable, potent, and reversible MetAP-2 inhibitors impede the growth of primary endothelial cells and demonstrated antitumoral activity in mouse models. This assessment led to the nomination of the clinical development compound M8891, which is currently in phase I clinical testing in oncology patients." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01070"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01070">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01070&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01070&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01070&amp;href=/doi/10.1021/acs.jmedchem.9b01070" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 11119-11134</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01126" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01229" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Methionine Aminopeptidase-2 (MetAP-2) Inhibitor <b>M8891</b>: A Clinical Compound for the Treatment of Cancer</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Timo Heinrich</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Timo Heinrich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#57233e3a38793f323e39253e343f173a3225343c30253822277934383a"><span class="__cf_email__" data-cfemail="14607d797b3a7c717d7a667d777c54797166777f73667b61643a777b79">[email protected]</span></a>. Tel: +49-61-51-72-65-89.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Timo++Heinrich">Timo Heinrich</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9120-8410" title="Orcid link">http://orcid.org/0000-0001-9120-8410</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeyaprakashnarayanan Seenisamy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeyaprakashnarayanan Seenisamy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Syngene International Ltd., Biocon Park, Plots 2 and 3, Bommasandra-Jigani Link Road, Bangalore 560 099, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeyaprakashnarayanan++Seenisamy">Jeyaprakashnarayanan Seenisamy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Frank Becker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frank Becker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Intana Bioscience GmbH, Lochhamer Str. 29a, D-82152 Planegg/Martinsried, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Becker">Frank Becker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Beatrix Blume</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Beatrix Blume</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Beatrix++Blume">Beatrix Blume</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jörg Bomke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jörg Bomke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%B6rg++Bomke">Jörg Bomke</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Melanie Dietz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Melanie Dietz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Melanie++Dietz">Melanie Dietz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Uwe Eckert</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Uwe Eckert</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Uwe++Eckert">Uwe Eckert</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manja Friese-Hamim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manja Friese-Hamim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manja++Friese-Hamim">Manja Friese-Hamim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jakub Gunera</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jakub Gunera</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jakub++Gunera">Jakub Gunera</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kerrin Hansen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kerrin Hansen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Intana Bioscience GmbH, Lochhamer Str. 29a, D-82152 Planegg/Martinsried, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kerrin++Hansen">Kerrin Hansen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Birgitta Leuthner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Birgitta Leuthner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Birgitta++Leuthner">Birgitta Leuthner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Djordje Musil</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Djordje Musil</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Djordje++Musil">Djordje Musil</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jens Pfalzgraf</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jens Pfalzgraf</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jens++Pfalzgraf">Jens Pfalzgraf</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Felix Rohdich</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Felix Rohdich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Felix++Rohdich">Felix Rohdich</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christian Siegl</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christian Siegl</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Siegl">Christian Siegl</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dieter Spuck</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dieter Spuck</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dieter++Spuck">Dieter Spuck</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ansgar Wegener</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ansgar Wegener</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ansgar++Wegener">Ansgar Wegener</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Frank T. Zenke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frank T. Zenke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frank+T.++Zenke">Frank T. Zenke</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01070&amp;href=/doi/10.1021%2Facs.jmedchem.9b01070" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 11119–11134</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 14, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 July 2019</li><li><span class="item_label"><b>Published</b> online</span>14 November 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 December 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01070" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01070</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D11119%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTimo%2BHeinrich%252C%2BJeyaprakashnarayanan%2BSeenisamy%252C%2BFrank%2BBecker%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D24%26contentID%3Dacs.jmedchem.9b01070%26title%3DIdentification%2Bof%2BMethionine%2BAminopeptidase-2%2B%2528MetAP-2%2529%2BInhibitor%2BM8891%253A%2BA%2BClinical%2BCompound%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D11134%26publicationDate%3DDecember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01070"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1511</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01070" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Methionine Aminopeptidase-2 (MetAP-2) Inhibitor M8891: A Clinical Compound for the Treatment of Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Timo&quot;,&quot;last_name&quot;:&quot;Heinrich&quot;},{&quot;first_name&quot;:&quot;Jeyaprakashnarayanan&quot;,&quot;last_name&quot;:&quot;Seenisamy&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Becker&quot;},{&quot;first_name&quot;:&quot;Beatrix&quot;,&quot;last_name&quot;:&quot;Blume&quot;},{&quot;first_name&quot;:&quot;Jörg&quot;,&quot;last_name&quot;:&quot;Bomke&quot;},{&quot;first_name&quot;:&quot;Melanie&quot;,&quot;last_name&quot;:&quot;Dietz&quot;},{&quot;first_name&quot;:&quot;Uwe&quot;,&quot;last_name&quot;:&quot;Eckert&quot;},{&quot;first_name&quot;:&quot;Manja&quot;,&quot;last_name&quot;:&quot;Friese-Hamim&quot;},{&quot;first_name&quot;:&quot;Jakub&quot;,&quot;last_name&quot;:&quot;Gunera&quot;},{&quot;first_name&quot;:&quot;Kerrin&quot;,&quot;last_name&quot;:&quot;Hansen&quot;},{&quot;first_name&quot;:&quot;Birgitta&quot;,&quot;last_name&quot;:&quot;Leuthner&quot;},{&quot;first_name&quot;:&quot;Djordje&quot;,&quot;last_name&quot;:&quot;Musil&quot;},{&quot;first_name&quot;:&quot;Jens&quot;,&quot;last_name&quot;:&quot;Pfalzgraf&quot;},{&quot;first_name&quot;:&quot;Felix&quot;,&quot;last_name&quot;:&quot;Rohdich&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Siegl&quot;},{&quot;first_name&quot;:&quot;Dieter&quot;,&quot;last_name&quot;:&quot;Spuck&quot;},{&quot;first_name&quot;:&quot;Ansgar&quot;,&quot;last_name&quot;:&quot;Wegener&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;T. Zenke&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;11119-11134&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01070&quot;},&quot;abstract&quot;:&quot;The recently disclosed next generation of reversible, selective, and potent MetAP-2 inhibitors introduced a cyclic tartronic diamide scaffold. However, the lead compound 1a suffered from enterohepatic circulation, preventing further development. Nevertheless, 1a served as a starting point for further optimization. Maintaining potent antiproliferation activity, while improving other compound properties, enabled the generation of an attractive array of new MetAP-2 inhibitors. The most promising derivatives were identified by a multiparameter analysis of the compound properties. Essential for the efficient selection of candidates with in vivo activity was the identification of molecules with a long residence time on the target protein, high permeability, and low efflux ratio not only in Caco-2 but also in the MDR-MDCK cell line. Orally bioavailable, potent, and reversible MetAP-2 inhibitors impede the growth of primary endothelial cells and demonstrated antitumoral activity in mouse models. This assessment led t&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01070&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01070" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01070&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01070" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01070&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01070" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01070&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01070&amp;href=/doi/10.1021/acs.jmedchem.9b01070" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01070" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01070" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01070%26sid%3Dliteratum%253Aachs%26pmid%3D31725285%26genre%3Darticle%26aulast%3DHeinrich%26date%3D2019%26atitle%3DIdentification%2Bof%2BMethionine%2BAminopeptidase-2%2B%2528MetAP-2%2529%2BInhibitor%2BM8891%253A%2BA%2BClinical%2BCompound%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D24%26spage%3D11119%26epage%3D11134%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/jmcmar.2019.62.issue-24/20191226/jmcmar.2019.62.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The recently disclosed next generation of reversible, selective, and potent MetAP-2 inhibitors introduced a cyclic tartronic diamide scaffold. However, the lead compound <b>1a</b> suffered from enterohepatic circulation, preventing further development. Nevertheless, <b>1a</b> served as a starting point for further optimization. Maintaining potent antiproliferation activity, while improving other compound properties, enabled the generation of an attractive array of new MetAP-2 inhibitors. The most promising derivatives were identified by a multiparameter analysis of the compound properties. Essential for the efficient selection of candidates with in vivo activity was the identification of molecules with a long residence time on the target protein, high permeability, and low efflux ratio not only in Caco-2 but also in the MDR-MDCK cell line. Orally bioavailable, potent, and reversible MetAP-2 inhibitors impede the growth of primary endothelial cells and demonstrated antitumoral activity in mouse models. This assessment led to the nomination of the clinical development compound <b>M8891</b>, which is currently in phase I clinical testing in oncology patients.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Removal of N-terminal methionine by methionine aminopeptidases (MetAP) is a crucial step in the maturation of proteins during protein biosynthesis. MetAP-2, one of the two cytoplasmic methionine aminopeptidases expressed in mammalian cells, has been identified as a target of the highly potent and irreversible inhibitor fumagillin, to which antiangiogenic and antitumoral properties have been ascribed.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> These and other findings rationalize the development of MetAP-2 inhibitors for cancer therapy.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Fumagillin derivatives like CKD-732, PPI-2458, and TNP-470 have been evaluated in oncology clinical trials, but development was discontinued likely due to unfavorable pharmacokinetics and adverse events attributed to the inherent reactivity of these molecules.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In addition to the fumagillin class of MetAP-2 inhibitors, structurally divergent MetAP-2 inhibitors have also been described including the substrate-like bestatin class,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> modified marine natural products like the bengamide class,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> anthranilic acid sulfonamide analogues,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> triazole<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> or purine<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> derivatives, and others. Structural investigations of this chemical matter revealed divergent interaction patterns.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Recently, a new binding motif was introduced, which includes a key cyclic hydroxy-malonic acid (tartronic)-diamide scaffold.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Initial structure-based SAR exploration and compound optimization led to <b>1a</b>. This lead showed in vivo tumor growth inhibition in a human glioblastoma efficacy model (U87-MG; T/C = 45% at 10 mg/kg per os daily dosing). In-depth characterization and the multiparameter optimization are described herein culminated in the identification of the clinical candidate <b>M8891</b>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27201" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27201" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Key MetAP-2 Interactions of Lead Compound <b>1a</b></h3><div class="NLM_p">Critical polar and lipophilic interactions between <b>1a</b> and the MetAP-2 protein are well-understood due to the evaluation of the molecule in the protein crystal structure (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Description of <b>1a</b> in the active site of MetAP-2. Distances are given in angstroms (Å). (Left) Polar interactions; (middle) lipophilic contacts; (right) snapshot of the <b>1a</b> surface in green (molecules in black) and the MetAP-2 pocket in magenta (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QED">6QED</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The depiction in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A shows that the cyclic tartronic diamide scaffold coordinates to two manganese ions in a chelating manner. The tertiary alcoholic oxygen is 2.22 Å from the more buried Mn<sup>2+</sup> ion and 2.25 Å from the Mn<sup>2+</sup> ion closer to the pocket entrance. The lactam oxygen interacts with the latter Mn<sup>2+</sup> ion and the imidazoles of His331 and His339 (2.75 Å, 3.12 Å, and 2.72 Å, respectively). The amide moiety makes two interactions, as the amide oxygen coordinates with the buried Mn<sup>2+</sup> ion (2.37 Å), while the amide NH interacts with the imidazole of His231 (3.11 Å). His231 imidazole also makes lipophilic contacts to the benzylamide residue (4.15 Å) and the tetrahydroquinolinone bound to the lactam nitrogen (3.72 Å). The tetrahydroquinolinone residue is rotated out of the pyrrolidinone plane by 53.3° and makes several van der Waals (vdW) interactions at the top of the pocket (Leu447, 3.62 Å; His231, 3.72 Å; Leu328, 3.74 Å) and a hydrogen bond with the lactam-NH and Asn329 side chain (3.06 Å) near the bottom. The halogenated benzyl moiety occupies the substrate recognition pocket and is involved in a couple of vdW contacts with MetAP-2. The fluorine points upward to the side chain of Ala414 (3.24 Å), while the chlorine approaches Ile338 (3.68 Å). In addition, the chlorine is involved in a reverse cation−π interaction: the negatively polarized crown around the σ-hole of the chlorine atom is stacking on the putatively charged imidazole moiety of His339 (3.52 Å and 3.76 Å., not shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). This structural basis was considered as a suitable starting point to investigate different halogen substitution patterns on the benzylic residue and their effect on potency.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthetic Routes for Dedicated Recognition Pocket Evaluation and General Compound Preparation</h3><div class="NLM_p">A previously described synthetic route to the tartronic scaffold was optimized, which allowed facile exploration of amide bond derivatives from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Diversity in the Last Synthetic Step to Optimize the Amide Residue<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ACN/DMF = 10:3, 6-amino-1,2,3,4-tetrahydroquinolin-2-one 60 °C, 12 h, 81%; (b) MMPP, DMF, 12 h, 60 °C, 68%; (c) EtOH, HCl, 4 h, 80 °C, 84%; (d) Chiralpak AD-H; (e) NaOH, H<sub>2</sub>O, 4 h, rt; 84%; (f) R<sub>1</sub>-NH<sub>2</sub>, HATU, NMM, rt, 2 h, 21–54%.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Enzymatic and Cellular Activity of Lead Analogues <b>1a</b><i>–</i><b>1n</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0011.gif" alt="" id="GRAPHIC-d7e480-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center">R3</th><th class="colsep0 rowsep0" align="center">R4</th><th class="colsep0 rowsep0" align="center">R5</th><th class="colsep0 rowsep0" align="center" char="±">enzyme IC<sub>50</sub> [nM]<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">HUVEC proliferation IC<sub>50</sub> [nM]<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">75 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">15 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">52 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">110 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1c</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">53 ± 10</td><td class="colsep0 rowsep0" align="char" char="±">68 ± 11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1d</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">52 ± 16</td><td class="colsep0 rowsep0" align="char" char="±">140 ± 21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1e</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">110 ± 23</td><td class="colsep0 rowsep0" align="char" char="±">2757 ± 990</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1f</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">110 ± 16</td><td class="colsep0 rowsep0" align="char" char="±">4300 ± 566</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1g</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">94 ± 26</td><td class="colsep0 rowsep0" align="char" char="±">809 ± 134</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1h</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">58 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">16 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1i</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">44 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">49 ± 11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1j</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">62 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">170 ± 14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1k</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">120 ± 13</td><td class="colsep0 rowsep0" align="char" char="±">1100 ± 71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1l</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">160 ± 100</td><td class="colsep0 rowsep0" align="char" char="±">930 ± 148</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1m</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">95 ± 10</td><td class="colsep0 rowsep0" align="char" char="±">900 ± 262</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1n</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">79 ± 17</td><td class="colsep0 rowsep0" align="char" char="±">490 ± 92</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Values are the mean of three repetitions.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">8-F-tetrahydroquinolinone.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last"><i>N</i>-Methyl-tetrahydroquinolinone.</p></div></div></div><div class="NLM_p">The synthetic sequence starts with the reaction of cyclopropyl Meldrum’s acid <b>2</b> with 6-amino-1,2,3,4-tetrahydroquinolin-2-one to give <b>3</b>, which was then oxidized with magnesium monoperoxyphthalate (MMPP) in DMF. Chromatographic separation of the resulting hydroxy acid <b>4</b> enantiomers proved to be more efficient after conversion into the corresponding hydroxy ethyl ester <b>5</b> with HCl in ethanol. The desired enantiomer (<i>R</i>)<i>-</i><b>5</b> was saponified with lithium hydroxide in a THF/water mixture of 3:1. The resulting hydroxy-acid scaffold (<i>R</i>)-<b>4</b> was coupled under standard conditions with a library of amines to yield the desired amides <b>1a</b>–<b>l</b>.</div><div class="NLM_p">Dual optimization of the lactam residue and the amide moiety required a slightly different synthetic approach. A racemic, three-step synthesis was established, which was followed by separation of enantiomers via chiral chromatography (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Racemic Three-Step Synthesis and Chiral Chromatography<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ACN/DMF = 10:3, R<sub>1</sub>-NH<sub>2</sub> 60 °C, 12 h, 81%; (b) R<sub>2</sub>-NH<sub>2</sub>, coupling reagent, DMF, 12 h, 60 °C, 22−74%; (c) <i>tert</i>-butyl hydroperoxide, <i>t</i>BuOH, 4 h, 80 °C, 84%; (d) Chiralpak AD-H; (e) NCS, THF, 5 h, 60 °C, <b>13</b> = 52%; <b>14</b> = 22%.</p></p></figure><div class="NLM_p last">The first reaction in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> is similar to the first step described above (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), where the R1 residue’s primary amine reacts with Meldrum’s acid <b>2</b>. After preparation of the pyrrolidinone <b>6</b>, the free carboxylic acid is converted into the corresponding amide <b>7</b> enabled by coupling reagents like T3P or HATU. For <b>12</b>, the acid was transferred into the corresponding methyl ester in methanol with sulfuric acid, which then was treated with 3-chloro-5-fluoro benzylamine at 130 °C for 48 h in a closed flask to obtain the corresponding amide. Oxidation of the chiral carbon with peroxides like <i>tert</i>-butyl hydroperoxide or MMPP completes the formation of the cyclic tartronic MetAP-2 binding moiety. The eutomers (<b>1m</b>, <b>1n</b>, <b>8–12</b>, <b>15–17</b>) were isolated by chiral chromatography either by HPLC or SFC. Depending on the individual target molecule, modifications of the residue R1 were applied. Chlorination with NCS of R1 = 7-azaindole (<b>13</b>, <b>14</b>) or amide couplings with R1 = 5-indolyl-2-carboxylic acid were performed.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Occupancy of the Substrate Recognition Pocket Effects HUVEC Proliferation Inhibition</h3><div class="NLM_p">The introduction of halogen substituents can provide additional and specific bonding interactions with protein substructures, impacting the activity of ligands significantly.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> A halogen scanning approach was applied to study the effect of double and triple halogen substitution of the benzyl moiety buried in the substrate recognition pocket (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p last">The synthesized derivatives were tested in enzymatic and cellular assays. Enzyme assay evaluation revealed minimal potency differences. Unexpectedly, however, a broad potency range was observed in the HUVEC proliferation assay. Seven of the compounds, <b>1a</b>–<b>1d</b> and <b>1h</b>–<b>1j</b>, each inhibit the endothelial cell proliferation with sub-200 nM IC<sub>50</sub> values, whereas all other compounds have a cellular activity around or above 500 nM. Attempts to delineate a structure–activity relationship among the compounds reveals that an <i>ortho</i>-chlorine moiety, like in compounds <b>1e</b> and <b>1f</b>, is not tolerated. Derivative <b>1g</b> is characterized by double <i>ortho</i>-fluorine substitution, which is also not accepted. Fluorine, on the other hand, is tolerated in the <i>ortho</i> position, as analogues <b>1h</b>–<b>1j</b> prove, but only in the presence of a <i>meta</i>-substituted halogen (see <b>1g</b>). Introduction of a <i>para</i>-substituted fluorine, as in compounds <b>1k</b> and <b>1l</b>, is modestly tolerated, perhaps due to fluorine-derived perturbations in the edge-to-face arrangement of the benzyl moieties of the MetAP-2 inhibitors and Tyr444 of the protein. Overall, these efforts reveal that the cellular activity of <b>1a</b> could not be increased by lipophilic or halogen-bonding interactions.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Investigation of the H-Bond Interaction of MetAP-2 Inhibitors to Asn329</h3><div class="NLM_p">The previously described hydrogen bond between <b>1a</b> lactam NH to Asn329 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A) was considered to be essential for activity. Further optimization of the H-bond interaction was envisioned via increasing the acidity of the NH proton. The calculated p<i>K</i><sub>a</sub> of the unsubstituted 1,2,3,4-tetrahydroquinolin-2-one is 13.9. The introduction of fluorine into the 8-position of the tetrahydroquinolinone moiety (<b>1m</b>) reduces the calculated p<i>K</i><sub>a</sub> to 11.9, but negatively impacts cell proliferation (<b>1m</b> is 60× less potent than <b>1a</b>). Directly removing the proton available for hydrogen bonding via <i>N</i>-methylation led to compound <b>1n</b>. The modest cellular activity of <b>1n</b> challenges the relevance of this polar interaction and provides the impetus for further evaluating the importance of the hydrogen bond to Asn329 with an array of different hydrogen donor functions. The results of these efforts are provided in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, along with enzymatic and cellular activities and the calculated p<i>K</i><sub>a</sub> of the lactam-bound residue.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Enzymatic and Cellular Activities<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> and the Calculated p<i>K</i><sub>a</sub> of the Lactam-N-Bound Moiety<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0012.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Values are the mean of three repetitions.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">p<i>K</i><sub>a</sub> values were calculated with MarvinSketch 18.22.2, 2018, ChemAxon (<a href="http://chemaxon.com" class="extLink">http://chemaxon.com</a>), and are identical for the matched pairs <b>9</b>/<b>10</b>, <b>11</b>/<b>12</b>, <b>13</b>/<b>14</b>, <b>15</b>/<b>16</b>, and 2-indol-amides <b>18</b>/<b>19</b>; calculated p<i>K</i><sub>a</sub> for the protonated.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Indazole.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">N7 of the azaindole.</p></div></div><div></div></div><div class="NLM_p last">All of the evaluated compounds from <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> have comparable enzymatic activity. The inhibition of HUVEC proliferation is also quite similar across the collection of compounds, even though the general character of the residue R1 and the calculated p<i>K</i><sub>a</sub> values are significantly different. Sulfonamide <b>8</b> presents the NH donor in a more flexible way, allowing some rotational freedom around the nitrogen phenyl bond. The p<i>K</i><sub>a</sub> of <i>N</i>-phenylmethanesulfonamide (<b>8</b>) is lower than the p<i>K</i><sub>a</sub> of the quinolinone in <b>1a</b>; however, <b>8</b> is slightly less active than <b>1a</b>. Introduction of the NH donor via bicyclic scaffolds like the indazoles <b>9</b> and <b>10</b>, aza-indoles <b>11</b>–<b>14</b>, and indoles <b>15</b>–<b>19</b> with predicted less acidic protons has no significant effect on the cellular activity. According to these results, the hydrogen bonding character of the MetAP-2 inhibitors discussed here and the Asn329 side chain of the MetAP-2 protein has no fundamental relevance for the cellular activity. Nevertheless, compounds <b>15</b>–<b>17</b> contain one less H-bond acceptor than lead <b>1a</b>, which could be important for subsequent optimization.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Methionine Aminopeptidase Selectivity</h3><div class="NLM_p last">Selective inhibition of MetAP-2 over MetAP-1 is a relevant design parameter as complete inhibition of N-terminal methionine cleavage is considered to be too toxic.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> As such, a MetAP-1 enzymatic assay was established. All derivatives tested, including <b>1a</b> and <b>16</b>, did not inhibit MetAP-1 (IC<sub>50</sub> > 10 μM, data not shown), suggesting that MetAP-2 selectivity is a class-specific property for this series of compounds.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> A MetAP-2 Binding Assay Based on Fluorescence Cross-Correlation Analysis Confirms High-Affinity Inhibitors</h3><div class="NLM_p">Target binding affinity and residence times are important information for compound characterization and for the rational selection of promising candidates. No suitable conditions for the immobilization of functional MetAP-2 protein to allow for surface plasmon resonance (SPR) measurements could be found. Fluorescence cross-correlation spectroscopy (FCCS) served as an alternative method to analyze the affinity and residence time of the compounds in cell lysates. The FCCS binding assay was established,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> using a GFP-MetAP-2 fusion protein expressed in HEK293 cells and a fluorescently labeled derivative, <b>19</b>-Dy647, as a tracer for the compound binding side at the target (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01070/suppl_file/jm9b01070_si_001.pdf" class="ext-link">Supporting Information</a>). <i>K</i><sub>i</sub> values of the tested inhibitors were calculated with the Cheng–Prusoff eq (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Besides lead compound <b>1a</b>, the 7-azaindole matched pair, <b>11</b> and <b>12</b>, and the indole analogue, <b>16</b>, were investigated because of their most favorable PK properties (vide infra).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Binding Affinities as an Inhibition Constant (<i>K</i><sub>i</sub>), Dissociation Constant from Kinetic Measurements (<i>K</i><sub>Dkin</sub>), and Residence Time (RT) Calculated from FCCS Data of the Tested Inhibitors<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub> [nM]</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub> [nM]</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>D</sub> kin [nM]</th><th class="colsep0 rowsep0" align="center" char=".">RT [min]</th><th class="colsep0 rowsep0" align="center" char=".">enzyme</th><th class="colsep0 rowsep0" align="center" char=".">HUVEC</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">3.36</td><td class="colsep0 rowsep0" align="char" char=".">1.14</td><td class="colsep0 rowsep0" align="char" char=".">15.9</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">0.90</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">4.33</td><td class="colsep0 rowsep0" align="char" char=".">2.10</td><td class="colsep0 rowsep0" align="char" char=".">27.9</td><td class="colsep0 rowsep0" align="char" char=".">54</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Enzymatic and cellular IC<sub>50</sub> values from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> are added to ease analysis.</p></div></div></div><div class="NLM_p last">The equilibrium FCCS assay confirmed the high affinity of the molecules to the target protein, well below the apparent assay limit of the enzyme assay at approximately 50 nM. However, a clear correlation with the observed cellular activity is not obtained. Binding kinetics might be a possible reason for this inconsistent activity translation, in addition to the above-discussed topics. FCCS spectroscopy was applied to analyze the rate constants and residence time (RT) of the compounds as described before.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Only for <b>1a</b>, no reliable kinetic parameter could be determined. <i>K</i><sub>off</sub> values were further used to calculate residence times of unlabeled compounds on GFP-MetAP-2. Derivative <b>16</b> shows a slightly lower affinity than the other inhibitors with a <i>K</i><sub>i</sub> of 4.3 nM, but apparently has the longest residence time of 27.9 min.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> FCS-Based Target Occupancy Assays Discriminate MetAP-2 Inhibitors in Cells</h3><div class="NLM_p">Target occupancy measurements are critical to evaluate and confirm the binding of candidates to the endogenous target in a cellular environment and were performed using intact A549 cells as a disease-relevant model system. The absence of any significant background binding of the tracer to lysates from cells lacking MetAP-2 overexpression enabled the investigation of the binding to endogenous MetAP-2. The specificity of the signal was confirmed in a cell lysate, where the MetAP-2 transcript was degraded using a target-specific siRNA pool (siPOOL).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The absence of the protein was confirmed by Western blot (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01070/suppl_file/jm9b01070_si_001.pdf" class="ext-link">Supporting Information</a>). Now, the binding was analyzed by fluorescence correlation spectroscopy (FCS), following the increased diffusion time of the bound compared to the unbound tracer. In order to assess the target occupancy, cells were incubated with different concentrations of compounds or DMSO for 4 h (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). After the cells were washed and after a quick lysis step, the unbound fraction of the endogenous MetAP-2 was probed with the tracer <b>19</b>-Dy647.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Target occupancy in A549 cells incubated with different concentrations of indicated inhibitors. The MetAP-2 dependency of the determined signal was determined using siPOOL-treated A549 cells (+).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The target engagement of all compounds was confirmed in this assay. Significant occupancies of 50% or more were detected at 30 nM or higher compound concentrations. The lowest dose required for full occupancy was determined for <b>1a</b>, followed by <b>11</b> and <b>16</b>. For <b>12</b>, significant occupancy was only found for 300 nM or higher concentrations. Interestingly, this lower occupancy is consistent with a shorter target residence time of this inhibitor. MetAP-2 occupancy of <b>16</b> in HCT116 cells in a pulse-chase experiment is described in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01070/suppl_file/jm9b01070_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Pharmacokinetic Characterization of Interesting MetAP-2 Inhibitors</h3><div class="NLM_p">Biochemical, biophysical, and cellular data qualified the lead compound <b>1a</b> as an attractive candidate for extended PK analysis (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Dose-normalized iv PK (iv 0.2 mg/kg) for <b>1a</b> in a rat, dog, and monkey.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While the compound had a favorable PK in rats (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, red), further profiling in nonrodent species revealed the reappearance of the drug in the central circulation up to 72 h after administration, likely associated with an enterohepatic circulation (EHC) in these species (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, dog (black), monkey (blue)). This characteristic was considered as suboptimal for an accurate human PK and dose prediction as well as for controlling exposure in the clinical setting. In line with the anticipated EHC, <b>1a</b> also showed a relatively great extent of unchanged drug in feces after iv administration in both rodent species (mouse data given in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), indicative of active secretion of the drug, together with a subsequent reabsorption. It was found that the extent of active biliary secretion correlated nicely with the efflux ratio observed in Caco-2 permeability tests (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), and therefore, the latter was considered as an essential parameter for further evaluation. In line with the careful analysis of Caco-2 permeability, results from an iv PK study in P-gp knockout mice show that approximately 50% of the overall clearance of <b>1a</b> is mediated by active secretion via P-gp (data not shown). These drawbacks for <b>1a</b> required in-depth analysis of additional putative development candidates (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. PhysChem Properties, ADME, and PK Data of Potent MetAP-2 Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center" char="/">clint (m/h)</th><th class="colsep0 rowsep0" align="center" char=".">PBS [μg/mL]</th><th class="colsep0 rowsep0" align="center" char=".">Caco-2 a > b [1 × 10<sup>–6</sup> cm/s]</th><th class="colsep0 rowsep0" align="center" char=".">ER</th><th class="colsep0 rowsep0" align="center" char="/"><i>F</i>ub [%] m/h</th><th class="colsep0 rowsep0" align="center" char=".">AUC @ 1 mg/kg iv [ng/mL h]</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>ave</sub> free/potency free</th><th class="colsep0 rowsep0" align="center" char=".">CL [L/h/kg]</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i>ss [L/kg]</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> [h]</th><th class="colsep0 rowsep0" align="center" char=".">% unchanged after iv PK</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="char" char="/">13/10</td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char="/">1.7/2.3</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td><td class="colsep0 rowsep0" align="char" char=".">0.78</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="char" char="/"><10/<10</td><td class="colsep0 rowsep0" align="char" char=".">210</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char="/">6.6/11</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char="/"><10/<10</td><td class="colsep0 rowsep0" align="char" char=".">109</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char="/">12/2.8</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td><td class="colsep0 rowsep0" align="char" char=".">0.57</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char="/">108/<10</td><td class="colsep0 rowsep0" align="char" char=".">157</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char="/">19/19</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">1.15</td><td class="colsep0 rowsep0" align="char" char=".">0.99</td><td class="colsep0 rowsep0" align="char" char=".">0.82</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char="/">14/<10</td><td class="colsep0 rowsep0" align="char" char=".">122</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char="/">3.4/3.5</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char="/">26/<10</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char="/">22/7.5</td><td class="colsep0 rowsep0" align="char" char=".">220</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td><td class="colsep0 rowsep0" align="char" char=".">0.32</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char="/">94/26</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char="/">0.2/0.4</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="char" char=".">0.17</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">1.14</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char="/">86/10</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char="/">1.5/1.5</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td><td class="colsep0 rowsep0" align="char" char=".">1.12</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char="/">114/24</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char="/">1.1/1.1</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">2.65</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char="/">76/11</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="/">2.8/1.8</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td><td class="colsep0 rowsep0" align="char" char=".">2.75</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr></tbody></table></div></div><div class="NLM_p">As such, a multiparameter data review was necessary to understand the subtle differences of these MetAP-2 inhibitors, showing all favorable ADME, PK, and potency characteristics. Protein binding of the compounds ranges from <90% (e.g., <b>12</b>) to >99% (e.g., <b>13</b>); therefore, correction of the total systemic exposure of the compounds in the body needs to be taken into account (AUC; expressed as free AUC<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> or average free concentration <i>C</i><sub>ave</sub>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Similarly, the measured cellular IC<sub>50</sub> of the MetAP-2 inhibitors were corrected for protein binding, as the assay contained about 5% serum (HUVEC IC<sub>50</sub> from <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> multiplied by the fraction unbound).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The ratio of the average unbound compound concentration over corrected HUVEC potency is given in the column “<i>C</i><sub>ave</sub> free/potency free”. This integrative evaluation demonstrated the superiority of <b>11</b>, <b>12</b>, and <b>16</b> in comparison to the other derivatives, including the initial lead <b>1a</b>, as these optimized derivatives have values > 0.1. The extended in vivo PK investigations of <b>16</b> in mouse, rat, dog, and cynomolgus monkey exhibited favorable properties for this derivative. In all species investigated, <b>16</b> showed a low clearance (CL ∼ 0.03–0.4 L/h/kg corresponding to ∼1–6% of the liver blood flow), small to medium volume of distribution (<i>V</i>ss ∼0.23–1.3 L/kg), and medium to high oral bioavailability (<i>F</i> ∼ 40–80%; <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Parameters of <b>16</b> in Preclinical Species Obtained by Noncompartmental Analysis</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">CL<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (L/h/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i>ss<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">0.378</td><td class="colsep0 rowsep0" align="char" char=".">0.368</td><td class="colsep0 rowsep0" align="char" char=".">0.801</td><td class="colsep0 rowsep0" align="char" char=".">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">0.350</td><td class="colsep0 rowsep0" align="char" char=".">1.34</td><td class="colsep0 rowsep0" align="char" char=".">3.36</td><td class="colsep0 rowsep0" align="char" char=".">65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="char" char=".">0.0776</td><td class="colsep0 rowsep0" align="char" char=".">0.407</td><td class="colsep0 rowsep0" align="char" char=".">3.89</td><td class="colsep0 rowsep0" align="char" char=".">67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">0.0341</td><td class="colsep0 rowsep0" align="char" char=".">0.227</td><td class="colsep0 rowsep0" align="char" char=".">4.70</td><td class="colsep0 rowsep0" align="char" char=".">80</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Plasma clearance.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Volume of distribution.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Plasma half-life.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Oral bioavailability.</p></div></div></div><div class="NLM_p">Moreover, the optimization approach to get rid of the EHC apparently was successful because systemic elimination of <b>16</b> in the two higher nonclinical species, dog and monkey, followed linear kinetics (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) and showed no transient increases at later time points as it was observed for <b>1a</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose-normalized iv PK (iv 0.2 mg/kg) for <b>16</b> in a rat, dog, and monkey.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Permeability Investigations to Gauge CNS Availability</h3><div class="NLM_p last">The in vivo efficacy of <b>1a</b> had been demonstrated in a glioblastoma model implanted subcutaneously in immunodeficient mice.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, efficacy in a glioblastoma model in situ required further efforts to identify brain penetrant molecules. The MDR-MDCK cell monolayer was established as an in vitro model to classify compounds into CNS-positive or CNS-negative based on permeability coefficients (<i>P</i><sub>app</sub>, a > b). Accordingly, triaging was further tuned by permeability and efflux investigations in the MDR-MDCK cell line. Based on published data, compounds showing <i>P</i><sub>app</sub> (a > b) > 3 × 10–6 cm/s are classified as compounds with a high brain uptake potential, whereas compounds with <i>P</i><sub>app</sub> (a > b) < 1 × 10–6 cm/s are almost unable to penetrate the blood–brain barrier (BBB).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> According to this classification, the aza-indole matched pair, <b>11</b> and <b>12</b>, was considered to exhibit a low potential for significant brain uptake because they showed only moderate permeability but high efflux ratios [(<b>11</b>) a > b, 3.34; ER 17; (<b>12</b>) a > b, 1.28, ER 41]. In contrast, the indole derivative <b>16</b> displayed high permeability (a > b: 15) with little efflux (ER: 4), suggesting the potential for high brain permeability for this compound. Subsequent mice PK studies reveal that <b>16</b> is able to pass the blood–brain barrier, with a <i>k</i><sub>p,uu</sub> ratio of ∼0.6 (data not shown).</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> In Vivo Investigations of Development Candidates</h3><div class="NLM_p">The results of the biophysical, enzymatic, cellular, and PK analyses supported the decision to evaluate <b>11</b>, <b>12</b>, and <b>16</b> in in vivo efficacy studies using xenograft models. As indicated before, glioblastoma is an important indication, and thus, the human U87 MG model was used as a screening model. The highly permeable compound, <b>16</b>, with a long residence time was compared with the medium residence time derivative, <b>11</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo tumor growth inhibition of <b>11</b> and <b>16</b> in the human U87-MG glioblastoma model. Mean tumor volumes over the 14 day treatment period are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Both compounds, <b>11</b> and <b>16</b>, exhibited strong tumor growth inhibition when dosed with 20 mg/kg every day. Improved efficacy was achieved with <b>16</b> (T/C value of 19%), while <b>11</b> only showed a T/C value of 45%. Both treatments were well-tolerated, and no body weight loss was observed during the treatment period with either compound (data not shown). The in vivo efficacy of <b>16</b> in this glioblastoma xenograft model appeared to be at least as good as <b>1a</b> (T/C = 45% at 20 mg/kg),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> considering the variability of such in vivo models.</div><div class="NLM_p">In addition to this glioblastoma model, the human renal Caki-1 tumor model was also used to investigate the tumor growth inhibition potential. In this approach, <b>16</b> was compared with <b>12</b>, which has a 4-fold higher affinity to MetAP-2 but a 3-fold shorter residence time (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo tumor growth inhibition of <b>M8891</b> and <b>12</b> in the human Caki-1 renal model. Mean tumor volumes over the 36 day treatment period are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Both compounds showed strong tumor growth inhibition with an administered dose of 25 mg/kg bidaily. A slightly better efficacy was achieved with <b>16</b> (T/C value of 22%), while <b>12</b> resulted in a T/C value of 39%. Both treatments were tolerated well during the treatment period of 36 days (tumor volumes of the individual animals and body weight change in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01070/suppl_file/jm9b01070_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p last">The comprehensive analysis of different attractive derivatives led to the nomination of <b>16</b> as clinical candidate <b>M8891</b>.</div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Asymmetric Synthesis of Development Compound <b>M8891</b></h3><div class="NLM_p">The nomination of <b>M8891</b> for clinical development required a reanalysis of the synthetic route, as the requisite chiral separation after racemic synthesis reduced potential yields by 50%. The asymmetric synthesis of <b>M8891</b> was considered to be the most attractive approach. The asymmetric oxidation of amide-Cα is described in the literature, and accordingly, different protocols were investigated.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Davis and co-workers had identified oxaziridines as electrophilic oxidants for the hydroxylation of enolates,<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> including chiral camphorsulfonyl oxaziridine (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A), which has been employed to a greater extent in the synthesis of several natural products.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The implementation of this oxidant required an extensive validation, and the final scheme adopted is depicted below (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Asymmetric Synthesis of <b>M8891</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (3,5-difluorophenyl)methanamine, T3P, DMF, 12 h, 60 °C, 68%; (b) 1 M NaHMDS in THF, Davis oxaziridine, THF, 3 h, −70 °C, 76%; (c) NaOH, THF/ethanol = 4:1, 4 h, 50 °C, 87%.</p></p></figure><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Chemical structure of Davis oxaziridine. (B) Visualization of the sodium enolate substructure, indicating the different steric demands around the amide and lactam nitrogen, respectively; the pro-chiral center is indicated with an asterisk. (C) Transition state of asymmetric oxidation with an indication of steric clash of the chlorine with the substitution of the lactam nitrogen (bottom; <i>re</i> side attack) and the more favorable positioning of the chlorine close to the amide nitrogen when the reagent approaches the enolate from the <i>si</i> side.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The first two synthetic steps are comparable to the aforementioned synthetic route discussed in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. 1-(Phenylsulfonyl)-1<i>H</i>-indol-5-amine was reacted with cyclopropyl-Meldrum’s acid in an acetonitrile/DMF mixture to give <b>20</b>. This intermediate was amidated in the presence of T3P to <b>21</b>. Deprotonation with NaHMDS between −70 to −55 °C and oxidation with Davis oxaziridine at −70 °C gave <b>22</b> in 76% yield. The deprotection of the benzene sulphonyl group was carried out using NaOH in a THF/EtOH mixture and delivered <b>M8891</b> in an 87% yield. Final crystallization led to the isolation of the product in >99.8% enantiomeric excess (ee). The observed chirality during the oxidation with Davis oxaziridine might be rationalized by a preferred conformation of the enolate substrate and the facial selectivity of the attacking oxaziridine (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><div class="NLM_p last">The preference for the <i>si</i> side attack is triggered by the different substitution patterns of the nitrogen of the <b>M8891</b> precursor. The steric demand of the arylated, 3-fold substituted lactam nitrogen is higher than for the benzylated 2-fold substituted amide nitrogen. The steric clash between chlorine of the Davis reagent and the lactam nitrogen substituents disfavor <i>re</i> side attack, and accommodation of the “Davis chlorine” close to the amide nitrogen proton is preferred. This is also in line with the observation that hardly any enantiomeric excess was obtained when oxidizing the <b>M8891</b>-precursor enolate with the des-Cl oxaziridine analogue (results not shown). It was also possible to obtain the (<i>R</i>)-enantiomer of <b>M8891</b> in >80% ee when using the enantiomeric (−)-oxaziridine. Besides this substrate-controlled asymmetric synthesis, alternative catalytic oxidations are currently considered. Organic catalysis based on chiral phosphoric acids<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> as well as Lewis-acid-catalyzed mechanisms<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> are investigated to optimize the production of the development compound even further.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30687" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30687" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Initial lead compound <b>1a</b> with an unfavorable high metabolic stability and enterohepatic circulation was further optimized. An integrative data analysis of an array of equally potent derivatives considering protein binding and exposure over time enabled ranking of the MetAP-2 inhibitors. In addition, biophysical analysis of the binding characteristics via FCCS revealed differences of the compounds with respect to affinity and residence time. The favorable properties as well as in vivo efficacy of <b>M8891</b> support the clinical development as an anticancer drug, and clinical phase I testing is currently ongoing.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62127" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62127" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry and General Information</h3><div class="NLM_p">All reactions were carried out under a nitrogen atmosphere or in sealed vials unless noted otherwise. Dry solvents and reagents were of commercial quality and were used as purchased. Reactions were magnetically stirred and monitored by thin-layer chromatography (TLC) using Merck silica gel 60 F254 by fluorescence quenching under UV light or by high-pressure liquid chromatography with subsequent mass detection, except if indicated otherwise. Oxidation reactions done with peroxides like <i>tert</i>-butyl hydroperoxide, magnesium monoperoxyphthalate hydrates, or others were analyzed before workup with Merck test MQuant. In the case of detected traces of peroxide, the reaction mixture was treated with sodium thiosulfate accordingly. The purity of the compounds reported in the manuscript was analyzed through HPLC-MS methodology. HPLC-Analysis: Agilent_LC-MS_1200_6110A; (A) H<sub>2</sub>O + 0.05% HCOOH (B) MeCN + 0.04% HCOOH. Flow: 2.4 mL/min. MS: 85–800 amu. Column: Chromolith RP-18e 50–4.6 mm; 4% → 100% (B) 0 → 2.8 min, 100% (B) 2.8 → 3.3 min. Retention times (<i>t</i><sub>R</sub>) are given in minutes. In addition, TLC plates were stained using phosphomolybdic acid or potassium permanganate stain. Chromatographic purification of products (flash chromatography) was performed on Isco Combiflash systems using Redisep columns and ethyl acetate (EtOAc)/heptane gradients. Concentration under reduced pressure was performed by rotary evaporation at 40 °C at the appropriate pressure unless otherwise stated. <sup>1</sup>H NMR (in DMSO-<i>d</i><sub>6</sub>) and mass spectra are in agreement with the structures and were recorded on a Bruker NMR 400 MHz spectrometer if not stated differently (TMS as an internal standard) and Vacuum Generators VG 70-70 or 70-250 at 70 eV, respectively. High- resolution mass (HRMS) analyses (obtained with a Bruker maXis analyzer) for the final products were within 0.4% of calculated values if not stated otherwise. All compounds reported in the manuscript have a purity ≥ 95% unless noted otherwise.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Procedures to Prepare Compounds from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a></h4><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 2-Oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-pyrrolidine-3-carboxylic Acid</h5><div class="NLM_p last">6-Amino-1,2,3,4-tetrahydroquinolin-2-one (50 g, 308 mmol) was dissolved in 300 mL of DMF and at 60 °C. 6,6-Dimethyl-5,7-dioxa-spiro[2.5]octane-4,8-dione (Meldrum’s acid, 70 g, 411 mmol) dissolved in 1 L of ACN was added dropwise fast. The temperature rose to 70 °C during addition and was kept at 60 °C for 12 h. After the reaction mixture cooled to 5 °C, the precipitated solid was filtered, washed with ACN, and dried in a vacuum at 70 °C for 4 h. Traces of Meldrum’s acid were detected, and the solid was suspended in 6 L of aqueous NaOH (1 N) at 40 °C. After stirring for 30 min, the mixture was filtered, cooled to 5 °C, acidified with aqueous HCl (37%) slowly to pH 3, and stirred for 2 h. The colorless solid was filtered and dried as described before to afford the title compound in an 81% yield (70 g, white solid). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.07 (s, 1H), 7.45 (d, <i>J</i> = 2.4 Hz, 1H), 7.37 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 6.85 (d, <i>J</i> = 8.5 Hz, 1H), 3.87–3.73 (m, 2H), 3.55 (dd, <i>J</i> = 9.0, 7.7 Hz, 1H), 2.87 (dd, <i>J</i> = 8.5, 6.6 Hz, 2H), 2.47–2.40 (m, 2H), 2.39–2.21 (m, 2H).</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxylic Acid</h5><div class="NLM_p last">2-Oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-pyrrolidine-3-carboxylic acid (150 g; 536 mmol) was dissolved in DMF (700 mL), and MMPP (330 g; 536 mmol) was added. This increased the reaction mixture temperature to ∼75 °C and created a yellow suspension. The reaction mixture was stirred overnight at 60 °C, which gave first a brown solution and later an orange suspension. No more starting material could be detected, and the reaction mixture was cooled to 5 °C and filtered; the solid was washed with 2-methoxy-2-methylpropane, giving the title compound in a 68% yield (110 g; white solid). HPLC: <i>t</i><sub>R</sub> = 1.213 min; [M + H]<sup>+</sup> 291.00. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.13 (s, 1H), 8.27–8.21 (m, 1H), 8.07–8.00 (m, 2H), 7.97 (ddd, <i>J</i> = 8.1, 7.0, 1.3 Hz, 1H), 7.48 (d, <i>J</i> = 2.4 Hz, 1H), 7.39 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 6.86 (d, <i>J</i> = 8.6 Hz, 1H), 4.10–3.97 (m, 2H), 3.20–3.10 (m, 1H), 2.87 (t, <i>J</i> = 7.6 Hz, 2H), 2.62–2.53 (m, 1H), 2.48–2.40 (m, 2H).</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> Ethyl 3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxylate</h5><div class="NLM_p last">3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic acid (5 g; 17 mmol) was suspended in ethanol (50 mL), and concentrated HCl (3.2 mL) was added dropwise, giving a brown suspension. The reaction mixture was stirred for 4 h at 80 °C, resulting in a clear brown solution, indicating the complete conversion of the starting material. The solvent was removed in a vacuum, and the residue was diluted with water. The mixture was stirred for 1 h at 0 °C, and the precipitate was filtered and dried in a vacuum for 2 h at 80 °C, giving the title compound in an 84% yield (4.6 g) as a white solid. <i>t</i><sub>R</sub>: 1.502 min; [M + H]<sup>+</sup> 319.10.</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> Ethyl (3<i>R</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxylate and Ethyl (3<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxylate</h5><div class="NLM_p last">Racemic ethyl-3-hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxylate (7.1 g) was separated into the enantiomers by chiral SCF chromatography (ChiralCel OJ-H; CO<sub>2</sub>/MeOH = 86:14) giving 2.8 g (39%) of each isomer. The (<i>R</i>)-enantiomer eluted at <i>t</i><sub>R</sub> = 2.88 min and the (<i>S</i>)-enantiomer at <i>t</i><sub>R</sub> = 4.49 min.</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> (<i>R</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxylate ((<i>R</i>)<b>-4</b>)</h5><div class="NLM_p last">Ethyl (3<i>R</i>)-3-hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxylate (5 g; 15.7 mmol) was suspended in ethanol (50 mL), and sodium hydroxide solution (5 mL; 32%) was added. The reaction mixture was stirred for 3 h at 50 °C, never giving a clear solution. As no more starting material could be detected, the reaction mixture was cooled to 5 °C and filtered. The solid was dried in a vacuum at 80 °C, giving the title compound as a white solid in a 98% yield (4.8 g). HPLC: <i>t</i><sub>R</sub> = 1.193 min; [M + H]<sup>+</sup> 291.05.</div></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>1a</b>)</h4><div class="NLM_p last">(<i>R</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxylate ((<i>R</i>)<b>-4</b>, 100 mg; 0.34 mmol) and 1-(3-chloro-5-fluorobenzyl) amine (55 mg; 0.34 mmol) were dissolved in 5 mL of DMF, NMM (100 μL; 0.91 mmol), and HATU (160 mg; 0.42 mmol) were added. The mixture was stirred for 12 h at rt. After removal of the solvent in a vacuum, the remainder was partitioned between water and ethyl acetate. The aqueous phase was extracted with ethyl acetate, and the combined organic phase was dried over sodium sulfate, filtered, and evaporated to dryness. The residue was purified by chromatography, giving the title compound as a white solid in a 54% yield (80 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.06 (s, 1H), 10.10 (s, 1H), 8.70 (t, <i>J</i> = 6.3, 1H), 7.65 (s, 1H), 7.47 (s, 1H), 7.43 (dd, <i>J</i> = 8.6, 2.4, 1H), 7.27 (dt, <i>J</i> = 8.7, 2.1, 1H), 7.20 (s, 1H), 7.09 (d, <i>J</i> = 8.9, 1H), 7.03 (s, 2H), 6.85 (d, <i>J</i> = 8.6, 1H), 6.72 (s, 1H), 4.37 (dd, <i>J</i> = 15.7, 6.8, 1H), 4.23 (dd, <i>J</i> = 15.7, 6.1, 1H), 3.79 (t, <i>J</i> = 6.8, 1H), 2.87 (t, <i>J</i> = 7.6, 1H), 2.61–2.52 (m, 1H), 2.43 (dd, <i>J</i> = 8.3, 6.7, 2H), 2.09 (dt, <i>J</i> = 12.9, 7.6, 1H). HPLC: <i>t</i><sub>R</sub> = 1.886 min; [M + H]<sup>+</sup> 432.0; HRMS: calcd for C<sub>21</sub>H<sub>20</sub>ClFN<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 432.1121; found, 432.1129.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic Acid 3,5-Difluoro-benzylamide (<b>1b</b>)</h4><div class="NLM_p last">The title compound was prepared as described before ((<i>R</i>)<b>-4</b>, 100 mg; 0.34 mmol), and 1-(3,5-difluorobenzyl) amine (75 mg; 0.42 mmol) in a 35% yield (50 mg) as a colorless solid. HPLC: <i>t</i><sub>R</sub> = 1.801; [M + H]<sup>+</sup> 416.10. <sup>1</sup>HNMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.07 (s, 1H), 8.66 (t, <i>J</i> = 6.4 Hz, 1H), 7.48 (d, <i>J</i> = 2.4 Hz, 1H), 7.43 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 7.05 (tt, <i>J</i> = 9.4, 2.4 Hz, 1H), 6.98 (h, <i>J</i> = 4.2 Hz, 2H), 6.87 (d, <i>J</i> = 8.6 Hz, 1H), 6.69 (s, 1H), 4.40 (dd, <i>J</i> = 15.8, 6.7 Hz, 1H), 4.26 (dd, <i>J</i> = 15.8, 6.0 Hz, 1H), 3.84–3.77 (m, 2H), 2.88 (t, <i>J</i> = 7.5 Hz, 2H), 2.58 (dt, <i>J</i> = 12.2, 5.8 Hz, 1H), 2.44 (dd, <i>J</i> = 8.5, 6.6 Hz, 3H), 2.11 (dt, <i>J</i> = 13.0, 7.6 Hz, 1H). HRMS: calcd for C<sub>21</sub>H<sub>20</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 416.1416; found, 416.1406.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic Acid 3-Chloro-2-fluoro-benzylamide (<b>1c</b>)</h4><div class="NLM_p last">The title compound was prepared as described before ((<i>R</i>)<b>-4</b>, 100 mg; 0.34 mmol), and 1-(3-chloro-2-fluorobenzyl) amine (65 mg; 0.41 mmol) in a 22% yield (33 mg) as a colorless solid. HPLC: <i>t</i><sub>R</sub> = 1.906; [M + H]<sup>+</sup> 432.10. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.06 (s, 1H), 8.58 (t, <i>J</i> = 6.3, 1H), 7.50–7.40 (m, 3H), 7.31 (t, <i>J</i> = 6.4, 1H), 7.18 (t, <i>J</i> = 8.1, 1H), 6.86 (d, <i>J</i> = 8.6, 1H), 6.67 (s, 1H), 4.44–4.30 (m, 2H), 3.84–3.75 (m, 2H), 2.88 (t, <i>J</i> = 7.5, 2H), 2.60–2.54 (m, 1H), 2.47–2.40 (m, 2H), 2.14–2.07 (m, 1H). HRMS: calcd for C<sub>21</sub>H<sub>20</sub>ClFN<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 432.1121; found, 432.1126.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic Acid 2,3-Difluoro-benzylamide (<b>1d</b>)</h4><div class="NLM_p last">The title compound was prepared as described before ((<i>R</i>)<b>-4</b>, 100 mg; 0.34 mmol), and 1-(2,3-difluorobenzyl) amine (60 mg; 0.42 mmol) in a 45% yield (65 mg) as a colorless solid. HPLC: <i>t</i><sub>R</sub> = 1.780; [M + H]<sup>+</sup> 416.10. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.06 (s, 1H), 8.57 (t, <i>J</i> = 6.3 Hz, 1H), 7.48 (d, <i>J</i> = 2.4 Hz, 1H), 7.43 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 7.35–7.21 (m, 1H), 7.16 (dd, <i>J</i> = 6.5, 3.1 Hz, 2H), 6.86 (d, <i>J</i> = 8.6 Hz, 1H), 6.66 (s, 1H), 4.42 (dd, <i>J</i> = 15.6, 6.4 Hz, 1H), 4.35 (dd, <i>J</i> = 15.5, 6.1 Hz, 1H), 3.85–3.74 (m, 2H), 2.88 (t, <i>J</i> = 7.5 Hz, 2H), 2.57 (ddd, <i>J</i> = 12.8, 7.1, 4.5 Hz, 1H), 2.47–2.41 (m, 2H), 2.10 (ddd, <i>J</i> = 12.9, 8.2, 7.1 Hz, 1H). HRMS: calcd for C<sub>21</sub>H<sub>20</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 416.1416; found, 416.14027.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic Acid 2-Chloro-6-fluoro-benzylamide (<b>1e</b>)</h4><div class="NLM_p last">The title compound was prepared as described before ((<i>R</i>)<b>-4</b>, 100 mg; 0.34 mmol), and 1-(2-chloro-6-fluoro benzyl) amine (60 mg; 0.38 mmol) in a 44% yield (65 mg) as a colorless solid. HPLC: <i>t</i><sub>R</sub> = 1.822; [M + H]<sup>+</sup> 432.10. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.06 (s, 1H), 7.97 (t, <i>J</i> = 5.6 Hz, 1H), 7.48 (d, <i>J</i> = 2.4 Hz, 1H), 7.44–7.40 (m, 1H), 7.37 (dd, <i>J</i> = 8.1, 5.9 Hz, 1H), 7.33 (dt, <i>J</i> = 8.1, 1.1 Hz, 1H), 7.22 (ddd, <i>J</i> = 9.6, 8.2, 1.3 Hz, 1H), 6.85 (d, <i>J</i> = 8.6 Hz, 1H), 6.57 (s, 1H), 4.51 (ddd, <i>J</i> = 14.3, 5.8, 1.5 Hz, 1H), 4.44 (ddd, <i>J</i> = 14.3, 5.5, 1.4 Hz, 1H), 3.84–3.70 (m, 2H), 2.88 (t, <i>J</i> = 7.5 Hz, 2H), 2.53 (s, 2H), 2.47–2.40 (m, 2H), 2.06 (ddd, <i>J</i> = 12.8, 8.6, 7.3 Hz, 1H). HRMS: calcd for C<sub>21</sub>H<sub>20</sub>ClFN<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 432.1121; found, 432.1106</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic Acid 2-Chloro-5-fluoro-benzylamide (<b>1f</b>)</h4><div class="NLM_p last">The title compound was prepared as described before ((<i>R</i>)<b>-4</b>, 100 mg; 0.34 mmol), and 1-(3-fluorobenzyl) amine (60 mg; 0.38 mmol) in a 44% yield (65 mg) as a colorless solid. HPLC: <i>t</i><sub>R</sub> = 1.871; [M + H]<sup>+</sup> 432.10. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.07 (s, 1H), 8.68 (t, <i>J</i> = 6.3 Hz, 1H), 7.50–7.45 (m, 2H), 7.44 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 7.19 (dd, <i>J</i> = 9.8, 3.1 Hz, 1H), 7.14 (td, <i>J</i> = 8.4, 3.1 Hz, 1H), 6.87 (d, <i>J</i> = 8.6 Hz, 1H), 6.76 (s, 1H), 4.42 (dd, <i>J</i> = 16.5, 6.7 Hz, 1H), 4.26 (dd, <i>J</i> = 16.5, 5.8 Hz, 1H), 3.87–3.78 (m, 2H), 2.88 (t, <i>J</i> = 7.5 Hz, 2H), 2.62 (ddd, <i>J</i> = 12.9, 6.8, 5.1 Hz, 1H), 2.47–2.40 (m, 2H), 2.18–2.02 (m, 1H). HRMS: calcd for C<sub>21</sub>H<sub>20</sub>ClFN<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 432.1121; found, 432.1108.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic Acid 2,6-Difluoro-benzylamide (<b>1g</b>)</h4><div class="NLM_p last">The title compound was prepared as described before ((<i>R</i>)<b>-4</b>, 130 mg; 0.45 mmol), and 1-(2,6-difluorobenzyl) amine (70 mg; 0.49 mmol) in a 48% yield (90 mg) as a colorless solid. HPLC: <i>t</i><sub>R</sub> = 1.720; [M + H]<sup>+</sup> 416.10. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.06 (s, 1H), 8.11 (t, <i>J</i> = 5.8 Hz, 1H), 7.47 (d, <i>J</i> = 2.4 Hz, 1H), 7.41 (dd, <i>J</i> = 8.5, 2.6 Hz, 1H), 7.40–7.34 (m, 1H), 7.07 (t, <i>J</i> = 7.9 Hz, 2H), 6.85 (d, <i>J</i> = 8.6 Hz, 1H), 6.56 (s, 1H), 4.42 (dd, <i>J</i> = 14.4, 5.9 Hz, 1H), 4.36 (dd, <i>J</i> = 14.4, 5.6 Hz, 1H), 3.84–3.71 (m, 2H), 2.88 (t, <i>J</i> = 7.5 Hz, 2H), 2.46–2.40 (m, 2H), 2.05 (ddd, <i>J</i> = 12.8, 8.6, 7.2 Hz, 1H). HRMS: calcd for C<sub>21</sub>H<sub>20</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 416.1416; found, 416.1405.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic Acid 3-Chloro-2,5-difluoro-benzylamide (<b>1h</b>)</h4><div class="NLM_p last">The title compound was prepared as described before ((<i>R</i>)<b>-4</b>, 100 mg; 0.34 mmol), and 1-(3-chloro-2,5-difluorobenzyl) amine (75 mg; 0.42 mmol) in a 32% yield (50 mg) as a colorless solid. HPLC: <i>t</i><sub>R</sub> = 1.966; [M + H]<sup>+</sup> 450.05. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.07 (s, 1H), 8.68 (t, <i>J</i> = 6.3, 1H), 7.53–7.45 (m, 2H), 7.43 (dd, <i>J</i> = 8.6, 2.5, 1H), 7.17 (ddd, <i>J</i> = 8.7, 5.2, 3.2, 1H), 6.86 (d, <i>J</i> = 8.6, 1H), 6.72 (s, 1H), 4.44 (dd, <i>J</i> = 16.0, 6.6, 1H), 4.30 (dd, <i>J</i> = 16.0, 5.9, 1H), 3.87–3.75 (m, 2H), 2.88 (t, <i>J</i> = 7.5, 2H), 2.59 (dt, <i>J</i> = 12.3, 5.9, 1H), 2.47–2.40 (m, 2H), 2.11 (dt, <i>J</i> = 13.0, 7.6, 1H). HRMS: calcd for C<sub>21</sub>H<sub>19</sub>ClF<sub>2</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 450.1027; found, 450.1028.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic Acid 2,3,5-Trifluoro-benzylamide (<b>1i</b>)</h4><div class="NLM_p last">The title compound was prepared as described before ((<i>R</i>)<b>-4</b>, 100 mg; 0.34 mmol), and 1-(2,3,5-trifluorobenzyl) amine (60 mg; 0.37 mmol) in a 43% yield (65 mg) as a colorless solid. HPLC: <i>t</i><sub>R</sub> = 1.801; [M + H]<sup>+</sup> 416.10. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.07 (s, 1H), 8.68 (t, <i>J</i> = 6.3 Hz, 1H), 7.48 (d, <i>J</i> = 2.4 Hz, 1H), 7.43 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 7.39 (ddt, <i>J</i> = 10.6, 6.2, 3.0 Hz, 1H), 7.03 (dq, <i>J</i> = 9.7, 2.5 Hz, 1H), 6.86 (d, <i>J</i> = 8.6 Hz, 1H), 6.72 (s, 1H), 4.45 (dd, <i>J</i> = 15.9, 6.6 Hz, 1H), 4.32 (dd, <i>J</i> = 15.9, 5.9 Hz, 1H), 3.81 (dd, <i>J</i> = 7.6, 5.9 Hz, 2H), 2.88 (t, <i>J</i> = 7.5 Hz, 2H), 2.62–2.54 (m, 1H), 2.46–2.41 (m, 2H), 2.11 (dt, <i>J</i> = 12.9, 7.5 Hz, 1H). HRMS: calcd for C<sub>21</sub>H<sub>19</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 434.1322; found, 434.1328.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic Acid 2,3,6-Trifluoro-benzylamide (<b>1j</b>)</h4><div class="NLM_p last">The title compound was prepared as described before ((<i>R</i>)<b>-4</b>, 100 mg; 0.34 mmol), and 1-(2,3,6-trifluorobenzyl) amine (60 mg; 0.37 mmol) in a 47% yield (70 mg) as a colorless solid. HPLC: <i>t</i><sub>R</sub> = 1.774; [M + H]<sup>+</sup> 434.10. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.07 (s, 1H), 8.32 (t, <i>J</i> = 5.8 Hz, 1H), 7.48 (d, <i>J</i> = 2.4 Hz, 1H), 7.47–7.39 (m, 2H), 7.11 (tdd, <i>J</i> = 9.2, 3.9, 2.1 Hz, 1H), 6.86 (d, <i>J</i> = 8.6 Hz, 1H), 6.57 (s, 1H), 4.44 (dd, <i>J</i> = 14.5, 5.9 Hz, 1H), 4.38 (dd, <i>J</i> = 14.5, 5.6 Hz, 1H), 3.85–3.73 (m, 2H), 2.89 (t, <i>J</i> = 7.5 Hz, 2H), 2.48 (dd, <i>J</i> = 7.3, 3.8 Hz, 1H), 2.47–2.42 (m, 2H), 2.07 (ddd, <i>J</i> = 12.9, 8.5, 7.2 Hz, 1H). HRMS: calcd for C<sub>21</sub>H<sub>19</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 434.1322; found, 434.1306.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic Acid 3,4,5-Trifluoro-benzylamide (<b>1k</b>)</h4><div class="NLM_p last">The title compound was prepared as described before ((<i>R</i>)<b>-4</b>, 100 mg; 0.34 mmol), and 1-(2,3,6-trifluorobenzyl) amine (70 mg; 0.39 mmol) in a 44% yield (65 mg) as a colorless solid. HPLC: <i>t</i><sub>R</sub> = 1.804; [M + H]<sup>+</sup> 434.1. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.07 (s, 1H), 8.69 (t, <i>J</i> = 6.4 Hz, 1H), 7.48 (d, <i>J</i> = 2.4 Hz, 1H), 7.43 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 7.25–7.16 (m, 2H), 6.86 (d, <i>J</i> = 8.6 Hz, 1H), 6.70 (s, 1H), 4.37 (dd, <i>J</i> = 15.7, 6.8 Hz, 1H), 4.22 (dd, <i>J</i> = 15.7, 6.0 Hz, 1H), 3.81 (dd, <i>J</i> = 7.6, 6.0 Hz, 2H), 2.88 (t, <i>J</i> = 7.5 Hz, 2H), 2.58 (dt, <i>J</i> = 12.9, 5.9 Hz, 1H), 2.47–2.41 (m, 2H), 2.10 (m, 1H). HRMS: calcd for C<sub>21</sub>H<sub>18</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 434.1249; found, 434.1300.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic Acid 3-Chloro-2,4-difluoro-benzylamide (<b>1l</b>)</h4><div class="NLM_p last">The title compound was prepared as described before ((<i>R</i>)<b>-4</b>, 100 mg; 0.34 mmol), and 1-(2,3,6-trifluorobenzyl) amine (70 mg; 0.39 mmol) in a 42% yield (65 mg) as a colorless solid. HPLC: <i>t</i><sub>R</sub> = 1.878; [M + H]<sup>+</sup> 450.0. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.06 (s, 1H), 8.60 (t, <i>J</i> = 6.2 Hz, 1H), 7.48 (d, <i>J</i> = 2.4 Hz, 1H), 7.43 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 7.37 (td, <i>J</i> = 8.4, 6.3 Hz, 1H), 7.29 (td, <i>J</i> = 8.8, 1.6 Hz, 1H), 6.86 (d, <i>J</i> = 8.6 Hz, 1H), 6.67 (s, 1H), 4.38 (dd, <i>J</i> = 15.4, 6.4 Hz, 1H), 4.31 (dd, <i>J</i> = 15.5, 6.0 Hz, 1H), 3.80 (ddt, <i>J</i> = 9.2, 5.9, 3.5 Hz, 2H), 2.88 (t, <i>J</i> = 7.5 Hz, 2H), 2.56 (ddd, <i>J</i> = 12.9, 6.9, 4.7 Hz, 1H), 2.48–2.40 (m, 2H), 2.15–2.05 (m, 1H). HRMS: calcd for C<sub>21</sub>H<sub>18</sub>ClF<sub>2</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 449.0954; found, 449.0970.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>S</i>)-1-(8-Fluoro-2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-3-hydroxy-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>1m</b>)</h4><div class="NLM_p last">The title compound was prepared as described before and was obtained in a 21% yield (14 mg) as a colorless solid. HPLC: <i>t</i><sub>R</sub> = 1.871; [M + H]<sup>+</sup> 432.10. <sup>1</sup>H NMR (400 MHz, DMSO): δ 10.15 (s, 1H), 8.74 (s, 1H), 7.60 (dd, <i>J</i> = 12.9, 1.9 Hz, 1H), 7.33–7.24 (m, 2H), 7.20 (s, 1H), 7.09 (d, <i>J</i> = 9.4 Hz, 1H), 6.78 (s, 1H), 4.37 (d, <i>J</i> = 15.6 Hz, 1H), 4.23 (d, <i>J</i> = 15.6 Hz, 1H), 3.81 (m, 2H), 2.93 (t, <i>J</i> = 7.4 Hz, 2H), 2.63–2.53 (m, 1H), 2.18–2.04 (m, 1H). HRMS: calcd for C<sub>21</sub>H<sub>19</sub>ClF<sub>2</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 450.1027; found, 450.1022.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>S</i>)-3-Hydroxy-1-(1-methyl-2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>1n</b>)</h4><div class="NLM_p last">The title compound was prepared as described before and was obtained in a 41% yield (33 mg) as a colorless solid. HPLC: <i>t</i><sub>R</sub> = 2.036; [M + H]<sup>+</sup> 446.10. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.80 (s, 1H), 7.64 (s, 1H), 7.48 (s, 1H), 7.14 (m, 1H), 7.07 (d, <i>J</i> = 7.5 Hz), 7.00 (s, 1H), 6.92 (s, 1H), 6.80 (d, <i>J</i> = 7.5 Hz), 4.18 (m, 2H), 4.02 (m, 1H), 3.76 (m, 1H), 3.37 (s, 3H), 3.16 (m, 1H), 3.00 (m, 1H), 2.79 (m, 1H), 2.61 (m, 1H), 2.43 (1H). HRMS: calcd for C<sub>22</sub>H<sub>22</sub>ClFN<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 446.1277; found, 446.1277.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Synthesis of Compounds from <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a></h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>S</i>)-3-Hydroxy-1-(3-methanesulfonylamino-phenyl)-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>8</b>)</h4><div id="sec4_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> Synthesis of 1-(3-Methanesulfonamidophenyl)-2-oxopyrrolidine-3-carboxylic Acid</h5><div class="NLM_p last">Meldrum’s acid (1 g, 5.9 mmol) and <i>N</i>-(3-aminophenyl)methanesulfonamide (2.2 g, 11.8 mmol) were dissolved in ACN (20 mL) and stirred overnight at 80 °C. The brown reaction mixture was evaporated to dryness and partitioned between ethyl acetate and saturated NaHCO<sub>3</sub> solution. The aqueous phase was acidified with HCl (1 N) and extracted with ethyl acetate. This extract was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, evaporated, and dried, giving the crude product as a brown oil (1.66 g, 95%), which was used without further purification.</div></div><div id="sec4_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> Synthesis of <i>N</i>-[(3-Chloro-5-fluorophenyl)methyl]-1-(3-methanesulfonamidophenyl)-2-oxopyrrolidine-3-carboxamide</h5><div class="NLM_p last">1-(3-Methanesulfonamidophenyl)-2-oxopyrrolidine-3-carboxylic acid (1.6 g, 5.4 mmol) and 3-chloro-5-fluoro-benzylamine (1 g, 6.4 mmol) were dissolved in DMF (25 mL) and cooled to 0 °C. TEA (2.2 mL, 16 mmol) and T3P (50% in DMF, 10.2 g, 16 mmol) were added, and the mixture was stirred for 1 h at rt. The solvent was removed in a vacuum and the residue partitioned between ethyl acetate and water. The organic phase was washed with NaHCO<sub>3</sub> solution and brine, dried, filtered, and evaporated. The crude brown oil (2.4 g) was used in the next step without further purification. HPLC: <i>t</i><sub>R</sub> = 2.146 min; [M + H]<sup>+</sup> 440.05.</div></div><div id="sec4_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> Synthesis of 3-Hydroxy-1-(3-methanesulfonylamino-phenyl)-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide</h5><div class="NLM_p"><i>N</i>-[(3-Chloro-5-fluorophenyl)methyl]-1-(3-methanesulfonamidophenyl)-2-oxopyrrolidine-3-carboxamide (2.39 g; 5.4 mmol), <i>tert</i>-butyl hydroperoxide (70% in water, 1.1 mL, 8.2 mmol), sodium ethylate (20% in ethanol, 3.1 mL, 8.2 mmol), and <i>tert</i>-butanol (25 mL) were heated to reflux for 3 h. After removal of all volatiles, the residue was partitioned between water and ethyl acetate and neutralized with HCl (1 N). The organic phase was dried, filtered, and evaporated, giving the product in a 89% yield (2.2 g).</div><div class="NLM_p last">Separation of the enantiomeric mixture (120 mg) via chiral HPLC chromatography (ChiralPak AD-H; <i>n</i>-heptane/2-propanol = 3:7) delivered 33 mg (27%) of the (<i>R</i>)-3-hydroxy-1-(3-methanesulfonylamino-phenyl)-2-oxo-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (<b>R-8</b>) and 27 mg (23%) of the desired (<i>S</i>)-3-hydroxy-1-(3-methanesulfonylamino-phenyl)-2-oxo-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (<b>8</b>) HPLC: <i>t</i><sub>R</sub> = 2.045 min; [M + H]<sup>+</sup> 456.00. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.69 (t, <i>J</i> = 6.4 Hz, 1H), 7.95 (s, 1H), 7.67 (t, <i>J</i> = 1.9 Hz, 1H), 7.26 (dt, <i>J</i> = 8.8, 2.1 Hz, 1H), 7.10 (dt, <i>J</i> = 9.7, 1.9 Hz, 1H), 7.03 (dt, <i>J</i> = 6.1, 2.2 Hz, 1H), 6.76 (s, 1H), 4.38 (dd, <i>J</i> = 15.7, 6.7 Hz, 1H), 4.26 (dd, <i>J</i> = 15.7, 6.2 Hz, 1H), 3.84 (tt, <i>J</i> = 8.7, 5.9 Hz, 2H), 2.99 (d, <i>J</i> = 0.7 Hz, 3H), 2.73 (d, <i>J</i> = 0.7 Hz, 3H), 2.59 (ddd, <i>J</i> = 11.9, 7.1, 4.4 Hz, 1H), 2.13 (dt, <i>J</i> = 12.8, 7.7 Hz, 1H). HRMS: calcd for C<sub>19</sub>H<sub>20</sub>ClFN<sub>3</sub>O<sub>5</sub>S [M + H]<sup>+</sup>, 456.0791; found, 456.0792.</div></div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>S</i>)-3-Hydroxy-1-(1<i>H</i>-indazol-5-yl)-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>9</b>)</h4><div id="sec4_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> Synthesis of 1-(1<i>H</i>-Indazol-5-yl)-2-oxopyrrolidine-3-carboxylic Acid</h5><div class="NLM_p last">Meldrum’s acid (5.6 g, 33 mmol) and 1<i>H</i>-indazol-5-amine (4.4 g, 33 mmol) were dissolved in ACN (50 mL) and DMF (50 mL) and stirred overnight at 80 °C. The solvent was removed in a vacuum, and the remainder was titurated with ACN. The crystals were washed with ACN and dried in a vacuum, giving the product as brown crystals (6.3 g; 78%). HPLC: <i>t</i><sub>R</sub> = 1.600 min; [M + H]<sup>+</sup> 246.05.</div></div><div id="sec4_2_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> Synthesis of <i>N</i>-[(3-Chloro-5-fluorophenyl)methyl]-1-(1<i>H</i>-indazol-5-yl)-2-oxopyrrolidine-3-carboxamide</h5><div class="NLM_p last">1-(1<i>H</i>-Indazol-5-yl)-2-oxopyrrolidine-3-carboxylic acid (500 mg; 2 mmol) was dissolved in DMF (15 mL). EDCI (780 mg, 4.1 mmol), HOBt (375 mg, 2.5 mmol), and NMM (1.8 mL, 16 mmol) were added for 10 min at rt. 3-Chloro-5-fluoro-benzylamine (360 mg, 2.6 mmol) dissolved in DMF (5 mL) was added slowly, and the mixture was stirred overnight at rt. The solvent was removed in a vacuum, and the residue was dissolved in ethyl acetate and water. The mixture was adjusted to pH 12 with NaOH (1 N) and extracted with ethyl acetate. The organic phase was dried, filtered, and evaporated, and the remainder was purified by chromatography, giving the title compound in a 32% yield (250 mg) as beige crystals. HPLC: <i>t</i><sub>R</sub> = 2.154 min. [M + H]<sup>+</sup> 387.1.</div></div><div id="sec4_2_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> Synthesis of 3-Hydroxy-1-(1<i>H</i>-indazol-5-yl)-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide</h5><div class="NLM_p"><i>N</i>-[(3-Chloro-5-fluorophenyl)methyl]-1-(1<i>H</i>-indazol-5-yl)-2-oxopyrrolidine-3-carboxamide (250 mg, 0.65 mmol) was dissolved in DMF (10 mL) and reacted with <i>tert</i>-butylhydroperoxide (70% in water, 0.13 mL, 0.97 mmol) and sodium ethylate (20% in ethanol, 0.37 mL, 0.97 mmol) for 1 h at 80 °C. The reaction mixture was evaporated to dryness and redissolved in methanol/DMF for purification via chromatography, giving the title compound in a 42% yield (110 mg) as a beige solid. HPLC: <i>t</i><sub>R</sub> = 2.101 min, [M + H]<sup>+</sup> 403.05.</div><div class="NLM_p last">Separation of the enantiomeric mixture (90 mg) via chiral HPLC (ChiralPak AD; heptane/isopropanol = 6:4) delivered 30 mg (33%; <i>t</i><sub>R</sub>: 14.72 min) of the (<i>R</i>)-3-hydroxy-1-(1<i>H</i>-indazol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (<b>R-9</b>) and 20 mg (22%; <i>t</i><sub>R</sub>: 8.59 min) of the desired (<i>S</i>)-3-hydroxy-1-(1<i>H</i>-indazol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (<b>9</b>). HPLC: <i>t</i><sub>R</sub> = 1.944 min; [M + H]<sup>+</sup> 403.00. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.09 (s, 1H), 8.70 (t, <i>J</i> = 6.4 Hz, 1H), 8.09 (d, <i>J</i> = 1.3 Hz, 1H), 7.92 (d, <i>J</i> = 1.9 Hz, 1H), 7.76 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 7.57 (d, <i>J</i> = 9.0 Hz, 1H), 7.27 (dt, <i>J</i> = 8.8, 2.2 Hz, 1H), 7.23 (d, <i>J</i> = 1.6 Hz, 1H), 7.12 (ddd, <i>J</i> = 9.7, 2.4, 1.3 Hz, 1H), 6.74 (s, 1H), 4.41 (dd, <i>J</i> = 15.7, 6.7 Hz, 1H), 4.27 (dd, <i>J</i> = 15.7, 6.0 Hz, 1H), 3.92 (dd, <i>J</i> = 8.0, 5.6 Hz, 2H), 2.63 (dt, <i>J</i> = 12.9, 5.5 Hz, 1H), 2.16 (dt, <i>J</i> = 12.9, 7.6 Hz, 1H). HRMS: calcd for C<sub>19</sub>H<sub>17</sub>ClFN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 403.0968; found, 403.0973.</div></div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>S</i>)-3-Hydroxy-1-(1<i>H</i>-indazol-5-yl)-2-oxo-pyrrolidine-3-carboxylic Acid 3,5-Difluoro-benzylamide (<b>10</b>)</h4><div id="sec4_2_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> Synthesis of <i>N</i>-[(3,5-Difluorophenyl)methyl]-1-(1<i>H</i>-indazol-5-yl)-2-oxopyrrolidine-3-carboxamide</h5><div class="NLM_p last">1-(1<i>H</i>-Indazol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid (8.5 g; 34.7 mmol) was dissolved in DMF (50 mL), and NMM (15 mL) and HATU (16 g; 42.1 mmol) were added. The mixture was stirred for 20 min at rt. This mixture was added to a solution of 3,5-difluoro-benzylamine (6 g; 42 mmol) in DMF (10 mL) and stirred for 2 h at 60 °C. The reaction mixture was evaporated, and the residue was extracted with water and ethyl acetate; brown crystals precipitated. The slurry was stirred for 1 h at rt, filtrated, washed with ethyl acetate, and dried overnight, giving the product as brown crystals in a 67% yield (9 g).</div></div><div id="sec4_2_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> Synthesis of <i>N</i>-[(3,5-Difluorophenyl)methyl]-3-hydroxy-1-(1<i>H</i>-indazol-5-yl)-2-oxopyrrolidine-3-carboxamide</h5><div class="NLM_p">1-(1<i>H</i>-Indazol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide (8.5 g; 23 mmol) was dissolved in DMF (50 mL), and MMPP (15.5 g; 25.1 mmol) was added, giving a yellow suspension. The reaction mixture was stirred for 12 h at 60 °C to give a brown solution. The reaction mixture was evaporated, diluted with ethyl acetate/water, and extracted. The organic phase was dried over sodium sulfate, filtrated, and evaporated. The residue was purified by chromatographym giving the product in a 55% yield (5.1 g) as a yellow oil.</div><div class="NLM_p last">The (<i>S</i>)-enantiomer was isolated by chiral chromatography (SFC, ChiralPak AS-H, CO<sub>2</sub>/methanol = 80.20). Separation of 5.1 g of the racemate and washing the product with diethyl ether delivered 1.35 g (27%; <i>t</i><sub>R</sub>: 5.50 min) of the (<i>R</i>)-enantiomer and 1.4 g (28%; 3.20 min) of <b>10</b> as beige crystals. HPLC: <i>t</i><sub>R</sub> = 1.776 min; [M + H]<sup>+</sup> 387.1. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.09 (s, 1H), 8.70 (t, <i>J</i> = 6.4 Hz, 1H), 8.09 (d, <i>J</i> = 1.3 Hz, 1H), 7.92 (d, <i>J</i> = 1.9 Hz, 1H), 7.76 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 7.57 (d, <i>J</i> = 9.0 Hz, 1H), 7.27 (dt, <i>J</i> = 8.8, 2.2 Hz, 1H), 7.23 (d, <i>J</i> = 1.6 Hz, 1H), 7.12 (ddd, <i>J</i> = 9.7, 2.4, 1.3 Hz, 1H), 6.74 (s, 1H), 4.41 (dd, <i>J</i> = 15.7, 6.7 Hz, 1H), 4.27 (dd, <i>J</i> = 15.7, 6.0 Hz, 1H), 3.92 (dd, <i>J</i> = 8.0, 5.6 Hz, 2H), 2.63 (dt, <i>J</i> = 12.9, 5.5 Hz, 1H), 2.16 (dt, <i>J</i> = 12.9, 7.6 Hz, 1H). HRMS: calcd for C<sub>19</sub>H<sub>17</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 387.1263; found, 387.1267.</div></div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>11</b>)</h4><div id="sec4_2_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> Synthesis of 2-Oxo-1-{1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl}pyrrolidine-3-carboxylic Acid</h5><div class="NLM_p last">5-Amino-7-azaindole (2 g; 15 mmol) and Meldrum’s acid (2.6 g; 15 mmol) were dissolved in ACN (100 mL) and heated for 20 h at 60 °C. The solvent was removed under reduced pressure and the residue was used in the next step without further purification. HPLC: <i>t</i><sub>R</sub> = 1.471 min; [M + H]<sup>+</sup> 246.10.</div></div><div id="sec4_2_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> Synthesis of <i>N</i>-[(3-Chloro-5-fluorophenyl)methyl]-2-oxo-1-{1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl}pyrrolidine-3-carboxamide</h5><div class="NLM_p">2-Oxo-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-pyrrolidine-3-carboxylic acid (2.3 g; 9.4 mmol) and 3-chloro-5-fluoro-benzylamine (1.5 g; 9.4 mmol) were dissolved in DMF (20 mL), cooled in an ice bath, and <i>o</i>-HATU (4.3 g; 11.3 mmol) and NMM (1.5 mL) were added. The mixture was slowly warmed to 25 °C, stirred at this temperature for 2 h, poured slowly into 300 mL of ice-cold water, and extracted three times with 100 mL of ethyl acetate. Combined organic phases were backwashed with 100 mL of brine, dried over MgSO<sub>4</sub>, and evaporated under reduced pressure. Chromatography yielded 2-oxo-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (2.2 g; 5.7 mmol).</div><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.66 (s, 1H), 8.78 (t, <i>J</i> = 6.1, 1H), 8.46 (d, <i>J</i> = 2.4, 1H), 8.12 (d, <i>J</i> = 2.3, 1H), 7.50 (t, <i>J</i> = 2.9, 1H), 7.30–7.26 (m, 2H), 7.21–7.16 (m, 1H), 6.46 (dd, <i>J</i> = 3.4, 1.9, 1H), 4.49 (dd, <i>J</i> = 16.0, 6.5, 1H), 4.29 (dd, <i>J</i> = 16.0, 5.6, 1H), 3.95–3.91 (m, 2H), 3.64 (t, <i>J</i> = 8.7, 1H), 2.48–2.39 (m, 1H), 2.37–2.29 (m, 1H).</div></div><div id="sec4_2_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> Synthesis of 3-Hydroxy-2-oxo-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide</h5><div class="NLM_p">2-Oxo-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (2.2 g; 6 mmol) was dissolved in <i>tert</i>-butanol (100 mL). Sodium ethoxide (20% solution in ethanol; 4 mL) and subsequently <i>tert</i>-butyl hydroperoxide (70% solution in water; 1.2 mL; 8.5 mmol) were added. The mixture was heated to 80 °C and stirred at this temperature for 1 h. The mixture was evaporated under reduced pressure and the residue was suspended in 100 mL of water. The pH was adjusted to ∼5 by the addition of acetic acid, and the mixture was extracted three times with 100 mL of ethyl acetate. Combined organic phases were backwashed with 50 mL of brine, dried, and evaporated under reduced pressure. The residue was recrystallized from 100 mL of ethanol/water = 1:2 (insoluble dark impurities were filtered off using charcoal). The solid was dried for 20 h in vacuo at 50 °C to yield the title compound in a 54% yield (1.3 g).</div><div class="NLM_p last">Separation of the enantiomeric mixture (17 mg) via chiral HPLC (ChiralPak AD; hexane/isopropanol = 1:9) delivered 7 mg (41%; <i>t</i><sub>R</sub>: 20.63 min) of the (<i>R</i>)-3-hydroxy-2-oxo-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (<b>R-11</b>) and 7 mg (41%; <i>t</i><sub>R</sub>: 18.80 min) of the desired (<i>S</i>)-3-hydroxy-2-oxo-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (<b>11</b>). HPLC: <i>t</i><sub>R</sub> = 1.915 min; [M + H]<sup>+</sup> 403.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.69 (s, 1H), 8.71 (t, <i>J</i> = 6.4 Hz, 1H), 8.49 (d, <i>J</i> = 2.4 Hz, 1H), 8.16 (d, <i>J</i> = 2.3, 0.7 Hz, 1H), 7.50 (t, <i>J</i> = 3.4, 2.5 Hz, 1H), 7.31–7.18 (m, 2H), 7.12 (d, <i>J</i> = 9.7 Hz, 1H), 6.75 (s, 1H), 6.47 (dd, <i>J</i> = 3.4, 1.9 Hz, 1H), 4.41 (dd, <i>J</i> = 15.7, 6.8 Hz, 1H), 4.27 (dd, <i>J</i> = 15.7, 6.0 Hz, 1H), 3.92 (dd, <i>J</i> = 7.6, 5.9 Hz, 2H), 2.70–2.54 (m, 1H), 2.24–2.06 (m, 1H). HRMS: calcd for C<sub>19</sub>H<sub>17</sub>ClFN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 403.0968; found, 403.0977.</div></div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-pyrrolidine-3-carboxylic Acid 3,5-Difluoro-benzylamide (<b>12</b>)</h4><div id="sec4_2_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> Synthesis of Methyl 2-Oxo-1-{1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl}pyrrolidine-3-carboxylate</h5><div class="NLM_p last">2-Oxo-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-pyrrolidine-3-carboxylic acid (35 g; 0.14 mol) was dissolved in methanol (400 mL), concentrated sulfuric acid (95–97%; 7.5 mL) was added slowly, and the mixture was stirred at 80 °C overnight. The reaction mixture was evaporated under reduced pressure, saturated aqueous NaHCO<sub>3</sub> solution was added to the residue, and the mixture was extracted two times with ethyl acetate. The organic layer was dried over sodium sulfate, filtrated, and evaporated under reduced pressure. The residue was purified by chromatography, giving the product as a black oil (7g, 17%). HPLC: <i>t</i><sub>R</sub> = 1.466 min; [M + H]<sup>+</sup> 260.10.</div></div><div id="sec4_2_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> Synthesis of <i>N</i>-[(3,5-Difluorophenyl)methyl]-2-oxo-1-{1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl}pyrrolidine-3-carboxamide</h5><div class="NLM_p last">In a microwave tube, 2-oxo-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-pyrrolidine-3-carboxylic acid methyl ester (1.5 g; 5.8 mmol) was dissolved in THF (30 mL), and 3,5-difluoro-benzylamine (1.6 g; 11.2 mmol) was added. The reaction mixture was stirred in the closed tube at 130 °C for 48 h, giving a brown solution. The reaction mixture was evaporated under vacuo. The residue was extracted with ethyl acetate/water. The organic layer was dried over sodium sulfate, filtered, and evaporated to dryness. The residue was purified by chromatography, giving the product as beige crystals (1.4 g, 64%).</div></div><div id="sec4_2_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> Synthesis of <i>N</i>-[(3,5-Difluorophenyl)methyl]-3-hydroxy-2-oxo-1-{1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl}pyrrolidine-3-carboxamide</h5><div class="NLM_p"><i>N</i>-[(3,5-Difluorophenyl)methyl]-2-oxo-1-{1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl}pyrrolidine-3-carboxamide (7 g; 18.9 mmol) was dissolved in DMF (100 mL). Sodium methylate (30% in methanol, 4.6 mL, 24.8 mmol) and <i>tert</i>-butyl hydroperoxide (70% in water, 3.1 mL, 22.6 mmol) were added, and the mixture was stirred at 80 °C for 1 h. DMF was removed under reduced pressure, and the remainder was dissolved in ethyl acetate (200 mL) and water (200 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The reminder was purified by chromatography, giving 4.6 g (61%) of the product as beige crystals.</div><div class="NLM_p last">Sepration of the enantiomeric mixture (300 mg) via chiral HPLC (Lux Amylose-2; <i>n</i>-heptane/ethanol = 2:8) delivered 103 mg (34%; <i>t</i><sub>R</sub>: 9.53 min) of the (<i>R</i>)-3-hydroxy-2-oxo-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide (<b>R-12</b>) and 106 mg (36%; <i>t</i><sub>R</sub>: 6.20 min) of the desired (<i>S</i>)-3-hydroxy-2-oxo-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide (<b>12</b>). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.69 (s, 1H), 8.71 (t, <i>J</i> = 6.4, 1H), 8.50 (d, <i>J</i> = 2.4, 1H), 8.21–8.13 (m, 1H), 7.52 (dd, <i>J</i> = 3.4, 2.6, 1H), 7.07 (tt, <i>J</i> = 9.3, 2.4, 1H), 7.04–6.98 (m, 2H), 6.76 (s, 1H), 6.49 (dd, <i>J</i> = 3.4, 1.8, 1H), 4.43 (dd, <i>J</i> = 15.8, 6.8, 1H), 4.29 (dd, <i>J</i> = 15.8, 6.0, 1H), 3.97–3.90 (m, 2H), 2.70–2.62 (m, 1H), 2.23–2.15 (m, 1H). HRMS: calcd for C<sub>19</sub>H<sub>17</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 387.1263; found, 387.1249.</div></div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>S</i>)-1-(3-Chloro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-3-hydroxy-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>13</b>)</h4><div class="NLM_p last">To a solution of (<i>S</i>)-3-hydroxy-2-oxo-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (150 mg; 0.37 mmol) in THF (5 mL) was added 1-chloro-pyrrolidine-2,5-dione (55 mg; 0.41 mmol). The reaction mixture was stirred for 5 h at 60 °C and evaporated, and the residue was extracted with water and ethyl acetate. The organic phase was concentrated, dissolved in DMF, and purified by chromatography. The desired fractions were combined and evaporated, giving the product as a white solid (85 mg; 52%). HPLC: <i>t</i><sub>R</sub> = 2.029 min; [M + H]<sup>+</sup> 437.00. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.06 (d, 1H), 8.75 (t, <i>J</i> = 6.4, 1H), 8.58 (d, <i>J</i> = 2.4, 1H), 8.18 (d, <i>J</i> = 2.1, 1H), 7.73 (d, <i>J</i> = 2.7, 1H), 7.28–7.24 (m, 1H), 7.22 (t, <i>J</i> = 1.6, 1H), 7.15–7.04 (m, 1H), 6.79 (s, 1H), 4.41 (dd, <i>J</i> = 15.7, 6.8, 1H), 4.27 (dd, <i>J</i> = 15.8, 6.0, 1H), 4.02–3.91 (m, 2H), 2.68–2.59 (m, 1H), 2.23–2.13 (m, 1H). HRMS: calcd for C<sub>19</sub>H<sub>16</sub>Cl<sub>2</sub>FN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 437.0578; found, 437.0584.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (<i>S</i>)-1-(3-Chloro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-3-hydroxy-2-oxo-pyrrolidine-3-carboxylic Acid 3,5-Difluoro-benzylamide (<b>14</b>)</h4><div class="NLM_p last">To a solution of (<i>S</i>)-3-hydroxy-2-oxo-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide (460 mg; 1.2 mmol) in THF (10 mL) was added 1-chloro-pyrrolidine-2,5-dione (190 mg; 1.4 mmol). The reaction mixture was stirred for 5 h at 60 °C. The reaction mixture was evaporated, and the residue was extracted with water and ethyl acetate. The organic phase was concentrated, dissolved in DMF, and separated by chromatography, giving the product as beige crystals (110 mg; 22%). HPLC: <i>t</i><sub>R</sub> = 1.922; [M + H]<sup>+</sup> 421.00. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.05 (s, 1H), 8.72 (t, <i>J</i> = 6.4, 1H), 8.58 (d, <i>J</i> = 2.4, 1H), 8.17 (d, <i>J</i> = 2.4, 1H), 7.72 (s, 1H), 7.13–6.92 (m, 3H), 6.78 (s, 1H), 4.42 (dd, <i>J</i> = 15.8, 6.8, 1H), 4.28 (dd, <i>J</i> = 15.8, 6.1, 1H), 4.06–3.91 (m, 2H), 2.70–2.58 (m, 1H), 2.27–2.13 (m, 1H). HRMS: calcd for C<sub>19</sub>H<sub>16</sub>ClF<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 421.0873; found, 421.0860.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (<i>S</i>)-3-Hydroxy-1-(1<i>H</i>-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>15</b>)</h4><div id="sec4_2_8_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> Synthesis of 1-(1<i>H</i>-Indol-5-yl)-2-oxopyrrolidine-3-carboxylic Acid</h5><div class="NLM_p">1<i>H</i>-Indol-5-ylamine (20 g; 151 mmol) and Meldrum’s acid (25.75 g; 151 mmol) were dissolved in ACN (500 mL) and DMF (50 mL). The mixture was heated to 60 °C and stirred at this temperature for 20 h.</div><div class="NLM_p last">All attempts to get the product solid failed! Thus, the mixture was evaporated under reduced pressure and used in the next step without purification. For analytical purposes 100 mg of the raw material was purified via prep. HPLC. <sup>1</sup>H NMR (400 MHz, DMSO): δ 11.10 (1H, s), 8.09 (1H, d, <i>J</i> = 97.5), 7.67 (1H, d, <i>J</i> 1.9), 7.37 (3H, m), 6.44 (1H, m), 3.89 (2H, m), 3.57 (1H, dd, <i>J</i> = 8.9, 7.8), 2.34 (2H, m).</div></div><div id="sec4_2_8_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> Synthesis of <i>N</i>-[(3-Chloro-5-fluorophenyl)methyl]-1-(1<i>H</i>-indol-5-yl)-2-oxopyrrolidine-3-carboxamide</h5><div class="NLM_p last">1-(1<i>H</i>-Indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid (13.8 g; 31.3 mmol) and 3-chloro-5-fluoro-benzylamine (5 g; 31.3 mmol) were dissolved in DMF (50 mL) and cooled in an ice bath, and <i>o</i>-HATU (14.3 g; 37.6 mmol) and NMM (5.2 mL; 47 mmol) were added. The mixture was slowly warmed to 25 °C and stirred at this temperature for 20 h. The mixture was poured slowly into ice-cold water (500 mL) and the precipitate collected by suction filtration. The residue was dissolved in ethyl acetate (400 mL), washed with HCl (100 mL, 1 N), dried over MgSO<sub>4</sub>, and evaporated under reduced pressure. Chromatography yielded the title compound in a 56% yield (6.8 g). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.08 (s, 1H), 8.80–8.72 (m, 1H), 7.67 (dt, <i>J</i> = 1.8, 0.8 Hz, 1H), 7.44–7.33 (m, 3H), 7.28 (dd, <i>J</i> = 7.3, 2.1 Hz, 2H), 7.23–7.15 (m, 1H), 6.43 (ddd, <i>J</i> = 2.8, 2.0, 0.7 Hz, 1H), 4.49 (dd, <i>J</i> = 16.0, 6.6 Hz, 1H), 4.29 (dd, <i>J</i> = 16.1, 5.5 Hz, 1H), 3.89 (dd, <i>J</i> = 8.1, 6.0 Hz, 2H), 3.62 (dd, <i>J</i> = 9.2, 8.1 Hz, 1H), 2.49–2.21 (m, 2H).</div></div><div id="sec4_2_8_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> Synthesis of 3-Hydroxy-1-(1<i>H</i>-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide</h5><div class="NLM_p last">1-(1<i>H</i>-Indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (1 g; 3 mmol) was dissolved in <i>tert</i>-butanol (50 mL). Sodium ethoxide (20% solution in ethanol, 2 mL; 5.2 mmol) and subsequently <i>tert</i>-butyl hydroperoxide (70% solution in water, 0.5 mL; 3.9 mmol) were added. The mixture was heated to 80 °C and stirred at this temperature for 1 h. The mixture was evaporated under reduced pressure and the residue suspended in water (50 mL). The pH was adjusted to ∼2 by the addition of 25% HCl, and the mixture was extracted three times with ethyl acetate (50 mL). The combined organic phases were dried and evaporated under reduced pressure, crystallized from 2-propanol (10 mL), and dried in vacuo for 20 h. Separation of the enantiomeric mixture (2.5 g) via chiral HPLC (ChiralPak AD-H; <i>n</i>-heptane/2-propanol = 1:9) delivered 1.17 g (47%; <i>t</i><sub>R</sub>: 6.51 min) of the (<i>R</i>)-3-hydroxy-1-(1<i>H</i>-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (<b>R-15</b>) and 1.14 g (46%; <i>t</i><sub>R</sub>: 4.73 min) of the desired (<i>S</i>)-3-hydroxy-1-(1<i>H</i>-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (<b>15</b>). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.10 (s, 1H), 8.66 (t, <i>J</i> = 6.4 Hz, 1H), 7.71 (dd, <i>J</i> = 1.9, 0.9 Hz, 1H), 7.46–7.37 (m, 2H), 7.36 (t, <i>J</i> = 2.7 Hz, 1H), 7.26 (dt, <i>J</i> = 8.8, 2.2 Hz, 1H), 7.23 (s, 1H), 7.12 (ddd, <i>J</i> = 9.7, 2.4, 1.3 Hz, 1H), 6.66 (s, 1H), 6.43 (t, <i>J</i> = 2.2 Hz, 1H), 4.41 (dd, <i>J</i> = 15.7, 6.7 Hz, 1H), 4.27 (dd, <i>J</i> = 15.7, 6.0 Hz, 1H), 3.88 (t, <i>J</i> = 7.0 Hz, 2H), 2.61 (ddd, <i>J</i> = 12.8, 6.5, 5.1 Hz, 1H), 2.19–2.09 (m, 1H). HRMS: calcd for C<sub>20</sub>H<sub>18</sub>ClFN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 402.1015; found, 402.1000.</div></div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (<i>S</i>)-3-Hydroxy-1-(1<i>H</i>-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic Acid 3,5-Difluoro-benzylamide (<b>16</b>)</h4><div id="sec4_2_9_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> Synthesis of <i>N</i>-[(3,5-Difluorophenyl)methyl]-1-(1<i>H</i>-indol-5-yl)-2-oxopyrrolidine-3-carboxamide</h5><div class="NLM_p last">1-(1<i>H</i>-Indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid (15.35 g; 34.93 mmol) and 3,5-difluorobenzylamine (5 g; 34.93 mmol) were dissolved in DMF (50 mL) and cooled in an ice bath, and HATU (15.94 g; 41.92 mmol) and NMM (5.8 mL; 52,4 mmol) were added. The mixture was slowly warmed to 25 °C and stirred at this temperature for 20 h. The mixture was poured slowly into 500 mL of ice-cold water and the supernatant liquid decanted from the tenacious precipitate. The residue was dissolved in 400 mL of ethyl acetate, washed twice with 100 mL of water, dried over MgSO<sub>4</sub>, and evaporated under reduced pressure. The residue was subjected to flash-chromatography (Isco CombiFlash Rf). Pure fractions were evaporated under reduced pressure to yield the title compound in a 74% yield (9.5 g). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.10 (s, 1H), 8.77 (t, <i>J</i> = 6.2 Hz, 1H), 7.71–7.66 (m, 1H), 7.44–7.34 (m, 3H), 7.14–7.03 (m, 3H), 6.44 (ddd, <i>J</i> = 2.9, 2.0, 0.7 Hz, 1H), 4.52 (dd, <i>J</i> = 16.1, 6.6 Hz, 1H), 4.30 (dd, <i>J</i> = 16.1, 5.5 Hz, 1H), 3.97–3.84 (m, 2H), 3.63 (dd, <i>J</i> = 9.2, 8.1 Hz, 1H), 2.47–2.25 (m, 2H).</div></div><div id="sec4_2_9_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> Synthesis of <i>N</i>-[(3,5-Difluorophenyl)methyl]-3-hydroxy-1-(1<i>H</i>-indol-5-yl)-2-oxopyrrolidine-3-carboxamide</h5><div class="NLM_p last">1-(1<i>H</i>-Indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide (5 g; 14 mmol) was dissolved in <i>tert</i>-butanol (200 mL). Sodium ethoxide (20% solution in ethanol,10.35 mL; 27.07 mmol) and subsequently <i>tert</i>-butyl hydroperoxide (70% solution in water, 2.8 mL; 20.3 mmol) were added. The mixture was heated to 80 °C and stirred at this temperature for 1 h. The mixture was evaporated under reduced pressure and the residue suspended in 100 mL of water. The pH was adjusted to ∼4 by the addition of 25% HCl, and the mixture was extracted three times with ethyl acetate (100 mL). The combined organic phases were dried and evaporated under reduced pressure. The residue was recrystallized from 100 mL of ethanol/water = 1:1 to yield the title compound in a 67% yield (3.7 g). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.10 (s, 1H), 8.66 (t, <i>J</i> = 6.4 Hz, 1H), 7.74–7.68 (m, 1H), 7.45–7.37 (m, 2H), 7.37–7.35 (m, 1H), 7.09–6.97 (m, 3H), 6.67 (s, 1H), 6.43 (ddd, <i>J</i> = 2.9, 2.0, 0.7 Hz, 1H), 4.42 (dd, <i>J</i> = 15.8, 6.8 Hz, 1H), 4.27 (dd, <i>J</i> = 15.8, 6.0 Hz, 1H), 3.92–3.84 (m, 2H), 2.62 (ddd, <i>J</i> = 12.9, 6.8, 4.9 Hz, 1H), 2.19–2.09 (m, 1H). Separation of the enantiomeric mixture (150 mg) via chiral HPLC (ChiralPak AD-H; <i>n</i>-heptane/2-propanol = 1:9) delivered 60 mg (40%; <i>t</i><sub>R</sub>: 6.29 min) of the (<i>R</i>)-3-hydroxy-1-(1<i>H</i>-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (<b>R-16</b>) and 65 mg (43%; <i>t</i><sub>R</sub>: 4.48 min) of the desired (<i>S</i>)-3-hydroxy-1-(1<i>H</i>-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (<b>16</b>). HRMS: calcd for C<sub>20</sub>H<sub>18</sub>F<sub>2</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 386.131074; found, 386.130077. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) ppm = 11.09 (s, 1H), 8.65 (t, <i>J</i> = 6.4, 1H), 7.78−7.61 (m, 1H), 7.45−7.37 (m, 2H), 7.36 (t, <i>J</i> = 2.7, 1H), 7.09−6.96 (m, 3H), 6.66 (s, 1H), 6.45−6.42 (m, 1H), 4.42 (dd, <i>J</i> = 15.8, 6.8, 1H), 4.27 (dd, <i>J</i> = 15.8, 6.0, 1H), 3.88 (ddt, <i>J</i> = 9.2, 6.6, 3.4, 2H), 2.62 (ddd, <i>J</i> = 11.9, 7.0, 4.7, 1H), 2.18−2.10 (m, 1H).</div></div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (<i>S</i>)-3-Hydroxy-1-(2-methyl-1<i>H</i>-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>17</b>)</h4><div id="sec4_2_10_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> Synthesis of 1-[2-Methyl-1<i>H</i>-indol-5-yl]-2-oxopyrrolidine-3-carboxylic Acid</h5><div class="NLM_p last">Meldrum’s acid (1.2 g, 7.1 mmol) and 2-methyl-1<i>H</i>-indole-5-amine (2 g, 10 mmol) were dissolved in ACN (20 mL) and stirred at 60 °C overnight. The solvent was removed in a vacuum and the remainder purified via chromatography giving 500 mg (27%) of the title compound as a brown oil. HPLC: <i>t</i><sub>R</sub> = 1.695 min; [M + H]<sup>+</sup> 260.05.</div></div><div id="sec4_2_10_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> Synthesis of <i>N</i>-[(3-Chloro-5-fluorophenyl)methyl]-1-(2-methyl-1<i>H</i>-indol-5-yl)-2-oxopyrrolidine-3-carboxamide</h5><div class="NLM_p last">1-[2-(Ethoxycarbonyl)-1<i>H</i>-indol-5-yl]-2-oxopyrrolidine-3-carboxylic acid (500 mg, 1.94 mmol) and 3-chloro-5-fluoro-benzylamine (370 mg, 2.32 mmol) were dissolved in DMF (10 mL), and T3P (50% in DMF; 2.5 g, 3.9 mmol) was added slowly. The mixture was stirred at 60 °C overnight. The solvent was removed in a vacuum and the remainder purified by chromatography, giving the title compound in 22% yield (170 mg) as a brown oil. HPLC: <i>t</i><sub>R</sub> = 2.331 min; [M + H]<sup>+</sup> 400.10.</div></div><div id="sec4_2_10_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> Synthesis of 3-Hydroxy-1-(2-methyl-1<i>H</i>-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide</h5><div class="NLM_p"><i>N</i>-[(3-Chloro-5-fluorophenyl)methyl]-1-(2-methyl-1<i>H</i>-indol-5-yl)-2-oxopyrrolidine-3-carboxamide (170 mg, 0.42 mmol) was dissolved in DMF (10 mL), and sodium ethylate (20% in ethanol, 0.24 mL, 0.63 mmol) and <i>tert</i>-butyl hydroperoxide (70% in water, 0.1 mL, 0.63 mmol) were added. The solution was stirred for 1 h at 80 °C. After removal of the solvents, the residue was stirred for 1 h in ethyl acetate and water, and the precipitate was filtered and dried in a vacuum to give 50 mg (28%) of the title compound as a white solid. HPLC: <i>t</i><sub>R</sub> = 2.206 min; [M + H]<sup>+</sup> 416.05.</div><div class="NLM_p last">Separation of the enantiomeric mixture (40 mg) via chiral HPLC (ChiralPak AD-H; <i>n</i>-heptane/2-propanol = 1:9) delivered 11 mg (28%; <i>t</i><sub>R</sub>: 7.76 min) of the (<i>R</i>)-3-hydroxy-1-(2-methyl-1<i>H</i>-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (<b>R-17</b>) and 9 mg (22%; <i>t</i><sub>R</sub>: 5.07 min) of the desired (<i>S</i>)-3-hydroxy-1-(2-methyl-1<i>H</i>-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (<b>17</b>). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.97–10.82 (m, 1H), 8.65 (t, <i>J</i> = 6.4 Hz, 1H), 7.57 (d, <i>J</i> = 2.0 Hz, 1H), 7.30 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 7.28–7.23 (m, 2H), 7.22 (d, <i>J</i> = 1.6 Hz, 1H), 7.12 (ddd, <i>J</i> = 9.7, 2.4, 1.4 Hz, 1H), 6.64 (s, 1H), 6.12 (dt, <i>J</i> = 2.1, 1.0 Hz, 1H), 4.40 (dd, <i>J</i> = 15.7, 6.8 Hz, 1H), 4.26 (dd, <i>J</i> = 15.7, 6.0 Hz, 1H), 3.86 (dd, <i>J</i> = 8.0, 5.6 Hz, 2H), 2.60 (dt, <i>J</i> = 12.8, 5.6 Hz, 1H), 2.37 (d, <i>J</i> = 1.0 Hz, 3H), 2.12 (dt, <i>J</i> = 12.8, 7.6 Hz, 1H). HRMS: calcd for C<sub>21</sub>H<sub>20</sub>ClFN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 416.1172; found, 416.1178.</div></div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 5-[(<i>S</i>)-3-(3-Chloro-5-fluoro-benzylcarbamoyl)-3-hydroxy-2-oxo-pyrrolidin-1-yl]-1<i>H</i>-indole-2-carboxylic Acid Ethylamide (<b>18</b>)</h4><div id="sec4_2_11_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> Synthesis of 1-[2-(Ethoxycarbonyl)-1<i>H</i>-indol-5-yl]-2-oxopyrrolidine-3-carboxylic Acid</h5><div class="NLM_p last">Meldrum’s acid (1.7 g, 10 mmol) and ethyl 5-amino-1<i>H</i>-indole-2-carboxylate (2 g, 10 mmol) were dissolved in 20 mL of ACN and stirred at 60 °C overnight. The solvent was removed in a vacuum and the remainder was purified via chromatography, giving 1.8 g (57%) of the title compound as beige crystals. HPLC: <i>t</i><sub>R</sub> = 1.831 min; [M + H]<sup>+</sup> 317.10.</div></div><div id="sec4_2_11_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> Synthesis of Ethyl 5-(3-{[(3-Chloro-5-fluorophenyl)methyl]carbamoyl}-2-oxopyrrolidin-1-yl)-1<i>H</i>-indole-2-carboxylate</h5><div class="NLM_p last">1-[2-(Ethoxycarbonyl)-1<i>H</i>-indol-5-yl]-2-oxopyrrolidine-3-carboxylic acid (1.8 g, 5.7 mmol) and 3-chloro-5-fluoro-benzylamine (0.9 g, 5.7 mmol) were dissolved in DMF (10 mL), and T3P (50% in DMF; 7.3 g, 11.5 mmol) was added slowly. The mixture was stirred at 60 °C overnight. The solvent was removed in a vacuum and the remainder was purified by chromatography, giving the title compound in an 88% yield (2.3 g) as a brown oil. HPLC: <i>t</i><sub>R</sub> = 2.403 min; [M + H]<sup>+</sup> 458.10.</div></div><div id="sec4_2_11_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> Synthesis of Ethyl 5-(3-{[(3-Chloro-5-fluorophenyl)methyl]carbamoyl}-3-hydroxy-2-oxopyrrolidin-1-yl)-1<i>H</i>-indole-2-carboxylate</h5><div class="NLM_p last">Ethyl 5-(3-{[(3-chloro-5-fluorophenyl)methyl]carbamoyl}-2-oxopyrrolidin-1-yl)-1<i>H</i>-indole-2-carboxylate (5.77 g, 12.6 mmol) was dissolved in DMF (100 mL), and MMPP (9.35 g, 15.1 mmol) was added, giving a yellow suspension. The reaction was stirred for 3 h at 60 °C. The reaction was not complete, and again MMPP (4.66 g,) was added. After removal of the solvent, the remainder was purified by chromatography, giving the title compound in a 47% yield (2.8 g) as a white solid. This racemic mixture (2.79 g) was separated into the enantiomers by chiral chromatography (HPLC; ChiralPak AD-H, <i>n</i>-heptane/2-propanol = 1:9; 0.98 g of (<i>R</i>)-enantiomer and 1.2 g of (<i>S</i>)-enantiomer).</div></div><div id="sec4_2_11_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> Synthesis of 5-[(3<i>S</i>)-3-{[(3-Chloro-5-fluorophenyl)methyl]carbamoyl}-3-hydroxy-2-oxopyrrolidin-1-yl]-1<i>H</i>-indole-2-carboxylic Acid</h5><div class="NLM_p">Ethyl 5-[(3S)-3-{[(3-chloro-5-fluorophenyl)methyl]carbamoyl}-3-hydroxy-2-oxopyrrolidin-1-yl]-1<i>H</i>-indole-2-carboxylate (1.2 g; 2.5 mmol) was suspended in ethanol (12 mL), and a solution of NaOH (32%, 1.35 in water, 1 mL) was added. The mixture was stirred for 4 h at 50 °C. After cooling to 0 °C, HCl (37%) was added to adjust the pH to 3. Beige crystals precipitated, which were filtered, washed with water, and dried overnight in a vacuum at 80 °C, giving the product as a white solid in an 87% yield (1 g).</div><div class="NLM_p last">HPLC: <i>t</i><sub>R</sub> = 1.995 min; [M + H]<sup>+</sup> 446.04. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.94 (s, 1H), 11.78 (s, 1H), 8.68 (t, <i>J</i> = 6.4, 1H), 7.81 (d, <i>J</i> = 2.0, 1H), 7.62 (dd, <i>J</i> = 9.0, 2.1, 1H), 7.44 (d, <i>J</i> = 8.9, 1H), 7.26 (dt, <i>J</i> = 8.8, 2.2, 1H), 7.23–7.21 (m, 1H), 7.15–7.07 (m, 2H), 6.69 (s, 1H), 4.40 (dd, <i>J</i> = 15.7, 6.8, 1H), 4.27 (dd, <i>J</i> = 15.7, 6.0, 1H), 3.93–3.84 (m, 2H), 2.65–2.57 (m, 1H), 2.19–2.09 (m, 1H).</div></div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Synthesis of 5-[(<i>S</i>)-3-(3-Chloro-5-fluoro-benzylcarbamoyl)-3-hydroxy-2-oxo-pyrrolidin-1-yl]-1<i>H</i>-indole-2-carboxylic Acid Ethylamide (<b>18</b>)</h4><div class="NLM_p last">5-[(3<i>S</i>)-3-{[(3-Chloro-5-fluorophenyl)methyl]carbamoyl}-3-hydroxy-2-oxopyrrolidin-1-yl]-1<i>H</i>-indole-2-carboxylic acid (100 mg; 0.2 mmol) and ethylamine (2.0 M solution in tetrahydrofuran, 0.14 mL; 0.27 mmol) were dissolved in DMF (5 mL). NMM (0.06 mL; 0.55 mmol) and HATU (100 mg; 0.26 mmol) were added. The mixture was stirred for 3 h at room temperature and evaporated to dryness, and the residue was dissolved in water and ethyl acetate. The organic phase was concentrated and purified by chromatography, giving the product as a white solid in a 33% yield (36 mg). HPLC: <i>t</i><sub>R</sub> = 2.047 min. [M + H]<sup>+</sup> 473.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.57 (s, 1H), 8.68 (t, <i>J</i> = 6.4, 1H), 8.47 (t, <i>J</i> = 5.6, 1H), 7.77 (d, <i>J</i> = 2.0, 1H), 7.52 (dd, <i>J</i> = 8.9, 2.1, 1H), 7.42 (d, <i>J</i> = 8.9, 1H), 7.26 (dt, <i>J</i> = 8.7, 2.2, 1H), 7.23 (s, 1H), 7.14–7.10 (m, 1H), 7.09 (d, <i>J</i> = 2.0, 1H), 6.68 (s, 1H), 4.40 (dd, <i>J</i> = 15.8, 6.8, 1H), 4.26 (dd, <i>J</i> = 15.8, 6.0, 1H), 3.93–3.85 (m, 2H), 3.35–3.31 (m, 2H), 2.61 (dt, <i>J</i> = 12.2, 5.8, 1H), 2.14 (dt, <i>J</i> = 12.8, 7.5, 1H), 1.15 (t, <i>J</i> = 7.2, 3H). HRMS: calcd for C<sub>23</sub>H<sub>23</sub>ClFN<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 473.1386; found, 473.1396.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 5-[(<i>S</i>)-3-(3- Chloro-5-fluoro-benzylcarbamoyl)-3-hydroxy-2-oxo-pyrrolidin-1-yl]-1<i>H</i>-indole-2-carboxylic Acid (3-Amino-propyl)-amide (<b>19</b>)</h4><div class="NLM_p last">5-[(<i>S</i>)-3-(3-Chloro-5-fluoro-benzylcarbamoyl)-3-hydroxy-2-oxo-pyrrolidin-1-yl]-1<i>H</i>-indole-2-carboxylic acid (100 mg; 0.224 mmol) was dissolved in DMF (5 mL). NMM (0.1 mL; 0.91 mmol) and HATU (100 mg; 0.263 mmol) were added, and the mixture was stirred for 20 min at rt. This reaction mixture was dropped into a solution of propane-1,3-diamine (20 mg; 0.27 mmol) in 2 mL of DMF. The reaction was stirred for 2 h at 60 °C. The reaction mixture was evaporated, and the residue was partitioned between water and ethyl acetate. The organic phase was concentrated and purified by chromatography to give the title compound (30 mg; 26%) as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.70 (s, 1H), 8.73 (t, <i>J</i> = 5.8, 1H), 8.69 (t, <i>J</i> = 6.4, 1H), 8.36 (s, 1H), 7.79 (d, <i>J</i> = 2.1, 1H), 7.53 (dd, <i>J</i> = 8.9, 2.1, 1H), 7.43 (d, <i>J</i> = 8.9, 1H), 7.26 (dt, <i>J</i> = 8.7, 2.2, 1H), 7.24–7.20 (m, 1H), 7.14–7.10 (m, 2H), 4.40 (dd, <i>J</i> = 15.7, 6.8, 1H), 4.26 (dd, <i>J</i> = 15.8, 6.0, 1H), 3.93–3.85 (m, 2H), 3.38–3.33 (m, 2H), 2.82 (t, <i>J</i> = 7.3, 2H), 2.64–2.57 (m, 1H), 2.18–2.11 (m, 1H), 1.79 (p, <i>J</i> = 6.9, 2H).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Chemistry II</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> (<i>S</i>)-1-(1-Benzenesulfonyl-1<i>H</i>-indol-5-yl)-3-hydroxy-2-oxo-pyrrolidine-3-carboxylic Acid 3,5-Difluoro-benzylamide (<b>21</b>)</h4><div class="NLM_p last"><i>N</i>-[(3-Chloro-5-fluorophenyl)methyl]-1-(1<i>H</i>-indol-5-yl)-2-oxopyrrolidine-3-carboxamide (<b>20</b>, 1 equiv) was dissolved in THF (13 w/v) and stirred for 10 min at 25 ± 3 °C. This solution was cooled to −70 ± 3 °C, and NaHMDS (1.0 M in THF, 1.1 equiv) was added slowly, while maintaining the reaction temperature at −70 ± 3 °C. The reaction mass was warmed to −55 ± 3 °C and stirred for 1 h. Then the reaction mass was cooled to −70 ± 3 °C again, and a solution of Davis oxaziridine in THF (1.25 equiv in 1.75 w/v) was added slowly. The reaction mixture was warmed to −25 ± 3 °C and stirred for 1 h and 30 min. The reaction temperature was raised to −10 ± 5 °C after the completion of the reaction. Then the reaction mass was quenched with ice-cold water (4 w/v) and stirred for 10 min. The product was extracted with ethyl acetate (10 w/v), and the organic layer was washed with water. The aqueous layer was again re-extracted with ethyl acetate (2 × 5 w/v). The combined organic layer was washed with brine and dried over sodium sulfate. The organic layer was filtered and concentrated and again redissolved in DCM (1 w/v). The crude product was filtered through silica gel with ethyl acetate/heptane = 10:80. The pure fractions were concentrated, and the product was isolated by the addition of <i>n</i>-heptane, giving 13.8 kg (76.4%) of product.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> (<i>S</i>)-3-Hydroxy-1-(1<i>H</i>-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic Acid 3,5-Difluoro-benzylamide (<b>M8891</b>)</h4><div class="NLM_p last">To a suspension of (<i>S</i>)-1-(1-benzenesulfonyl-1<i>H</i>-indol-5-yl)-3-hydroxy-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide in THF sodium hydroxide are added pellets at 23–25 °C. The reaction mixture was stirred for 15 min and then heated to 48 ± 3 °C for 2 h. After completion of the reaction, the mixture was concentrated under reduced pressure at 40 ± 5 °C. After removal of all volatiles, the remainder was cooled to 25 ± 3 °C. Water (20 vol) was added slowly at 25 ± 3 °C. After completion of the water addition, the mass was stirred at 25 ± 3 °C for 1 h. The precipitate was filtered and washed with water (5 vol) and 1.5 N HCl (1–2 vol, running wash). For neutralization, the product was washed with water again (approximately 20–30 vol). The crude material was dried at 40 ± 3 °C (limit: water content NMT 5.0% w/w) and crystallized from ethyl acetate. The product was dried at 75° ± 5 °C.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Biological Assays</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Biochemical Activity Testing of MetAP-2</h4><div class="NLM_p last">MetAP-2 activity was determined by an enzyme-coupled assay using the tripeptide Met-Ala-Ser (MAS) as a substrate and recombinant human MetAP-2 (His-Tev- MetAP-2, prepared at Merck). The released methionine is converted by <span class="smallcaps smallerCapital">l</span>-amino acid oxidase (AAO) to oxidized methionine, and hydrogen peroxide is released. In the second step, horse radish peroxidase catalyzes the oxidation of the leuko dye dianisidine to oxidized dianisidine using hydrogen peroxide as a cosubstrate. The produced oxidized dianisidine was detected photometrically as an increase in absorbance at 450 nm. MetAP-2 activity was determined in the kinetic measurement mode. The release of one molecule methionine corresponds to the production of one molecule oxidized dianisidine. The MetAP-2 enzymatic activity directly corresponds to the increase in absorbance per time. In detail, the assay was performed in 384-well microtiter plate (Greiner 78110 MTP, transparent) in a total reaction volume of 50 μL at 22 °C; 0.35 μg of N-terminal His tag human rec MetAP-2 (prepared in-house, AA 2-478, final concentration (fc) 123 nM), 1 unit horse radish Peroxidase (Roche, Mannheim), 0.02 unit <span class="smallcaps smallerCapital">l</span>-amino acid oxidase (Merck, Darmstadt), and 0.6 mM dianisidine (Merck, Darmstadt, dissolved in 50 mM HCl, 10% DMSO) were incubated in the absence or presence of the test compound (10 dilution concentrations) in 100 mM Hepes, 50 mM NaCl, and 50 μM MnCl<sub>2</sub> at pH 7.0 for 15 min at 22 °C. The reaction was started by the addition of 500 μM (fc) MAS peptide (Merck, Darmstadt). After mixing, the first absorbance measurement was performed on an Envision multimode reader (Perkin–Elmer, Waltham) at a wavelength of 450 nm. The reaction was incubated at 22 °C for an additional 45 min, and the second absorbance measurement was performed. The increase of absorbance per time was determined. The control value used was the inhibitor-free reaction with 0.5% DMSO (fc). To define the pharmacological zero value, Fumagillin (Merck, Darmstadt) at a final concentration of 5 μM was used. The inhibitory values (IC<sub>50</sub>) were determined using the program Assay Analyzer from GeneData (Basel, Switzerland).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> HUVEC Proliferation Assay</h4><div class="NLM_p last">Proliferation of HUVEC primary endothelial cells was used as a cell-based assay.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Applying the CyQUANT Direct Cell Proliferation Assay (Invitrogen C35011), which is based on a cell-permeant fluorescent DNA-binding dye, DNA content is used as a direct measure for cell number. Pooled HUVEC cells (Promocell C-12203) were cultivated in a Promocell medium (cat no. C-22020) for 4 passages maximum. For the assay, 500 cells/well were seeded into black 384-well culture plates with a clear bottom in 70 μL of a culture medium and incubated for 6 h at 37 °C and 5% CO<sub>2</sub>. Ten μL of prediluted test compounds were added and cells incubated for 3 days at 37 °C and 5% CO<sub>2</sub> before measurement of DNA content. The CyQUANT detection reagent was prepared according to the manufacturers protocol, 20 μL/well added, and incubated at 37 °C with 5% CO<sub>2</sub> for at least 1 h before the measurement of the fluorescence with an Envision multimode reader (Perkin–Elmer, Waltham) with an excitation of 480 nm and an emission of 535 nm (bottom read mode). The assay was performed as a dose response with 10 dilution steps per compound. Inhibitory values (IC<sub>50</sub>) were determined using the program Assay Analyzer from GeneData (Basel, Switzerland).</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Material and Methods for the FCS or FCCS Investigations</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Cell Culture Conditions</h4><div class="NLM_p last">A549 and HEK293 cells were cultured in Dulbecco’s modified Eagle medium (DMEM) with high glucose (cat. no 41966-029; Gibco, U.K.) supplemented with 10% (v/v) fetal calf serum (cat. no. S0115; Biochrom, Berlin, Germany). HCT116 were cultured in MEM Eagle (cat. no. M2279, Sigma-Aldrich) supplemented with 10% (v/v) fetal calf serum (cat. no. S0115; Biochrom, Berlin, Germany) and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamin. Cells are grown at 5% CO<sub>2</sub> and 37 °C in a humidified incubator.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> Expression of GFP-MetAP-2</h4><div class="NLM_p last">The full-length protein of MetAP-2 was cloned as an N-terminal GFP fusion in mammalian expression vector pCGTO (a derivative of pcDNA3.1, Invitrogen, cat. no. V860-20) under the control of the TET promoter and expressed in HEK293 cells. Expression of the fusion protein was confirmed by fluorescence microscopy and Western blotting. Typically, HEK293 cells (5 × 10<sup>6</sup>) were transfected with 8 μg of plasmids encoding the GFP-tagged protein using the Nanofectin transfection kit (PAA, cat. no. Q051-005). Transfected cells were investigated microscopically or harvested 24 h after the transfection. During the harvest, the cells were washed twice with PBS, pelleted for 5 min at 1100<i>g</i>, and then frozen at −80 °C.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> Labeling of the Tracer Molecule</h4><div class="NLM_p last">Tool compound <b>19</b> was dissolved in DMSO and labeled via the reactive amino group to Dy647-Peg4 (Dyomics) utilizing a reactive NHS ester group. Labeling has been carried out in 100% DMSO overnight at room temperature on a head over tail incubator (Hybridization Oven 6/12 V UniEquip, Martinsried, Germany). The reaction was run under light protection conditions. The labeled compound was purified on a C18 10 μ reverse phase column. The ACN/H<sub>2</sub>O gradient was optimized, a gradient from 20% to 80% ACN, allowing separation of unlabeled and labeled compounds. The elution fractions containing a purified labeled compound were collected and predried in a vacuum concentrator and lyophilized overnight. The product was dissolved in DMSO and analyzed for concentration by spectrophotometry.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> Steady-State (Equilibrium) FCCS</h4><div class="NLM_p last">FCCS measurements (typically with a sample volume of 20 μL) were performed either with a ConfoCor2 FCS unit connected to an Axiovert 100 M equipped with a C-Apochromat 40× water immersion lens, NA 1.2 (Carl Zeiss, Jena, Germany) or with an Insight plate reader (Evotec Technologies, Hamburg, Germany) fitted with a U-Apo300 40× water immersion lens, NA 1.15 (Olympus, Germany). Both systems used a 633 helium–neon laser for excitation of Cy5, Atto647, or Dy647 dyes and the 488 nm laser line of an argon–ion laser to excite GFP or Atto488. At the ConfoCor2 instrument, the emitted fluorescent light was directed over an HFT 488/633 and an NFT 610 beam splitter to the Avalanche Photo Diodes (APD). Fluorescence in the green channel was detected using a BP500–550 band-pass filter, fluorescence in the red channel with a LP650. At the Insight instrument, the emitted light was split into two APD channels set with a HQ 535/50 band-pass filter for green fluorescence and 670DF40 band-pass filter for red fluorescence. Data analysis and the fit were carried out either in the ConfoCor2 software or with FCS+plus Analyze (Evotec technologies software). For calculating the target protein level and the equilibrium dissociation constant for a labeled ligand (KD) from the saturation binding data, we used a single-site binding model as described before.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> Competition Experiments</h4><div class="NLM_p last">IC<sub>50</sub> values were determined from inhibition binding data by using a previously described four-parameter logistic function.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The equilibrium dissociation constant for an inhibitor (inhibition constant <i>K</i><sub>I</sub>) was calculated by using the Cheng–Prusoff equation.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> FCCS in Kinetic Mode</h4><div class="NLM_p last">Assuming a simple one binding site model for the reversible interaction between receptor and ligand and only a negligible change in concentration of free ligand during the binding of fluorescent probe to its cognate receptor, the kinetics for the receptor interaction with a fluorescent probe was analyzed as described before.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> Competition Kinetics between a Fluorescent Probe and Unlabeled Ligand</h4><div class="NLM_p last">The kinetics parameters of unlabeled ligands were calculated based on the theoretical method developed by Motulsky and Mahan.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Following this method, a fluorescent probe with known binding kinetics was simultaneously coincubated with an unlabeled ligand in a competitive binding assay. The competitive binding kinetics of the fluorescent probe is dependent on both the concentration and kinetic parameters of the unlabeled competitor, and therefore, the experimentally derived rate of specific ligand binding can be fitted to provide the association and dissociation rates of the unlabeled ligand.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> Target Occupancy in Cells</h4><div class="NLM_p last">Cells were incubated with different concentrations of compounds for 4 h. As control cells were incubated with a corresponding amount of DMSO, cells were washed, harvested, lysed, and cleared from cellular debris by a quick centrifugation step. After the addition of the tracer molecule target occupancy was assessed by FCS measurements based on the binding state of the tracer molecule. Specificity of the signal was confirmed in a cell lysate, where the MetAP-2 transcript was degraded by the use of a specific siPOOL.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The absence of the protein was confirmed by Western blot (data not shown). A549 cells were grown to 80% confluency per cell culture dish (cat. no 83.3902; Sarsted, Nümbrecht, Germany) at 37 °C and 5% CO<sub>2</sub>. The test compounds were added to final concentrations of 3 μM, 300 nM, 30 nM, 3 nM, and 0 nM of the growth medium. After 4 h at 37 °C and 5% CO<sub>2</sub>, the dishes were placed on ice, and the cell layer was rinsed 2 times with 10 mL of cooled Dulbecco’s Phosphate Buffered Saline (PBS, cat. no. D8537; Sigma-Aldrich, Taufkirchen, Germany). Then 10 mL of cooled PBS was added to harvest the cells with a cell scraper and collect them into centrifugation tubes on ice. Cells were pelleted by centrifugation for 5 min at 1000<i>g</i> at 4 °C and frozen at −80 °C.</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> Efficacy Testing in Vivo</h4><div class="NLM_p">The human U87-MG cell line (derived from malignant glioma, ATCC: HTB-14) used was directly prepared from frozen cell batches for tumor cell inoculation. Cell vials were rapidly thawed at 37 °C. The cell suspension of all vials was transferred into a sterile 50 mL centrifuge tube (Falcon). The tube was filled with PBS (w/o Ca/Mg) up to 50 mL and mixed, and cell number and viability were measured with ViCell (Automated Cell Viability Analyzer; Beckman Coulter). The cell suspension was centrifuged for 5 min at 1000<i>g</i> and adjusted to 10 × 10<sup>6</sup> viable cells/mL using PBS (w/o Ca/Mg). Then, 100 μL of the cell suspension w as subcutaneously inoculated in the right flank of nude mice. In the present study, female CD-1 nude mice, aged 6–7 weeks, were used. CD-1 nude mice are an outbred strain provided by Charles River Laboratories (CRL), Sulzfeld, Germany. The mice were housed and maintained under aseptic conditions in facilities approved by the German Association for Accreditation of Laboratory Animal Care and in accordance with current regulations and standards of the German Animal Protection Law, and their use was approved by the local responsible authorities.</div><div class="NLM_p">For animal identification, all animals were individually identified using subcutaneously implanted electronic NONATEC transponders (Lutronic, Luxemburg). Implantation was performed on the back by a hypodermic needle (18 gauge) after sterilization of the skin with 70% alcohol. An electronic reader allowed the identification of each individual animal with the corresponding code number.</div><div class="NLM_p last">For the formulation, test compounds were dissolved in 0.5% Methocel/0.25% Tween 20 in Milli-Q water and stored at 4 °C. The compound solution was freshly prepared all 3–4 days. On treatment days, the solution was allowed to return to room temperature followed by per os administration of 200 μL per 20 g mouse. For tumor volume and body weight measurements and calculations, when the tumors had reached a mean tumor volume typically of 150–300 mm<sup>3</sup>, the animals were assigned to treatment groups (10 animals/group). Tumor length (<i>L</i>) and width (<i>W</i>) were measured twice weekly by calipers. The tumor volume was calculated using the formula <i>L</i> × <i>W</i><sup>2</sup>/2. Body weights were monitored twice weekly. All animal data were collected in an electronical data collection system. For the T/C-value, the effect of a treatment on tumor growth was assessed at the end of each study by calculating the % T/C value according to following formulas: % T/C (for mean values > 0) = [(end tumor volume treatment – start tumor volume treatment)/(end tumor volume control – start tumor volume control)] × 100]</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i102"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01070" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15635" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15635" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01070?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01070</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HPLC traces for all described compounds; measured HUVEC proliferation inhibition IC<sub>50</sub>, protein binding and with protein binding corrected IC<sub>50</sub>; FCCS experimental details and further results; Western blot analysis of cell lysates; FCS-based target occupancy assays discriminate MetAP-2 inhibitors in cells; pulse-chase experiment of <b>M8891</b> in HCT116 cells; additional information for the in vivo experiments (tumor volume of individual tumor bearing mice at the end of the study; U87-MG and Cacki-1 models; body weight changes during the 36 days of treatment in the Caki-1 model) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01070/suppl_file/jm9b01070_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01070/suppl_file/jm9b01070_si_009.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01070/suppl_file/jm9b01070_si_001.pdf">jm9b01070_si_001.pdf (2.22 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01070/suppl_file/jm9b01070_si_009.csv">jm9b01070_si_009.csv (2.1 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code for <b>1a</b>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QED">6QED</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b01070" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77338" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77338" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timo Heinrich</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9120-8410" title="Orcid link">http://orcid.org/0000-0001-9120-8410</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5125383c3e7f3934383f23383239113c3423323a36233e24217f323e3c"><span class="__cf_email__" data-cfemail="483c21252766202d21263a212b2008252d3a2b232f3a273d38662b2725">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeyaprakashnarayanan Seenisamy</span> - <span class="hlFld-Affiliation affiliation">Syngene
International Ltd., Biocon Park, Plots 2 and 3, Bommasandra-Jigani
Link Road, Bangalore 560
099, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Becker</span> - <span class="hlFld-Affiliation affiliation">Intana
Bioscience GmbH, Lochhamer
Str. 29a, D-82152 Planegg/Martinsried, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beatrix Blume</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jörg Bomke</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melanie Dietz</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Uwe Eckert</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manja Friese-Hamim</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jakub Gunera</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kerrin Hansen</span> - <span class="hlFld-Affiliation affiliation">Intana
Bioscience GmbH, Lochhamer
Str. 29a, D-82152 Planegg/Martinsried, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Birgitta Leuthner</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Djordje Musil</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jens Pfalzgraf</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Felix Rohdich</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Siegl</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dieter Spuck</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ansgar Wegener</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank T. Zenke</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.S., F.B., and F.R. contributed equally</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">vdW</td><td class="NLM_def"><p class="first last">van der Waals</p></td></tr><tr><td class="NLM_term">EHC</td><td class="NLM_def"><p class="first last">enterohepatic circulation</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>′-ethylcarbodiimid hydrochloride</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazol hydrate</p></td></tr><tr><td class="NLM_term"><i>o</i>-HATU</td><td class="NLM_def"><p class="first last">dimethylamino-([1,2,3]triazolo[4,5-<i>b</i>]pyridin-3-yloxy)-methylene]-dimethylammonium hexafluoro phosphate</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>o</i>-(7-azabenzotrial-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">NaHMDS</td><td class="NLM_def"><p class="first last">sodium bis(trimethyl)amid</p></td></tr><tr><td class="NLM_term">T3P</td><td class="NLM_def"><p class="first last">2,4,6-tripropyl-[1,3,5,2,4,6]trioxatriphosphinane 2,4,6-trioxide</p></td></tr><tr><td class="NLM_term">FCCS</td><td class="NLM_def"><p class="first last">fluorescence cross-correlation spectroscopy</p></td></tr><tr><td class="NLM_term">FCS</td><td class="NLM_def"><p class="first last">fluorescence correlation spectroscopy</p></td></tr><tr><td class="NLM_term">Davis oxaziridine</td><td class="NLM_def"><p class="first last">(+)-(2<i>R</i>,4a<i>S</i>,7<i>S</i>,8a<i>R</i>)-4<i>H</i>-4a, 7-methanooxazirino[3, 2-<i>i</i>] [2,1]benzisothiazole, 8,8-dichlorotetrahydro-9,9-dimethyl-3,3-dioxide at −70 °C gave 1-[1-(benzenesulfonyl)-1<i>H</i>-indol-5-yl]-<i>N</i>-[(3-chloro-5-fluorophenyl)methyl]-3-hydroxy-2-oxopyrrolidine-3-carboxamide</p></td></tr><tr><td class="NLM_term">ee</td><td class="NLM_def"><p class="first last">enantiomeric excess</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i106">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53658" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53658" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folkman, J.</span></span> <span> </span><span class="NLM_article-title">Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">1070</span>– <span class="NLM_lpage">1076</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(91)91529-L</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1016%2F0006-291X%2891%2991529-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1705118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADyaK3MXhvF2lsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=1991&pages=1070-1076&author=M.+Kusakaauthor=K.+Sudoauthor=T.+Fujitaauthor=S.+Maruiauthor=F.+Itohauthor=D.+Ingberauthor=J.+Folkman&title=Potent+anti-angiogenic+action+of+AGM-1470%3A+comparison+to+the+fumagillin+parent&doi=10.1016%2F0006-291X%2891%2991529-L"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Potent antiangiogenic action of AGM-1470: comparison with the fumagillin parent</span></div><div class="casAuthors">Kusaka, Masami; Sudo, Katsuichi; Fujita, Takeshi; Marui, Shogo; Itoh, Fumio; Ingber, Donald; Folkman, Judah</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1070-6</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The antiangiogenic activity of AGM-1470 (I), a new synthetic analog of fumagillin isolated from Aspergillus fumigatus, was extensively examd. both in vitro and in vivo using 4 different types of assay and compared to that of fumagillin.  Locally administered I inhibited angiogenesis in the chick embryo chorioallantoic membrane assay and the rat corneal assay.  In the rat sponge implantation assay, systemically administered I inhibited angiogenesis induced by basic fibroblast growth factor.  Furthermore, in the rat blood vessel organ culture assay, I (1-1,000 ng/mL) was found to inhibit selectively the capillary-like tube formation of endothelial cells with a minimal effect on the non-endothelial cell growth.  I showed more potent antiangiogenic activity and less toxicity than the fumagillin parent.  Therefore, I is more active than the fumagillin parent as an antiangiogenic compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4mFTU7gDP_rVg90H21EOLACvtfcHk0lh5MDZxPSd_9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhvF2lsL4%253D&md5=5de7ce6f7523ce14abde38a91a93c24d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2891%2991529-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252891%252991529-L%26sid%3Dliteratum%253Aachs%26aulast%3DKusaka%26aufirst%3DM.%26aulast%3DSudo%26aufirst%3DK.%26aulast%3DFujita%26aufirst%3DT.%26aulast%3DMarui%26aufirst%3DS.%26aulast%3DItoh%26aufirst%3DF.%26aulast%3DIngber%26aufirst%3DD.%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DPotent%2520anti-angiogenic%2520action%2520of%2520AGM-1470%253A%2520comparison%2520to%2520the%2520fumagillin%2520parent%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1991%26volume%3D174%26spage%3D1070%26epage%3D1076%26doi%3D10.1016%2F0006-291X%2891%2991529-L" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagoya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, S.</span></span> <span> </span><span class="NLM_article-title">TNP-470 suppresses the tumorigenicity of HT1080 fibrosarcoma tumor through the inhibition of VEGF secretion from the tumor cells</span>. <i>Sarcoma</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1080/13577140120099182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1080%2F13577140120099182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=18521314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD38XovV2luw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2001&pages=197-202&author=M.+Kayaauthor=T.+Wadaauthor=S.+Nagoyaauthor=S.+Kawaguchiauthor=T.+Yamashitaauthor=N.+Yamamotoauthor=M.+Yoshimotoauthor=F.+Okadaauthor=S.+Ishii&title=TNP-470+suppresses+the+tumorigenicity+of+HT1080+fibrosarcoma+tumor+through+the+inhibition+of+VEGF+secretion+from+the+tumor+cells&doi=10.1080%2F13577140120099182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">TNP-470 suppresses the tumorigenicity of HT1080 fibrosarcoma tumor through the inhibition of VEGF secretion from the tumor cells</span></div><div class="casAuthors">Kaya, Mitsunori; Wada, Takuro; Nagoya, Satoshi; Kawaguchi, Satoshi; Yamashita, Toshihiko; Yamamoto, Nobuyuki; Yoshimoto, Mitsunori; Okada, Futoshi; Ishii, Seiichi</div><div class="citationInfo"><span class="NLM_cas:title">Sarcoma</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">197-202</span>CODEN:
                <span class="NLM_cas:coden">SARCFO</span>;
        ISSN:<span class="NLM_cas:issn">1357-714X</span>.
    
            (<span class="NLM_cas:orgname">Carfax Publishing</span>)
        </div><div class="casAbstract">The effects of the fumagillin analog TNP-470 (an angiogenesis inhibitor) on human fibrosarcoma cells were assessed in vivo (in mice implanted with the cells) and in vitro.  TNP-470 suppressed the tumorigenicity of HT1080 fibrosarcoma.  The conditioned medium from HT1080 fibrosarcoma cells treated with TNP-470 inhibited the proliferation and migration of the human endothelial cell lines HUVEC and ECV304.  The concn. of vascular endothelial growth factor (VEGF) in the conditioned medium from HT1080 cells treated with TNP-470 was lower than that in the medium of cells without TNP-470 treatment, indicating that TNP-470 downregulates the secretion of VEGF from HT1080 cells.  These findings strongly suggest that the direct action of TNP-470 on sarcoma cells inhibits angiogenesis through the downregulation of VEGF secretion and that this angiogenesis suppression resulted in the inhibition of tumorigenicity of HT1080 fibrosarcoma tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo83pPc7cn2P7Vg90H21EOLACvtfcHk0li64ff6choMaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovV2luw%253D%253D&md5=da26c6e09e82c93c8e0a0a465b3a4276</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1080%2F13577140120099182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13577140120099182%26sid%3Dliteratum%253Aachs%26aulast%3DKaya%26aufirst%3DM.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DNagoya%26aufirst%3DS.%26aulast%3DKawaguchi%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DYoshimoto%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DF.%26aulast%3DIshii%26aufirst%3DS.%26atitle%3DTNP-470%2520suppresses%2520the%2520tumorigenicity%2520of%2520HT1080%2520fibrosarcoma%2520tumor%2520through%2520the%2520inhibition%2520of%2520VEGF%2520secretion%2520from%2520the%2520tumor%2520cells%26jtitle%3DSarcoma%26date%3D2001%26volume%3D5%26spage%3D197%26epage%3D202%26doi%3D10.1080%2F13577140120099182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, J. P.</span></span> <span> </span><span class="NLM_article-title">Antiangiogenic drug design: Multiple pathways targeting tumor vasculature</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">849</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.2174/092986706776361085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.2174%2F092986706776361085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=16611071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD28XislygsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=849-862&author=H.+Zhongauthor=J.+P.+Bowen&title=Antiangiogenic+drug+design%3A+Multiple+pathways+targeting+tumor+vasculature&doi=10.2174%2F092986706776361085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenesis drug design: multiple pathways targeting tumor vasculature</span></div><div class="casAuthors">Zhong, Haizhen; Bowen, J. Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">849-862</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The initiation, growth, and development of new blood vessels through angiogenesis are essential for tumor growth.  Tumor masses require access to blood vessels for a sufficient supply of oxygen and nutrients to maintain growth and metastasis.  Inhibiting tumor blood vessel formation as proposed by Judah Folkman in the early 1970s, therefore, offers promising therapeutic approaches for treating tumor-afflicted patients.  The blood vessel growth in normal tissues is regulated though a delicate and complex balance between the collective action of proangiogenic factors (e.g., vascular endothelial growth factor, VEGF) and the collective action of angiogenic inhibitors (e.g., thrombospondin-1).  In pathol. angiogenesis, the angiogenic switch is shifted toward the proangiogenic factors, and if the imbalance continues, irregular tumor vessel growth is the result.  Despite intense research, the mechanism of the angiogenic switch is not fully understood.  Many factors, however, have been shown to be involved in regulating the equil. between angiogenic stimulants and inhibitors.  VEGFR tyrosine kinase, methionine aminopeptidase-2 (MetAP-2), p53, tubulin, cyclooxygenase-2 (COX-2), and matrix metalloproteinases (MMPs) all directly and(or) indirectly influence the angiogenic switch.  This review describes some of the advances in inhibitor design and the mechanisms of action for the aforementioned factors (targets) involved in angiogenesis regulation.  The discussion reveals that a diaryl group sepd. by various connecting modules is one of the most common features for antiangiogenesis drug design.  This idea has been a working pharmacophore hypothesis for the authors' own antiangiogenic drug design endeavors over the years.  The recent advances of combination therapy (angiogenesis inhibitors with other chemotherapy/radiation) are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtcsYwFJZe2bVg90H21EOLACvtfcHk0li64ff6choMaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislygsLc%253D&md5=c4ffce6ecc6ba18ea160ef93c7b542f1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F092986706776361085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706776361085%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DBowen%26aufirst%3DJ.%2BP.%26atitle%3DAntiangiogenic%2520drug%2520design%253A%2520Multiple%2520pathways%2520targeting%2520tumor%2520vasculature%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D849%26epage%3D862%26doi%3D10.2174%2F092986706776361085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-P.</span></span> <span> </span><span class="NLM_article-title">The development of MetAP-2 inhibitors in Cancer Treatment</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1021</span>– <span class="NLM_lpage">1035</span>, <span class="refDoi"> DOI: 10.2174/092986712799320709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.2174%2F092986712799320709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=22229417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1021-1035&author=S.-Q.+Yinauthor=J.-J.+Wangauthor=C.-M.+Zhangauthor=Z.-P.+Liu&title=The+development+of+MetAP-2+inhibitors+in+Cancer+Treatment&doi=10.2174%2F092986712799320709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The development of MetAP-2 inhibitors in cancer treatment</span></div><div class="casAuthors">Yin, S.-Q.; Wang, J.-J.; Zhang, C.-M.; Liu, Z.-P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1021-1035</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Methionine aminopeptidases (MetAPs), which remove methionine residue from newly synthesized polypeptide chains, are a class of metalloproteases ubiquitously distributed in both eukaryotes and prokaryotes.  MetAP-2 inhibition can induce G1 cell cycle arrest, cytostasis in tumor cells in vitro and inhibition of tumor growth in vivo.  The discovery of fumagillin with potent antiangiogenic and antiproliferative activities promoted the development of fumagillin analogs as a novel class of anticancer agents.  Early drug discovery efforts have focused on analogs of fumagillin, which irreversibly inhibit MetAP-2 through covalent modification of an epoxide.  Several fumagillin analogs, like CKD-732, TNP-470, and PPI-2458, were found to be potent selective inhibitors of MetAP-2 (proteolytic activity) and endothelial cell proliferation.  Further, they have entered in clin. trials for the treatment of different types of tumors.  Recently, attention was paid to reversible human MetAP-2 inhibitors, such as bengamides, 2-hydroxy-3-aminoamides, anthranilic acid sulfonamides, and triazole analogs, which have demonstrated their potential to inhibit angiogenesis and tumor growth in vivo as well.  This review article mainly discussed the development of MetAP-2 inhibitors in cancer therapy and also summarized their structure-activity relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9_jcycw6lErVg90H21EOLACvtfcHk0li64ff6choMaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSqtro%253D&md5=6bd1db81df9913ecd2b4cf14f3567677</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F092986712799320709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712799320709%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DS.-Q.%26aulast%3DWang%26aufirst%3DJ.-J.%26aulast%3DZhang%26aufirst%3DC.-M.%26aulast%3DLiu%26aufirst%3DZ.-P.%26atitle%3DThe%2520development%2520of%2520MetAP-2%2520inhibitors%2520in%2520Cancer%2520Treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D1021%26epage%3D1035%26doi%3D10.2174%2F092986712799320709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, F. D.</span></span> <span> </span><span class="NLM_article-title">TNP-470: An angiogenesis inhibitor in clinical development for cancer</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1383</span>– <span class="NLM_lpage">1396</span>, <span class="refDoi"> DOI: 10.1517/13543784.9.6.1383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1517%2F13543784.9.6.1383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=11060750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktFWjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=1383-1396&author=E.+A.+Krugerauthor=F.+D.+Figg&title=TNP-470%3A+An+angiogenesis+inhibitor+in+clinical+development+for+cancer&doi=10.1517%2F13543784.9.6.1383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">TNP-470: an angiogenesis inhibitor in clinical development for cancer</span></div><div class="casAuthors">Kruger, Erwin A.; Figg, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1383-1396</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 100 refs.  TNP-470, an analog of fumagillin, has been shown to inhibit angiogenesis in vitro and in vivo.  In 1992, TNP-470 entered clin. development for cancer as an anti-angiogenic agent.  It is currently in Phase I/II trials in Kaposi's sarcoma, renal cell carcinoma, brain cancer, breast cancer, cervical cancer and prostate cancer.  Terminal half-life values are short and have shown intermittent and intrapatient variation (range: 0.05 - 1.07 h).  Recently, mechanistic studies have identified cell cycle mediators and the protein methionine aminopeptidase-2 (MetAP-2) as mol. targets of TNP-470 and fumagillin.  In early clin. reports, TNP-470 is tolerated up to 177 mg/m2 with neurotoxic effects (fatigue, vertigo, ataxia, and loss of concn.) being the principal dose limiting toxicity (DLT).  Animal studies confirm some toxic effects on normal angiogenic processes such as the female reproductive system and wound healing, which will require caution and close monitoring in the clinic.  TNP-470 is one of the first anti-angiogenic compds. to enter clin. trials, making it a valuable prototype for future trials of angiogenesis inhibitors in oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6wwOg1czqDbVg90H21EOLACvtfcHk0li64ff6choMaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktFWjsb4%253D&md5=9963aa3a5d14aaccbbb22a8c4bfdd85f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543784.9.6.1383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.9.6.1383%26sid%3Dliteratum%253Aachs%26aulast%3DKruger%26aufirst%3DE.%2BA.%26aulast%3DFigg%26aufirst%3DF.%2BD.%26atitle%3DTNP-470%253A%2520An%2520angiogenesis%2520inhibitor%2520in%2520clinical%2520development%2520for%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2000%26volume%3D9%26spage%3D1383%26epage%3D1396%26doi%3D10.1517%2F13543784.9.6.1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BaMaung, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker-Garia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morowitz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shusterman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maris, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniewski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span> <span> </span><span class="NLM_article-title">Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">7861</span>– <span class="NLM_lpage">7869</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7861-7869&author=J.+Wangauthor=G.+S.+Sheppardauthor=P.+Louauthor=M.+Kawaiauthor=N.+BaMaungauthor=S.+A.+Ericksonauthor=L.+Tucker-Gariaauthor=C.+Parkauthor=J.+Bouskaauthor=Y.+C.+Wangauthor=D.+Frostauthor=P.+Tapangauthor=D.+H.+Albertauthor=S.+J.+Morganauthor=M.+Morowitzauthor=S.+Shustermanauthor=J.+M.+Marisauthor=R.+Lesniewskiauthor=J.+Henkin&title=Tumor+suppression+by+a+rationally+designed+reversible+inhibitor+of+methionine+aminopeptidase-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DBaMaung%26aufirst%3DN.%26aulast%3DErickson%26aufirst%3DS.%2BA.%26aulast%3DTucker-Garia%26aufirst%3DL.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DBouska%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DFrost%26aufirst%3DD.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DMorgan%26aufirst%3DS.%2BJ.%26aulast%3DMorowitz%26aufirst%3DM.%26aulast%3DShusterman%26aufirst%3DS.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DLesniewski%26aufirst%3DR.%26aulast%3DHenkin%26aufirst%3DJ.%26atitle%3DTumor%2520suppression%2520by%2520a%2520rationally%2520designed%2520reversible%2520inhibitor%2520of%2520methionine%2520aminopeptidase-2%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D22%26spage%3D7861%26epage%3D7869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenney, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, P.</span></span> <span> </span><span class="NLM_article-title">The bengamides: A mini-review of natural sources, analogues, biological properties, biosynthetic origins, and future prospects</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">740</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.6b00970</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.6b00970" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlGksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=740-755&author=K.+N.+Whiteauthor=K.+Tenneyauthor=P.+Crews&title=The+bengamides%3A+A+mini-review+of+natural+sources%2C+analogues%2C+biological+properties%2C+biosynthetic+origins%2C+and+future+prospects&doi=10.1021%2Facs.jnatprod.6b00970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Bengamides: A Mini-Review of Natural Sources, Analogues, Biological Properties, Biosynthetic Origins, and Future Prospects</span></div><div class="casAuthors">White, Kimberly N.; Tenney, Karen; Crews, Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">740-755</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  This review focuses entirely on the natural bengamides and selected synthetic analogs that have inspired decades of research.  Bengamide A was first reported in 1986 from the sponge Jaspis cf. coriacea, and bengamide-contg. sponges have been gathered from many biogeog. sites.  In 2005, a terrestrial Gram-neg. bacterium, Myxococcus virescens, was added as a source for bengamides.  Biol. activity data using varying bengamide-based scaffolds has enabled fine-tuning of structure-activity relationships.  Mol. target finding contributed to the creation of a synthetic "lead" compd., LAF389, that was the subject of a phase I anticancer clin. trial.  Despite clin. trial termination, the bengamide compd. class is still attracting worldwide attention.  Future breakthroughs based on the bengamide scaffold are possible and could build on their nanomolar in vitro and pos. in vivo antiproliferative and antiangiogenic properties.  Bengamide mol. targets include methionine aminopeptidases (MetAP1 and MetAP2) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB).  A mixed PKS/NRPS biosynthetic gene cluster appears to be responsible for creation of the bengamides.  This review highlights that the bengamides have driven inspirational studies and that they will remain relevant for future research, even 30 years after the discovery of the first structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo05ZANtPfNc7Vg90H21EOLACvtfcHk0lh_nI04r-jTyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlGksLY%253D&md5=99921eaff0fdbd23dcba1d9289856c4c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.6b00970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.6b00970%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DK.%2BN.%26aulast%3DTenney%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DP.%26atitle%3DThe%2520bengamides%253A%2520A%2520mini-review%2520of%2520natural%2520sources%252C%2520analogues%252C%2520biological%2520properties%252C%2520biosynthetic%2520origins%252C%2520and%2520future%2520prospects%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2017%26volume%3D80%26spage%3D740%26epage%3D755%26doi%3D10.1021%2Facs.jnatprod.6b00970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidanze, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BaMaung, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedrow, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolaczkowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantei, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palazzo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker-Garcia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniewski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidsen, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. L.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: A structural basis for the reduction of albumin binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3832</span>– <span class="NLM_lpage">3849</span>, <span class="refDoi"> DOI: 10.1021/jm0601001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0601001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFent74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3832-3849&author=G.+S.+Sheppardauthor=J.+Wangauthor=M.+Kawaiauthor=S.+D.+Fidanzeauthor=N.+Y.+BaMaungauthor=S.+A.+Ericksonauthor=D.+M.+Barnesauthor=J.+S.+Tedrowauthor=L.+Kolaczkowskiauthor=A.+Vasudevanauthor=D.+C.+Parkauthor=G.+T.+Wangauthor=W.+J.+Sandersauthor=R.+A.+Manteiauthor=F.+Palazzoauthor=L.+Tucker-Garciaauthor=P.+Louauthor=Q.+Zhangauthor=C.+H.+Parkauthor=K.+H.+Kimauthor=A.+Petrosauthor=E.+Olejniczakauthor=D.+Nettesheimauthor=P.+Hajdukauthor=J.+Henkinauthor=R.+Lesniewskiauthor=S.+K.+Davidsenauthor=R.+L.+Bell&title=Discovery+and+optimization+of+anthranilic+acid+sulfonamides+as+inhibitors+of+methionine+aminopeptidase-2%3A+A+structural+basis+for+the+reduction+of+albumin+binding&doi=10.1021%2Fjm0601001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Anthranilic Acid Sulfonamides as Inhibitors of Methionine Aminopeptidase-2: A Structural Basis for the Reduction of Albumin Binding</span></div><div class="casAuthors">Sheppard, George S.; Wang, Jieyi; Kawai, Megumi; Fidanze, Steve D.; BaMaung, Nwe Y.; Erickson, Scott A.; Barnes, David M.; Tedrow, Jason S.; Kolaczkowski, Lawrence; Vasudevan, Anil; Park, David C.; Wang, Gary T.; Sanders, William J.; Mantei, Robert A.; Palazzo, Fabio; Tucker-Garcia, Lora; Lou, Pingping; Zhang, Qian; Park, Chang H.; Kim, Ki H.; Petros, Andrew; Olejniczak, Edward; Nettesheim, David; Hajduk, Phillip; Henkin, Jack; Lesniewski, Richard; Davidsen, Steven K.; Bell, Randy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3832-3849</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methionine aminopeptidase-2 (MetAP2) is a novel target for cancer therapy.  As part of an effort to discover orally active reversible inhibitors of MetAP2, a series of anthranilic acid sulfonamides with micromolar affinities for human MetAP2 were identified using affinity selection by mass spectrometry (ASMS) screening.  These micromolar hits were rapidly improved to nanomolar leads on the basis of insights from protein crystallog.; however, the compds. displayed extensive binding to human serum albumin and had limited activity in cellular assays.  Modifications based on structural information on the binding of lead compds. to both MetAP2 and domain III of albumin allowed the identification of compds. with significant improvements in both parameters, which showed good cellular activity in both proliferation and methionine processing assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogG0eQ-sDeVrVg90H21EOLACvtfcHk0lh_nI04r-jTyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFent74%253D&md5=3d1a68c7397d9483647b0e099f3885cc</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm0601001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601001%26sid%3Dliteratum%253Aachs%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26aulast%3DBaMaung%26aufirst%3DN.%2BY.%26aulast%3DErickson%26aufirst%3DS.%2BA.%26aulast%3DBarnes%26aufirst%3DD.%2BM.%26aulast%3DTedrow%26aufirst%3DJ.%2BS.%26aulast%3DKolaczkowski%26aufirst%3DL.%26aulast%3DVasudevan%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DG.%2BT.%26aulast%3DSanders%26aufirst%3DW.%2BJ.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DPalazzo%26aufirst%3DF.%26aulast%3DTucker-Garcia%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DPetros%26aufirst%3DA.%26aulast%3DOlejniczak%26aufirst%3DE.%26aulast%3DNettesheim%26aufirst%3DD.%26aulast%3DHajduk%26aufirst%3DP.%26aulast%3DHenkin%26aufirst%3DJ.%26aulast%3DLesniewski%26aufirst%3DR.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DBell%26aufirst%3DR.%2BL.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520anthranilic%2520acid%2520sulfonamides%2520as%2520inhibitors%2520of%2520methionine%2520aminopeptidase-2%253A%2520A%2520structural%2520basis%2520for%2520the%2520reduction%2520of%2520albumin%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3832%26epage%3D3849%26doi%3D10.1021%2Fjm0601001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marino, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattern, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomazek, T. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S. K.</span></span> <span> </span><span class="NLM_article-title">Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3777</span>– <span class="NLM_lpage">3785</span>, <span class="refDoi"> DOI: 10.1021/jm061182w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061182w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslGqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3777-3785&author=J.+P.+Marinoauthor=P.+W.+Fisherauthor=G.+A.+Hofmannauthor=R.+B.+Kirkpatrickauthor=C.+A.+Jansonauthor=R.+K.+Johnsonauthor=C.+Maauthor=M.+Matternauthor=T.+D.+Meekauthor=M.+D.+Ryanauthor=C.+Schulzauthor=W.+W.+Smithauthor=D.+G.+Tewauthor=T.+A.+Tomazekauthor=D.+F.+Veberauthor=W.+C.+Xiongauthor=Y.+Yamamotoauthor=K.+Yamashitaauthor=G.+Yangauthor=S.+K.+Thompson&title=Highly+potent+inhibitors+of+methionine+aminopeptidase-2+based+on+a+1%2C2%2C4-triazole+pharmacophore&doi=10.1021%2Fjm061182w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent Inhibitors of Methionine Aminopeptidase-2 Based on a 1,2,4-Triazole Pharmacophore</span></div><div class="casAuthors">Marino, Joseph P., Jr.; Fisher, Paul W.; Hofmann, Glenn A.; Kirkpatrick, Robert B.; Janson, Cheryl A.; Johnson, Randall K.; Ma, Chun; Mattern, Michael; Meek, Thomas D.; Ryan, M. Dominic; Schulz, Christina; Smith, Ward W.; Tew, David G.; Tomazek, Thaddeus A., Jr.; Veber, Daniel F.; Xiong, Wenfang C.; Yamamoto, Yuuichi; Yamashita, Keizo; Yang, Guang; Thompson, Scott K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3777-3785</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High-throughput screening for inhibitors of the human metalloprotease, methionine aminopeptidase-2 (MetAP2), identified a potent class of 3-anilino-5-benzylthio-1,2,4-triazole compds.  Efficient array and interative synthesis of triazoles led to rapid SAR development around the aniline, benzylthio, and triazole moieties.  Evaluation of these analogs in a human MetAP2 enzyme assay led to the identification of several inhibitors with potencies in the 50-100 picomolar range.  The deleterious effects on inhibitor potency by methylation of the anilino-triazole nitrogens, as well as the X-ray crystal structure of triazole I bound in the active site of MetAP2, confirm the key interactions between the triazole nitrogens, the active site cobalt atoms, and the His-231 side-chain.  The structure has also provided a rationale for interpreting SAR within the triazole series.  Key aniline (2-isopropylphenyl) and sulfur substituents (furanylmethyl) identified in the SAR studies led to the identification of potent inhibitors (II and III) of endothelial cell proliferation.  Triazoles II and III also exhibited dose-dependent activity in an aortic ring tissue model of angiogenesis highlighting the potential utility of MetAP2 inhibitors as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ4trPzfxMH7Vg90H21EOLACvtfcHk0liDxmhWkTWWng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslGqt7Y%253D&md5=4a598306bdc2c1f4d78f813029a6f557</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm061182w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061182w%26sid%3Dliteratum%253Aachs%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DFisher%26aufirst%3DP.%2BW.%26aulast%3DHofmann%26aufirst%3DG.%2BA.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DR.%2BK.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DMattern%26aufirst%3DM.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DRyan%26aufirst%3DM.%2BD.%26aulast%3DSchulz%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DTomazek%26aufirst%3DT.%2BA.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DXiong%26aufirst%3DW.%2BC.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DThompson%26aufirst%3DS.%2BK.%26atitle%3DHighly%2520potent%2520inhibitors%2520of%2520methionine%2520aminopeptidase-2%2520based%2520on%2520a%25201%252C2%252C4-triazole%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3777%26epage%3D3785%26doi%3D10.1021%2Fjm061182w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cezanne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bomke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friese-Hamim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knochel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, F.</span></span> <span> </span><span class="NLM_article-title">Novel reversible methionine aminopeptidase-2 (MetAP-2) inhibitors based on purine and related bicyclic templates</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1016%2Fj.bmcl.2016.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=27998678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFamtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=551-556&author=T.+Heinrichauthor=H.-P.+Buchstallerauthor=B.+Cezanneauthor=F.+Rohdichauthor=J.+Bomkeauthor=M.+Friese-Hamimauthor=M.+Krierauthor=T.+Knochelauthor=D.+Musilauthor=B.+Leuthnerauthor=F.+Zenke&title=Novel+reversible+methionine+aminopeptidase-2+%28MetAP-2%29+inhibitors+based+on+purine+and+related+bicyclic+templates&doi=10.1016%2Fj.bmcl.2016.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Novel reversible methionine aminopeptidase-2 (MetAP-2) inhibitors based on purine and related bicyclic templates</span></div><div class="casAuthors">Heinrich, Timo; Buchstaller, Hans-Peter; Cezanne, Bertram; Rohdich, Felix; Bomke, Joerg; Friese-Hamim, Manja; Krier, Mireille; Knoechel, Thorsten; Musil, Djordje; Leuthner, Birgitta; Zenke, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">551-556</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The natural product fumagillin 1 and derivs. like TNP-470 2 or beloranib 3 bind to methionine aminopeptidase 2 (MetAP-2) irreversibly.  This enzyme is crit. for protein maturation and plays a key role in angiogenesis.  In this paper we describe the synthesis, MetAP-2 binding affinity and structural anal. of reversible MetAP-2 inhibitors.  Optimization of enzymic activity of screening hit 10 (IC50: 1 μM) led to the most potent compd. 27 (IC50: 0.038 μM), with a concomitant improvement in LLE from 2.1 to 4.2.  Structural anal. of these MetAP-2 inhibitors revealed an unprecedented conformation of the His339 side-chain imidazole ring being co-planar sandwiched between the imidazole of His331 and the aryl-ether moiety, which is bound to the purine scaffold.  Systematic alteration and redn. of H-bonding capability of this metal binding moiety induced an unexpected 180° flip for the triazolo[1,5-a]pyrimdine bicyclic template.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_0XQ7H4uUXLVg90H21EOLACvtfcHk0liDxmhWkTWWng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFamtLrN&md5=fb10c549d94343a4cc37da474b609b65</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DBuchstaller%26aufirst%3DH.-P.%26aulast%3DCezanne%26aufirst%3DB.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DBomke%26aufirst%3DJ.%26aulast%3DFriese-Hamim%26aufirst%3DM.%26aulast%3DKrier%26aufirst%3DM.%26aulast%3DKnochel%26aufirst%3DT.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DZenke%26aufirst%3DF.%26atitle%3DNovel%2520reversible%2520methionine%2520aminopeptidase-2%2520%2528MetAP-2%2529%2520inhibitors%2520based%2520on%2520purine%2520and%2520related%2520bicyclic%2520templates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D551%26epage%3D556%26doi%3D10.1016%2Fj.bmcl.2016.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniewski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span> <span> </span><span class="NLM_article-title">Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">5035</span>– <span class="NLM_lpage">5042</span>, <span class="refDoi"> DOI: 10.1021/bi020670c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi020670c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislSitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=5035-5042&author=J.+Wangauthor=G.+S.+Sheppardauthor=P.+Louauthor=M.+Kawaiauthor=C.+Parkauthor=D.+A.+Eganauthor=A.+Schneiderauthor=J.+Bouskaauthor=R.+Lesniewskiauthor=J.+Henkin&title=Physiologically+relevant+metal+cofactor+for+methionine+aminopeptidase-2+is+manganese&doi=10.1021%2Fbi020670c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Physiologically Relevant Metal Cofactor for Methionine Aminopeptidase-2 Is Manganese</span></div><div class="casAuthors">Wang, Jieyi; Sheppard, George S.; Lou, Pingping; Kawai, Megumi; Park, Chang; Egan, David A.; Schneider, Andrew; Bouska, Jennifer; Lesniewski, Rick; Henkin, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5035-5042</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identity of the physiol. metal cofactor for human methionine aminopeptidase-2 (MetAP2) has not been established.  To examine this question, we first investigated the effect of eight divalent metal ions, including Ca2+, Co2+, Cu2+, Fe2+, Mg2+, Mn2+, Ni2+, and Zn2+, on recombinant human methionine aminopeptidase apoenzymes in releasing N-terminal methionine from three peptide substrates: MAS, MGAQFSKT, and 3H-MASK(biotin)G.  The activity of MetAP2 on either MAS or MGAQFSKT was enhanced 15-25-fold by Co2+ or Mn2+ metal ions in a broad concn. range (1-1000 μM).  In the presence of reduced glutathione to mimic the cellular environment, Co2+ and Mn2+ were also the best stimulators (∼30-fold) for MetAP2 enzyme activity.  To det. which metal ion is physiol. relevant, we then tested inhibition of intracellular MetAP2 with synthetic inhibitors selective for MetAP2 with different metal cofactors.  A-310840 below 10 μM did not inhibit the activity of MetAP2-Mn2+ but was very potent against MetAP2 with other metal ions including Co2+, Fe2+, Ni2+, and Zn2+ in the in vitro enzyme assays.  In contrast, A-311263 inhibited MetAP2 with Mn2+, as well as Co2+, Fe2+, Ni2+, and Zn2+.  In cell culture assays, A-310840 did not inhibit intracellular MetAP2 enzyme activity and did not inhibit cell proliferation despite its ability to permeate and accumulate in cytosol, while A-311263 inhibited both intracellular MetAP2 and proliferation in a similar concn. range, indicating cellular MetAP2 is functioning as a manganese enzyme but not as a cobalt, zinc, iron, or nickel enzyme.  We conclude that MetAP2 is a manganese enzyme and that therapeutic MetAP2 inhibitors should inhibit MetAP2-Mn2+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnOVJL9uJhw7Vg90H21EOLACvtfcHk0ljcGZjtU0oXgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislSitrY%253D&md5=cb8ddc7017dc11f1327a0d83fcb2d417</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi020670c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi020670c%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DEgan%26aufirst%3DD.%2BA.%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DBouska%26aufirst%3DJ.%26aulast%3DLesniewski%26aufirst%3DR.%26aulast%3DHenkin%26aufirst%3DJ.%26atitle%3DPhysiologically%2520relevant%2520metal%2520cofactor%2520for%2520methionine%2520aminopeptidase-2%2520is%2520manganese%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26spage%3D5035%26epage%3D5042%26doi%3D10.1021%2Fbi020670c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seenisamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blume, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bomke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friese-Hamim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, T. F.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-based optimization of next generation reversible methionine aminopeptidase-2 (MetAP-2) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5025</span>– <span class="NLM_lpage">5039</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00041</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC1MXms1aiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5025-5039&author=T.+Heinrichauthor=J.+Seenisamyauthor=B.+Blumeauthor=J.+Bomkeauthor=M.+Calderiniauthor=U.+Eckertauthor=M.+Friese-Hamimauthor=M.+Lehmannauthor=B.+Leuthnerauthor=D.+Musilauthor=F.+Rohdichauthor=T.+F.+Zenke&title=Discovery+and+structure-based+optimization+of+next+generation+reversible+methionine+aminopeptidase-2+%28MetAP-2%29+inhibitors&doi=10.1021%2Facs.jmedchem.9b00041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors</span></div><div class="casAuthors">Heinrich, Timo; Seenisamy, Jeyaprakashnarayanan; Blume, Beatrix; Bomke, Joerg; Calderini, Michel; Eckert, Uwe; Friese-Hamim, Manja; Kohl, Rainer; Lehmann, Martin; Leuthner, Birgitta; Musil, Djordje; Rohdich, Felix; Zenke, Frank T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5025-5039</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Co- and posttranslational processing are crucial maturation steps to generate functional proteins.  MetAP-2 plays an important role in this process and inhibition of its proteolytic activity has been shown to be important for angiogenesis and tumor growth suggesting that small mol. inhibitors of MetAP-2 may be promising options for the treatment of cancer.  This work describes the discovery and structure-based hit optimization of a novel MetAP-2 inhibitory scaffold.  Of crit. importance, a cyclic tartronic diamide coordinates the MetAP-2 metal ion in the active site while addnl. side chains of the mol. were designed to occupy the liphophilic methionine side chain recognition pocket as well as the shallow cavity at the opening of the active site.  The racemic screening hit from a HTS campaign I was discovered with an enzymic IC50 of 150 nM.  The resynthesized eutomer confirmed this activity and inhibited HUVEC proliferation with an IC50 of 1.9 μM.  Its structural anal. revealed a sophisticated interaction pattern of polar and lipophilic contacts that were used to improve cellular potency to an IC50 of 15 nM.  In parallel, the mol. properties were optimized on plasma exposure and antitumor efficacy which led to the identification of advanced lead II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsd8oNNAZALLVg90H21EOLACvtfcHk0ljcGZjtU0oXgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXms1aiu7c%253D&md5=d3841fb334e4d75cc5050936c882fa2b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00041%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DSeenisamy%26aufirst%3DJ.%26aulast%3DBlume%26aufirst%3DB.%26aulast%3DBomke%26aufirst%3DJ.%26aulast%3DCalderini%26aufirst%3DM.%26aulast%3DEckert%26aufirst%3DU.%26aulast%3DFriese-Hamim%26aufirst%3DM.%26aulast%3DLehmann%26aufirst%3DM.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DZenke%26aufirst%3DT.%2BF.%26atitle%3DDiscovery%2520and%2520structure-based%2520optimization%2520of%2520next%2520generation%2520reversible%2520methionine%2520aminopeptidase-2%2520%2528MetAP-2%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5025%26epage%3D5039%26doi%3D10.1021%2Facs.jmedchem.9b00041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Exner, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeckler, F. M.</span></span> <span> </span><span class="NLM_article-title">Using surface scans for the evaluation of halogen bonds toward the side chains of aspartate, asparagine, glutamate, and glutamine</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1373</span>– <span class="NLM_lpage">1383</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.6b00075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.6b00075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSrtLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2016&pages=1373-1383&author=M.+O.+Zimmermannauthor=A.+Langeauthor=S.+Zahnauthor=T.+E.+Exnerauthor=F.+M.+Boeckler&title=Using+surface+scans+for+the+evaluation+of+halogen+bonds+toward+the+side+chains+of+aspartate%2C+asparagine%2C+glutamate%2C+and+glutamine&doi=10.1021%2Facs.jcim.6b00075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Using surface scans for the evaluation of halogen bonds toward the side chains of aspartate, asparagine, glutamate, and glutamine</span></div><div class="casAuthors">Zimmermann, Markus O.; Lange, Andreas; Zahn, Stefan; Exner, Thomas E.; Boeckler, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1373-1383</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using halogen-specific Connolly type mol. surfaces, we herein invented a new type of surface-based interaction anal. employed for the study of halogen bonding toward model systems of biol. relevant carboxylates (ASP/GLU) and carboxamides (ASN/GLN).  Database mining and statistical assessment of the PDB revealed that such interactions are widely underrepresented at the moment.  We obsd. important distance-dependent adaptation of the binding modes of halobenzenes from a preferential oxygen-directed to a bifurcated interaction geometry of the carboxylate.  In addn., halogen···π contacts perpendicular to the nitrogen atom of the carboxamide become increasingly important for the lighter halogens.  Our anal. on a MP2/TZVPP level of theory is backed by CCSD(T)/CBS ref. calcns.  To put the vast interaction energies into perspective, we also performed COSMO-RS calcns. of the solvation free energy.  Facilitating the visualization of our results mapped onto any binding site of choice, we aim to inspire more design studies showcasing these underrepresented interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5NarrHjH8HrVg90H21EOLACvtfcHk0ljcGZjtU0oXgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSrtLbI&md5=a0b63faead8bbb541ae0344223c10869</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.6b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.6b00075%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DM.%2BO.%26aulast%3DLange%26aufirst%3DA.%26aulast%3DZahn%26aufirst%3DS.%26aulast%3DExner%26aufirst%3DT.%2BE.%26aulast%3DBoeckler%26aufirst%3DF.%2BM.%26atitle%3DUsing%2520surface%2520scans%2520for%2520the%2520evaluation%2520of%2520halogen%2520bonds%2520toward%2520the%2520side%2520chains%2520of%2520aspartate%252C%2520asparagine%252C%2520glutamate%252C%2520and%2520glutamine%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2016%26volume%3D56%26spage%3D1373%26epage%3D1383%26doi%3D10.1021%2Facs.jcim.6b00075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabelli, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacev, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenney, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span> <span> </span><span class="NLM_article-title">Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3996</span>– <span class="NLM_lpage">4016</span>, <span class="refDoi"> DOI: 10.1021/jm400227z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400227z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVyhu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3996-4016&author=F.+Zhangauthor=S.+Bhatauthor=S.+B.+Gabelliauthor=X.+Chenauthor=M.+S.+Millerauthor=B.+A.+Nacevauthor=Y.+L.+Chengauthor=D.+J.+Meyersauthor=K.+Tenneyauthor=J.+S.+Shimauthor=P.+Crewsauthor=L.+M.+Amzelauthor=D.+Maauthor=J.+O.+Liu&title=Pyridinylquinazolines+selectively+inhibit+human+methionine+aminopeptidase-1+in+cells&doi=10.1021%2Fjm400227z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridinylquinazolines Selectively Inhibit Human Methionine Aminopeptidase-1 in Cells</span></div><div class="casAuthors">Zhang, Feiran; Bhat, Shridhar; Gabelli, Sandra B.; Chen, Xiaochun; Miller, Michelle S.; Nacev, Benjamin A.; Cheng, Yim Ling; Meyers, David J.; Tenney, Karen; Shim, Joong Sup; Crews, Phillip; Amzel, L. Mario; Ma, Dawei; Liu, Jun O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3996-4016</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methionine aminopeptidases (MetAPs), which remove the initiator methionine from nascent peptides, are essential in all organisms.  While MetAP2 has been demonstrated to be a therapeutic target for inhibiting angiogenesis in mammals, MetAP1 seems to be vital for cell proliferation.  The authors' earlier efforts identified two structural classes of human MetAP1 (HsMetAP1)-selective inhibitors, but all of them failed to inhibit cellular HsMetAP1.  Using Mn(II) or Zn(II) to activate HsMetAP1, the authors found that select inhibitors could only effectively inhibit purified HsMetAP1 in the presence of physiol. unachievable concns. of Co(II).  In an effort to seek Co(II)-independent inhibitors, a novel structural class contg. a 2-(pyridin-2-yl)quinazoline core has been discovered.  Many compds. in this class potently and selectively inhibited HsMetAP1 without Co(II).  Subsequently, the authors demonstrated 4-[4-(4-Methoxyphenyl)piperazin-1-yl]-2-(pyridin-2-yl)-quinazoline, an auxiliary metal-dependent inhibitor, effectively inhibited HsMetAP1 in primary cells.  This is the first report that an HsMetAP1-selective inhibitor is effective against its target in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmoPt5R9K8a7Vg90H21EOLACvtfcHk0lj6x25QxQESmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVyhu74%253D&md5=0409345988d6f77f2ba5fa51193e9bc1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm400227z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400227z%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DBhat%26aufirst%3DS.%26aulast%3DGabelli%26aufirst%3DS.%2BB.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DMiller%26aufirst%3DM.%2BS.%26aulast%3DNacev%26aufirst%3DB.%2BA.%26aulast%3DCheng%26aufirst%3DY.%2BL.%26aulast%3DMeyers%26aufirst%3DD.%2BJ.%26aulast%3DTenney%26aufirst%3DK.%26aulast%3DShim%26aufirst%3DJ.%2BS.%26aulast%3DCrews%26aufirst%3DP.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26atitle%3DPyridinylquinazolines%2520selectively%2520inhibit%2520human%2520methionine%2520aminopeptidase-1%2520in%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3996%26epage%3D4016%26doi%3D10.1021%2Fjm400227z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y. H.</span></span> <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">12357</span>– <span class="NLM_lpage">12361</span>, <span class="refDoi"> DOI: 10.1073/pnas.92.26.12357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1073%2Fpnas.92.26.12357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=8618900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADyaK28Xhtl2muw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Li%2C+X.%3B+Chang%2C+Y.+H.+Proc.+Natl.+Acad.+Sci.+U.+S.+A.+1995%2C+92%2C+12357%E2%80%9312361%2C+10.1073%2Fpnas.92.26.12357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases</span></div><div class="casAuthors">Li, Xuan; Chang, Yie-Hwa</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">12357-61</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We previously characterized a methionine aminopeptidase (EC 3.4.11.18; Met-AP1; also called peptidase M) in Saccharomyces cerevisiae, which differs from its prokaryotic homologs in that it (i) contains an N-terminal zinc-finger domain and (ii) does not produce lethality when disrupted, although it does slow growth dramatically; it is encoded by a gene called MAP1.  Here we describe a second methionine aminopeptidase (Met-AP2) in S. cerevisiae, encoded by MAP2, which was cloned as a suppressor of the slow-growth phenotype of the map1 null strain.  The DNA sequence of MAP2 encodes a protein of 421 amino acids that shows 22% identity with the sequence of yeast Met-AP1.  Surprisingly, comparison with sequences in the GenBank data base showed that the product of MAP2 has even greater homol. (55% identity) with rat p67, which was characterized as an initiation factor 2-assocd. protein but not yet shown to have Met-AP activity.  Transformants of map1 null cells expressing MAP2 in a high-copy-no. plasmid contained 3- to 12-fold increases in Met-AP activity on different peptide substrates.  The epitope-tagged suppressor gene product was purified by immunoaffinity chromatog. and shown to contain Met-AP activity.  To evaluate the physiol. significance of Met-AP2, the MAP2 gene was deleted from wild-type and map1 null yeast strains.  The map2 null strain, like the map1 null strain, is viable but with a slower growth rate.  The map1, map2 double-null strains are nonviable.  Thus, removal of N-terminal methionine is an essential function in yeast, as in prokaryotes, but yeast require two methionine aminopeptidases to provide the essential function which can only be partially provided by Met-AP1 or Met-AP2 alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTth2TLXouprVg90H21EOLACvtfcHk0lj6x25QxQESmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xhtl2muw%253D%253D&md5=e73add916a407e1e626356ff0b178be2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.26.12357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.26.12357%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DY.%2BH.%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D12357%26epage%3D12361%26doi%3D10.1073%2Fpnas.92.26.12357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antoine, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannus, S.</span></span> <span> </span><span class="NLM_article-title">Homogeneous time-resolved G protein-coupled receptor-ligand binding assay based on fluorescence cross-correlation spectroscopy</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>502</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2016.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1016%2Fj.ab.2016.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=26954998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVWmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=502&publication_year=2016&pages=24-35&author=T.+Antoineauthor=D.+Ottauthor=K.+Ebellauthor=K.+Hansenauthor=L.+Henryauthor=F.+Beckerauthor=S.+Hannus&title=Homogeneous+time-resolved+G+protein-coupled+receptor-ligand+binding+assay+based+on+fluorescence+cross-correlation+spectroscopy&doi=10.1016%2Fj.ab.2016.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Homogeneous time-resolved G protein-coupled receptor-ligand binding assay based on fluorescence cross-correlation spectroscopy</span></div><div class="casAuthors">Antoine, Thomas; Ott, David; Ebell, Katharina; Hansen, Kerrin; Henry, Luc; Becker, Frank; Hannus, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">502</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-35</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) mediate many important physiol. functions and are considered as one of the most successful therapeutic target classes for a wide spectrum of diseases.  Drug discovery projects generally benefit from a broad range of exptl. approaches for screening compd. libraries and for the characterization of binding modes of drug candidates.  Owing to the difficulties in solubilizing and purifying GPCRs, assay formats have been so far mainly limited to cell-based functional assays and radioligand binding assays.  In this study, we used fluorescence cross-correlation spectroscopy (FCCS) to analyze the interaction of detergent-solubilized receptors to various types of GPCR ligands: endogenous peptides, small mols., and a large surrogate antagonist represented by a blocking monoclonal antibody.  Our work demonstrates the suitability of the homogeneous and time-resolved FCCS assay format for a robust, high-throughput detn. of receptor-ligand binding affinities and kinetic rate consts. for various therapeutically relevant GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOYce-xGzJ67Vg90H21EOLACvtfcHk0lj6x25QxQESmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVWmsrk%253D&md5=7035221d68a3e982e4b665ea7a70e858</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2016.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2016.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DAntoine%26aufirst%3DT.%26aulast%3DOtt%26aufirst%3DD.%26aulast%3DEbell%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DHenry%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DF.%26aulast%3DHannus%26aufirst%3DS.%26atitle%3DHomogeneous%2520time-resolved%2520G%2520protein-coupled%2520receptor-ligand%2520binding%2520assay%2520based%2520on%2520fluorescence%2520cross-correlation%2520spectroscopy%26jtitle%3DAnal.%2520Biochem.%26date%3D2016%26volume%3D502%26spage%3D24%26epage%3D35%26doi%3D10.1016%2Fj.ab.2016.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung-Chi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (IC<sub>50</sub>) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=4202581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=C.+Yung-Chiauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28K1%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28IC50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DYung-Chi%26aufirst%3DC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528K1%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528IC50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hannus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beitzinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelmann, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weickert, M.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, G.</span></span> <span> </span><span class="NLM_article-title">siPools: highly complex but accurately defined siRNA pools eliminate off-target effects</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">8049</span>– <span class="NLM_lpage">8061</span>, <span class="refDoi"> DOI: 10.1093/nar/gku480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1093%2Fnar%2Fgku480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=24875475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCqsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=8049-8061&author=M.+Hannusauthor=M.+Beitzingerauthor=J.+C.+Engelmannauthor=M.-T.+Weickertauthor=R.+Spangauthor=S.+Hannusauthor=G.+Meister&title=siPools%3A+highly+complex+but+accurately+defined+siRNA+pools+eliminate+off-target+effects&doi=10.1093%2Fnar%2Fgku480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">siPools: highly complex but accurately defined siRNA pools eliminate off-target effects</span></div><div class="casAuthors">Hannus, Michael; Beitzinger, Michaela; Engelmann, Julia C.; Weickert, Marie-Theresa; Spang, Rainer; Hannus, Stefan; Meister, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8049-8061</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Short interfering RNAs (siRNAs) are widely used as tool for gene inactivation in basic research and therapeutic applications.  One of the major shortcomings of siRNA expts. are sequence-specific off-target effects.  Such effects are largely unpredictable because siRNAs can affect partially complementary sequences and function like microRNAs (miRNAs), which inhibit gene expression on mRNA stability or translational levels.  Here we demonstrate that novel, enzymically generated siRNA pools-referred to as siPools-contg. up to 60 accurately defined siRNAs eliminate off-target effects.  This is achieved by the low concn. of each individual siRNA dilg. sequence-specific off-target effects below detection limits.  In fact, whole transcriptome analyses reveal that single siRNA transfections can severely affect global gene expression.  However, when complex siRNA pools are transfected, almost no transcriptome alterations are obsd.  Taken together, we present enzymically produced complex but accurately defined siRNA pools with potent on-target silencing but without detectable off-target effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHBEMb-YiZK7Vg90H21EOLACvtfcHk0lgWEzr3VKHrzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCqsrjL&md5=b5306bf86eb8d896cff94bb42b162d5f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgku480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgku480%26sid%3Dliteratum%253Aachs%26aulast%3DHannus%26aufirst%3DM.%26aulast%3DBeitzinger%26aufirst%3DM.%26aulast%3DEngelmann%26aufirst%3DJ.%2BC.%26aulast%3DWeickert%26aufirst%3DM.-T.%26aulast%3DSpang%26aufirst%3DR.%26aulast%3DHannus%26aufirst%3DS.%26aulast%3DMeister%26aufirst%3DG.%26atitle%3DsiPools%253A%2520highly%2520complex%2520but%2520accurately%2520defined%2520siRNA%2520pools%2520eliminate%2520off-target%2520effects%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26spage%3D8049%26epage%3D8061%26doi%3D10.1093%2Fnar%2Fgku480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="note"><p class="first last">AUC free @ 1 mg/kg iv [nM  h] = AUC/MW × fub.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last"><i>C</i><sub>ave</sub>, free @ 1 mg/kg iv [nM] = AUC free @ 1 mpk/24.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">IC<sub>50</sub>, cell free [nM] = HUVEC IC<sub>50</sub> × fub (5% fetal calf serum).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rager, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kardos, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, I. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1016/j.ijpharm.2004.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1016%2Fj.ijpharm.2004.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=15620875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGhurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2005&pages=349-359&author=Q.+Wangauthor=J.+D.+Ragerauthor=K.+Weinsteinauthor=P.+S.+Kardosauthor=G.+L.+Dobsonauthor=J.+Liauthor=I.+J.+Hidalgo&title=Evaluation+of+the+MDR-MDCK+cell+line+as+a+permeability+screen+for+the+blood-brain+barrier&doi=10.1016%2Fj.ijpharm.2004.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier</span></div><div class="casAuthors">Wang, Qing; Rager, Joseph D.; Weinstein, Kathryn; Kardos, Paula S.; Dobson, Glenn L.; Li, Jibin; Hidalgo, Ismael J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">349-359</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The objectives of this study were to (1) characterize MDR-MDCK monolayers as an in vitro model to predict brain uptake potential; (2) examine the ability of MDR-MDCK monolayers to identify the brain uptake potential of compds. that interact with P-glycoprotein (P-gp).  The study measured the bi-directional transport of 28 compds. across MDR-MDCK monolayers.  The brain uptake of a subset of the compds. was detd. in the rat brain perfusion model.  Drug concns. were analyzed by LC-MS-MS.  CNS-pos. drugs exhibited absorptive permeability coeffs. (Papp, A-B) values ranging from 3.4 × 10-6 to 20.2 × 10-6 cm/s; whereas CNS-neg. drugs showed Papp (A-B) ranging from 0.03 × 10-6 to 0.83 × 10-6 cm/s.  Inhibition of P-gp by cyclosporin A (CsA) significantly reduced secretory flux of compds. known to be P-pg substrates, but only enhanced the absorptive flux of compds. with high efflux ratio (>100).  In vitro results were confirmed by brain perfusion studies on selected compds.  MDR-MDCK monolayers can be used to classify compds. into CNS-pos. or CNS-neg. based on the permeability coeffs. (Papp, A-B).  Under the authors' exptl. conditions, compds. with Papp (A-B) >3 × 10-6 cm/s have high brain uptake potential; compds. with Papp (A-B) < 1 × 10-6 cm/s are unable to penetrate the blood-brain barrier (BBB); the brain uptake of compds. with Papp (A-B) < 1 × 10-6 cm/s and a P-gp-mediated efflux ratio of >100 may be enhanced by inhibiting P-gp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvF-zoLte8trVg90H21EOLACvtfcHk0lgWEzr3VKHrzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGhurvE&md5=7d2cb9e13b2767b337bf808e73141ae1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2004.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2004.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DRager%26aufirst%3DJ.%2BD.%26aulast%3DWeinstein%26aufirst%3DK.%26aulast%3DKardos%26aufirst%3DP.%2BS.%26aulast%3DDobson%26aufirst%3DG.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHidalgo%26aufirst%3DI.%2BJ.%26atitle%3DEvaluation%2520of%2520the%2520MDR-MDCK%2520cell%2520line%2520as%2520a%2520permeability%2520screen%2520for%2520the%2520blood-brain%2520barrier%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2005%26volume%3D288%26spage%3D349%26epage%3D359%26doi%3D10.1016%2Fj.ijpharm.2004.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rzepa, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hii, K. K. M.</span></span> <span> </span><span class="NLM_article-title">Delineating origins of stereocontrol in asymmetric Pd-catalyzed a-hydroxylation of 1,3-ketoesters</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">3085</span>– <span class="NLM_lpage">3096</span>, <span class="refDoi"> DOI: 10.1021/jo1002906</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo1002906" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFeqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=3085-3096&author=A.+M.+R.+Smithauthor=H.+S.+Rzepaauthor=A.+J.+P.+Whiteauthor=D.+Billenauthor=K.+K.+M.+Hii&title=Delineating+origins+of+stereocontrol+in+asymmetric+Pd-catalyzed+a-hydroxylation+of+1%2C3-ketoesters&doi=10.1021%2Fjo1002906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Delineating Origins of Stereocontrol in Asymmetric Pd-Catalyzed α-Hydroxylation of 1,3-Ketoesters</span></div><div class="casAuthors">Smith, AlexanderM. R.; Rzepa, Henry S.; White, Andrew J. P.; Billen, Denis; Hii, King Kuok</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3085-3096</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Systematic studies of reaction conditions and subsequent optimization led to the identification of important parameters for stereoselectivity in the asym. α-hydroxylation reaction of 1,3-ketoesters.  Enantioselectivities of up to 98% can be achieved for cyclic substrates and 88% for acyclic ketoesters.  Subsequently, the combination of cyclic/acyclic ketoester, catalyst, and oxidant was found to have a profound effect on reaction rates and turnover-limiting steps.  The stereochem. of the reaction contradicts that obsd. for other similar electrophilic substitution reactions.  This was rationalized by transition-state modeling, which revealed a no. of cooperative weak interactions between oxidant, ligand, and counterion, together with C-H/π interactions that cumulatively account for the unusual stereoselectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOop3BMKBWxLVg90H21EOLACvtfcHk0lgWEzr3VKHrzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFeqs7g%253D&md5=1d9305fa8479204590fdc1367bfa2141</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjo1002906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo1002906%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DA.%2BM.%2BR.%26aulast%3DRzepa%26aufirst%3DH.%2BS.%26aulast%3DWhite%26aufirst%3DA.%2BJ.%2BP.%26aulast%3DBillen%26aufirst%3DD.%26aulast%3DHii%26aufirst%3DK.%2BK.%2BM.%26atitle%3DDelineating%2520origins%2520of%2520stereocontrol%2520in%2520asymmetric%2520Pd-catalyzed%2520a-hydroxylation%2520of%25201%252C3-ketoesters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D3085%26epage%3D3096%26doi%3D10.1021%2Fjo1002906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. C.</span></span> <span> </span><span class="NLM_article-title">Asymmetric hydroxylation of enolates with N-sulfonyloxaziridines</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1021/cr00013a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr00013a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADyaK38XkvV2mtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1992&pages=919-934&author=F.+A.+Davisauthor=B.+C.+Chen&title=Asymmetric+hydroxylation+of+enolates+with+N-sulfonyloxaziridines&doi=10.1021%2Fcr00013a008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric hydroxylation of enolates with N-sulfonyloxaziridines</span></div><div class="casAuthors">Davis, Franklin A.; Chen, Bang Chi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">919-34</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    </div><div class="casAbstract">A review with 81 refs. on enantioselective synthesis of α-hydroxy carbonyl compds. by asym. hydroxylation of enolates using N-sulfonyloxaziridines, with particular emphasis on application in natural product synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt3Zc-tltJcbVg90H21EOLACvtfcHk0liaWGPfbthNjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XkvV2mtbg%253D&md5=1db2ac18a11cd57a142aed7a0e75aac2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fcr00013a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00013a008%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DF.%2BA.%26aulast%3DChen%26aufirst%3DB.%2BC.%26atitle%3DAsymmetric%2520hydroxylation%2520of%2520enolates%2520with%2520N-sulfonyloxaziridines%26jtitle%3DChem.%2520Rev.%26date%3D1992%26volume%3D92%26spage%3D919%26epage%3D934%26doi%3D10.1021%2Fcr00013a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span> <span> </span><span class="NLM_article-title">Oxidation of 1,3-dicarbonyl compounds using (camphorylsulfonyl)oxaziridines</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">10481</span>– <span class="NLM_lpage">10492</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(98)00500-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1016%2FS0040-4020%2898%2900500-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVClsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=10481-10492&author=F.+A.+Davisauthor=H.+Liuauthor=B.-C.+Chenauthor=P.+Zhou&title=Oxidation+of+1%2C3-dicarbonyl+compounds+using+%28camphorylsulfonyl%29oxaziridines&doi=10.1016%2FS0040-4020%2898%2900500-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of 1,3-dicarbonyl compounds using (camphorylsulfonyl)oxaziridines</span></div><div class="casAuthors">Davis, Franklin A.; Liu, Hu; Chen, Bang-Chi; Zhou, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10481-10492</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The oxidn. of 1,3-dicarbonyl compds. with (camphorylsulfonyl)oxaziridines was studied in both cyclic and acyclic systems.  Two reaction pathways were identified: enolate α-hydroxylation and a novel Baeyer-Villiger type oxidn.  The Baeyer-Villiger oxidn. product was obsd. only for the ketones and arises via rearrangement of an alkoxy epoxide.  Synthetically useful ee's (82-95%) were obsd. only for enolates of β-ketoesters where the keto group is part of a 6-membered ring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE0-O-IH3x6bVg90H21EOLACvtfcHk0liaWGPfbthNjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVClsbw%253D&md5=b8cffba5bbfdafa4825cd21b510f1688</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2898%2900500-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252898%252900500-6%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DF.%2BA.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DZhou%26aufirst%3DP.%26atitle%3DOxidation%2520of%25201%252C3-dicarbonyl%2520compounds%2520using%2520%2528camphorylsulfonyl%2529oxaziridines%26jtitle%3DTetrahedron%26date%3D1998%26volume%3D54%26spage%3D10481%26epage%3D10492%26doi%3D10.1016%2FS0040-4020%2898%2900500-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candela-Lena, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Fernandez, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J. E.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis of N, O, O, O-tetra-acetyl D-lyxophytosphingosine, jaspine B (pachastrissamine) and its C(2)-epimer</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2510</span>– <span class="NLM_lpage">2513</span>, <span class="refDoi"> DOI: 10.1016/j.tetasy.2007.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1016%2Fj.tetasy.2007.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=2510-2513&author=E.+Abrahamauthor=J.+I.+Candela-Lenaauthor=S.+G.+Daviesauthor=M.+Georgiouauthor=R.+L.+Nicholsonauthor=P.+M.+Robertsauthor=A.+J.+Russellauthor=E.+M.+Sanchez-Fernandezauthor=A.+D.+Smithauthor=J.+E.+Thomson&title=Asymmetric+synthesis+of+N%2C+O%2C+O%2C+O-tetra-acetyl+D-lyxophytosphingosine%2C+jaspine+B+%28pachastrissamine%29+and+its+C%282%29-epimer&doi=10.1016%2Fj.tetasy.2007.10.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric synthesis of N,O,O,O-tetra-acetyl D-lyxo-phytosphingosine, jaspine B (pachastrissamine) and its C(2)-epimer</span></div><div class="casAuthors">Abraham, Elin; Candela-Lena, Jose I.; Davies, Stephen G.; Georgiou, Matthew; Nicholson, Rebecca L.; Roberts, Paul M.; Russell, Angela J.; Sanchez-Fernandez, Elena M.; Smith, Andrew D.; Thomson, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2510-2513</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The highly diastereoselective conjugate addn. of lithium (S)-N-benzyl-N-(α-methylbenzyl)amide to a γ-silyloxy-α,β-unsatd. ester and in situ enolate oxidn. with (+)-(camphorsulfonyl)oxaziridine has been used as the key step in the asym. synthesis of N,O,O,O-tetra-acetyl D-lyxo-phytosphingosine I, jaspine B (pachastrissamine) II and its C(2)-epimer III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1hqKOTHxZMbVg90H21EOLACvtfcHk0lhYazSRyk49aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7fK&md5=891ec081de4105f8318bd2ed7045acdd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2007.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2007.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DE.%26aulast%3DCandela-Lena%26aufirst%3DJ.%2BI.%26aulast%3DDavies%26aufirst%3DS.%2BG.%26aulast%3DGeorgiou%26aufirst%3DM.%26aulast%3DNicholson%26aufirst%3DR.%2BL.%26aulast%3DRoberts%26aufirst%3DP.%2BM.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DSanchez-Fernandez%26aufirst%3DE.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BD.%26aulast%3DThomson%26aufirst%3DJ.%2BE.%26atitle%3DAsymmetric%2520synthesis%2520of%2520N%252C%2520O%252C%2520O%252C%2520O-tetra-acetyl%2520D-lyxophytosphingosine%252C%2520jaspine%2520B%2520%2528pachastrissamine%2529%2520and%2520its%2520C%25282%2529-epimer%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2007%26volume%3D18%26spage%3D2510%26epage%3D2513%26doi%3D10.1016%2Fj.tetasy.2007.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shevchenko, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pupo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">List, B.</span></span> <span> </span><span class="NLM_article-title">Direct asymmetric S-hydroxylation of cyclic --branched ketones through enol catalysis</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1055/s-0037-1611084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1055%2Fs-0037-1611084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ChsbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=49-53&author=G.+A.+Shevchenkoauthor=G.+Pupoauthor=B.+List&title=Direct+asymmetric+S-hydroxylation+of+cyclic+%2D%2Dbranched+ketones+through+enol+catalysis&doi=10.1055%2Fs-0037-1611084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Asymmetric α-Hydroxylation of Cyclic α-Branched Ketones through Enol Catalysis</span></div><div class="casAuthors">Shevchenko, Grigory A.; Pupo, Gabriele; List, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Synlett</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-53</span>CODEN:
                <span class="NLM_cas:coden">SYNLES</span>;
        ISSN:<span class="NLM_cas:issn">0936-5214</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Enantiopure α-hydroxy carbonyl compds. are common scaffolds in natural products and pharmaceuticals.  Although indirect approaches towards their synthesis are known, direct asym. methodologies are scarce.  Herein, we report the first direct asym. α-hydroxylation of α-branched ketones through enol catalysis, enabling a facile access to valuable α-keto tertiary alcs.  The transformation, characterized by the use of nitrosobenzene as the oxidant and a new chiral phosphoric acid as the catalyst, delivers a good scope and excellent enantioselectivities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh1imlwX1aNLVg90H21EOLACvtfcHk0lhYazSRyk49aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ChsbjP&md5=75ab4da4cdffaf14421d0c35c2555325</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1055%2Fs-0037-1611084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0037-1611084%26sid%3Dliteratum%253Aachs%26aulast%3DShevchenko%26aufirst%3DG.%2BA.%26aulast%3DPupo%26aufirst%3DG.%26aulast%3DList%26aufirst%3DB.%26atitle%3DDirect%2520asymmetric%2520S-hydroxylation%2520of%2520cyclic%2520--branched%2520ketones%2520through%2520enol%2520catalysis%26jtitle%3DSynlett%26date%3D2019%26volume%3D30%26spage%3D49%26epage%3D53%26doi%3D10.1055%2Fs-0037-1611084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baidya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span> <span> </span><span class="NLM_article-title">Catalytic enantioselective O-nitrosocarbonyl aldol reaction of B-dicarbonyl compounds</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">18566</span>– <span class="NLM_lpage">18569</span>, <span class="refDoi"> DOI: 10.1021/ja309311z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja309311z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFygtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=18566-18569&author=M.+Baidyaauthor=K.+A.+Griffinauthor=H.+Yamamoto&title=Catalytic+enantioselective+O-nitrosocarbonyl+aldol+reaction+of+B-dicarbonyl+compounds&doi=10.1021%2Fja309311z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic Enantioselective O-Nitrosocarbonyl Aldol Reaction of β-Dicarbonyl Compounds</span></div><div class="casAuthors">Baidya, Mahiuddin; Griffin, Kimberly A.; Yamamoto, Hisashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18566-18569</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first example of a Cu-catalyzed asym. O-nitrosocarbonyl aldol reaction is described.  This novel protocol allows convenient access to highly enantioenriched α-hydroxy-β-ketoesters including the antibacterial natural product kjellmanianone (up to 99% ee).  MnO2 was introduced as a mild efficient oxidant for the in situ generation of nitrosocarbonyl species from hydroxamic acid derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq62nAT9ohxYrVg90H21EOLACvtfcHk0lhYazSRyk49aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFygtL3F&md5=1aab01cb5e995e06cf887daebcf39203</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja309311z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja309311z%26sid%3Dliteratum%253Aachs%26aulast%3DBaidya%26aufirst%3DM.%26aulast%3DGriffin%26aufirst%3DK.%2BA.%26aulast%3DYamamoto%26aufirst%3DH.%26atitle%3DCatalytic%2520enantioselective%2520O-nitrosocarbonyl%2520aldol%2520reaction%2520of%2520B-dicarbonyl%2520compounds%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D18566%26epage%3D18569%26doi%3D10.1021%2Fja309311z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-4644(20000601)77:3<465::AID-JCB11>3.0.CO;2-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1002%2F%28SICI%291097-4644%2820000601%2977%3A3%3C465%3A%3AAID-JCB11%3E3.0.CO%3B2-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10760954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivFWju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2000&pages=465-473&author=J.+Wangauthor=P.+Louauthor=J.+Henkin&title=Selective+inhibition+of+endothelial+cell+proliferation+by+fumagillin+is+not+due+to+differential+expression+of+methionine+aminopeptidases&doi=10.1002%2F%28SICI%291097-4644%2820000601%2977%3A3%3C465%3A%3AAID-JCB11%3E3.0.CO%3B2-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases</span></div><div class="casAuthors">Wang, Jieyi; Lou, Pingping; Henkin, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">465-473</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The angiogenesis inhibitors fumagillin and TNP-470 selectively inhibit the proliferation of endothelial cells, as compared with most other cell types.  The mechanism of this selective inhibition remains uncertain, although methionine aminopeptidase-2 (MetAP2) has recently been found to be a target for fumagillin or TNP-470, which inactivates MetAP2 enzyme activity through covalent modification.  Primary cultures of human endothelial cells and six other non-endothelial cell types were treated with fumagillin to det. its effect on cell proliferation.  Only the growth of endothelial cells was completely inhibited at low concns. of fumagillin.  MetAP1 and MetAP2 levels in these cells were investigated to det. whether differential enzyme expression plays a role in the selective action of fumagillin.  Western blot anal. and RT-PCR data showed that MetAP1 and MetAP2 were both expressed in these different types of cells, thus, ruling out differential expression of MetAP1 and MetAP2 as an explanation for the cell specificity of fumagillin.  Expression of MetAP2, but not of MetAP1, is regulated.  Treatment of human microvascular endothelial cells (HMVEC) with fumagillin resulted in threefold increases of MetAP2 protein in the cells, while MetAP1 remained const.  Similar upregulation of MetAP2 by exposure to fumagillin was also obsd. in non-endothelial cells, eliminating this response as an explanation for cell specificity.  Taken together, these results indicate that while MetAP2 plays a crit. role in the effect of fumagillin on endothelial cell proliferation, differential endogenous expression or fumagillin-induced upregulation of methionine aminopeptidases is not responsible for this obsd. selective inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnEHBXHmConLVg90H21EOLACvtfcHk0lg1COpTC9fwnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivFWju7k%253D&md5=f05de66bc107cb486c48ee6a81991234</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-4644%2820000601%2977%3A3%3C465%3A%3AAID-JCB11%3E3.0.CO%3B2-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-4644%252820000601%252977%253A3%253C465%253A%253AAID-JCB11%253E3.0.CO%253B2-M%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DHenkin%26aufirst%3DJ.%26atitle%3DSelective%2520inhibition%2520of%2520endothelial%2520cell%2520proliferation%2520by%2520fumagillin%2520is%2520not%2520due%2520to%2520differential%2520expression%2520of%2520methionine%2520aminopeptidases%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2000%26volume%3D77%26spage%3D465%26epage%3D473%26doi%3D10.1002%2F%28SICI%291097-4644%2820000601%2977%3A3%3C465%3A%3AAID-JCB11%3E3.0.CO%3B2-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Motulsky, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahan, L. C.</span></span> <span> </span><span class="NLM_article-title">The kinetics of competitive radioligand binding predicted by the law of mass action</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=6708928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A280%3ADyaL2c7mslOmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1984&pages=1-9&author=H.+J.+Motulskyauthor=L.+C.+Mahan&title=The+kinetics+of+competitive+radioligand+binding+predicted+by+the+law+of+mass+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetics of competitive radioligand binding predicted by the law of mass action</span></div><div class="casAuthors">Motulsky H J; Mahan L C</div><div class="citationInfo"><span class="NLM_cas:title">Molecular pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Although equilibrium competitive radioligand binding studies are often used to characterize hormone and neurotransmitter receptors, the kinetics of such experiments have not been extensively explored.  The interactions of the radioligand and competitor with the receptors can be described by two differential equations which can be solved to yield a single equation describing the binding of the radioligand as a function of time.  This equation has several applications: First, it can be used to simulate competitive binding reactions under defined conditions.  Second, fitting experimental data to this equation allows one to determine the association and dissociation rate constants of the competing ligand, parameters that cannot be derived from equilibrium experiments.  Furthermore, this method can be used to determine the KI of the competing drug from data acquired before equilibrium is reached.  Third, mathematical analysis of the binding equation allowed us to answer two specific questions regarding the kinetics of competitive radioligand binding: how long such an incubation takes to equilibrate, and how the IC50 varies over time.  The answers to these questions depended, to a large extent, on the relative values of the dissociation rate constants of the radioligand and competitor, which can be determined as noted above.  When the competitor dissociates from the receptors more rapidly than the radioligand, the IC50 first decreases and then increases, but never has a value less than the KI.  At low radioligand concentrations, equilibrium is reached in the same amount of time required of the radioligand to dissociate completely from the receptors as determined in an "off-rate experiment." At higher concentrations of radioligand this time is halved.  When the competitor dissociates from the receptor more slowly than does the radioligand, then the time required to equilibrate depends only on the dissociation rate constant of the competitor, and the IC50 decreases over time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCXDwvoK7MbN1QT_1O5WBYfW6udTcc2eYX0x0oIVEiw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c7mslOmtQ%253D%253D&md5=f0c09a16d7f8947fe0d72c256e2e4914</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMotulsky%26aufirst%3DH.%2BJ.%26aulast%3DMahan%26aufirst%3DL.%2BC.%26atitle%3DThe%2520kinetics%2520of%2520competitive%2520radioligand%2520binding%2520predicted%2520by%2520the%2520law%2520of%2520mass%2520action%26jtitle%3DMol.%2520Pharmacol.%26date%3D1984%26volume%3D25%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':[],'ref20':[],'ref21':[],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Junping Pei, Guan Wang, Lu Feng, Jifa Zhang, Tingting Jiang, Qiu Sun, <span class="NLM_string-name hlFld-ContribAuthor">Liang Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Lysosomal Degradation Pathways: New Strategies and Techniques for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 3493-3507. <a href="https://doi.org/10.1021/acs.jmedchem.0c01689" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01689</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01689%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BLysosomal%252BDegradation%252BPathways%25253A%252BNew%252BStrategies%252Band%252BTechniques%252Bfor%252BDrug%252BDiscovery%26aulast%3DPei%26aufirst%3DJunping%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26092020%26date%3D25032021%26volume%3D64%26issue%3D7%26spage%3D3493%26epage%3D3507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabian H.  Knaup</span>, <span class="hlFld-ContribAuthor ">Christian  Meyners</span>, <span class="hlFld-ContribAuthor ">Anna  Charalampidou</span>, <span class="hlFld-ContribAuthor ">Patryk  Krajczy</span>, <span class="hlFld-ContribAuthor ">Patrick L.  Purder</span>, <span class="hlFld-ContribAuthor ">Tatjana  Ross</span>, <span class="hlFld-ContribAuthor ">Felix  Hausch</span>. </span><span class="cited-content_cbyCitation_article-title">Med Chem Remote: The Frontiers in Medicinal Chemistry 2021. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>157 </em><a href="https://doi.org/10.1002/cmdc.202100355" title="DOI URL">https://doi.org/10.1002/cmdc.202100355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100355%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DMed%252BChem%252BRemote%25253A%252BThe%252BFrontiers%252Bin%252BMedicinal%252BChemistry%252B2021%26aulast%3DKnaup%26aufirst%3DFabian%2BH.%26date%3D2021%26date%3D2021%26volume%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Safana  Albayati</span>, <span class="hlFld-ContribAuthor ">Abdullahi Ibrahim  Uba</span>, <span class="hlFld-ContribAuthor ">Kemal  Yelekçi</span>. </span><span class="cited-content_cbyCitation_article-title">Potential inhibitors of methionine aminopeptidase type II identified via structure-based pharmacophore modeling. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>95 </em><a href="https://doi.org/10.1007/s11030-021-10221-7" title="DOI URL">https://doi.org/10.1007/s11030-021-10221-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-021-10221-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-021-10221-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DPotential%252Binhibitors%252Bof%252Bmethionine%252Baminopeptidase%252Btype%252BII%252Bidentified%252Bvia%252Bstructure-based%252Bpharmacophore%252Bmodeling%26aulast%3DAlbayati%26aufirst%3DSafana%26date%3D2021%26date%3D2021%26volume%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Hirst</span>, <span class="hlFld-ContribAuthor ">Martin  Brandt</span>, <span class="hlFld-ContribAuthor ">Gordon  Bruton</span>, <span class="hlFld-ContribAuthor ">Erica  Christodoulou</span>, <span class="hlFld-ContribAuthor ">Leanne  Cutler</span>, <span class="hlFld-ContribAuthor ">Nigel  Deeks</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Goodacre</span>, <span class="hlFld-ContribAuthor ">Torquil  Jack</span>, <span class="hlFld-ContribAuthor ">Matthew  Lindon</span>, <span class="hlFld-ContribAuthor ">Afjal  Miah</span>, <span class="hlFld-ContribAuthor ">Kevin  Page</span>, <span class="hlFld-ContribAuthor ">Nigel  Parr</span>, <span class="hlFld-ContribAuthor ">Lena  Shukla</span>, <span class="hlFld-ContribAuthor ">Martin  Sims</span>, <span class="hlFld-ContribAuthor ">Pamela  Thomas</span>, <span class="hlFld-ContribAuthor ">James  Thorpe</span>, <span class="hlFld-ContribAuthor ">Duncan S.  Holmes</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based optimisation of orally active & reversible MetAP-2 inhibitors maintaining a tight ‘molecular budget’. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (21)
                                     , 127533. <a href="https://doi.org/10.1016/j.bmcl.2020.127533" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127533</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127533%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Boptimisation%252Bof%252Borally%252Bactive%252B%252526%252Breversible%252BMetAP-2%252Binhibitors%252Bmaintaining%252Ba%252Btight%252B%2525E2%252580%252598molecular%252Bbudget%2525E2%252580%252599%26aulast%3DHirst%26aufirst%3DDavid%2BJ.%26date%3D2020%26volume%3D30%26issue%3D21%26spage%3D127533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siwen  Yuan</span>, <span class="hlFld-ContribAuthor ">Jannu Vinay  Gopal</span>, <span class="hlFld-ContribAuthor ">Shuya  Ren</span>, <span class="hlFld-ContribAuthor ">Litong  Chen</span>, <span class="hlFld-ContribAuthor ">Lan  Liu</span>, <span class="hlFld-ContribAuthor ">Zhizeng  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer fungal natural products: Mechanisms of action and biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112502. <a href="https://doi.org/10.1016/j.ejmech.2020.112502" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112502</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112502%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnticancer%252Bfungal%252Bnatural%252Bproducts%25253A%252BMechanisms%252Bof%252Baction%252Band%252Bbiosynthesis%26aulast%3DYuan%26aufirst%3DSiwen%26date%3D2020%26volume%3D202%26spage%3D112502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tana S.  Pottorf</span>, <span class="hlFld-ContribAuthor ">Micaella P.  Fagan</span>, <span class="hlFld-ContribAuthor ">Bryan F.  Burkey</span>, <span class="hlFld-ContribAuthor ">David J.  Cho</span>, <span class="hlFld-ContribAuthor ">James E.  Vath</span>, <span class="hlFld-ContribAuthor ">Pamela V.  Tran</span>. </span><span class="cited-content_cbyCitation_article-title">MetAP2 inhibition reduces food intake and body weight in a ciliopathy mouse model of obesity. </span><span class="cited-content_cbyCitation_journal-name">JCI Insight</span><span> <strong>2020,</strong> <em>5 </em>
                                    (2)
                                     <a href="https://doi.org/10.1172/jci.insight.134278" title="DOI URL">https://doi.org/10.1172/jci.insight.134278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/jci.insight.134278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2Fjci.insight.134278%26sid%3Dliteratum%253Aachs%26jtitle%3DJCI%2520Insight%26atitle%3DMetAP2%252Binhibition%252Breduces%252Bfood%252Bintake%252Band%252Bbody%252Bweight%252Bin%252Ba%252Bciliopathy%252Bmouse%252Bmodel%252Bof%252Bobesity%26aulast%3DPottorf%26aufirst%3DTana%2BS.%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Description of <b>1a</b> in the active site of MetAP-2. Distances are given in angstroms (Å). (Left) Polar interactions; (middle) lipophilic contacts; (right) snapshot of the <b>1a</b> surface in green (molecules in black) and the MetAP-2 pocket in magenta (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QED">6QED</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Diversity in the Last Synthetic Step to Optimize the Amide Residue<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ACN/DMF = 10:3, 6-amino-1,2,3,4-tetrahydroquinolin-2-one 60 °C, 12 h, 81%; (b) MMPP, DMF, 12 h, 60 °C, 68%; (c) EtOH, HCl, 4 h, 80 °C, 84%; (d) Chiralpak AD-H; (e) NaOH, H<sub>2</sub>O, 4 h, rt; 84%; (f) R<sub>1</sub>-NH<sub>2</sub>, HATU, NMM, rt, 2 h, 21–54%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Racemic Three-Step Synthesis and Chiral Chromatography<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ACN/DMF = 10:3, R<sub>1</sub>-NH<sub>2</sub> 60 °C, 12 h, 81%; (b) R<sub>2</sub>-NH<sub>2</sub>, coupling reagent, DMF, 12 h, 60 °C, 22−74%; (c) <i>tert</i>-butyl hydroperoxide, <i>t</i>BuOH, 4 h, 80 °C, 84%; (d) Chiralpak AD-H; (e) NCS, THF, 5 h, 60 °C, <b>13</b> = 52%; <b>14</b> = 22%.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Target occupancy in A549 cells incubated with different concentrations of indicated inhibitors. The MetAP-2 dependency of the determined signal was determined using siPOOL-treated A549 cells (+).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Dose-normalized iv PK (iv 0.2 mg/kg) for <b>1a</b> in a rat, dog, and monkey.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose-normalized iv PK (iv 0.2 mg/kg) for <b>16</b> in a rat, dog, and monkey.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo tumor growth inhibition of <b>11</b> and <b>16</b> in the human U87-MG glioblastoma model. Mean tumor volumes over the 14 day treatment period are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo tumor growth inhibition of <b>M8891</b> and <b>12</b> in the human Caki-1 renal model. Mean tumor volumes over the 36 day treatment period are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Asymmetric Synthesis of <b>M8891</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (3,5-difluorophenyl)methanamine, T3P, DMF, 12 h, 60 °C, 68%; (b) 1 M NaHMDS in THF, Davis oxaziridine, THF, 3 h, −70 °C, 76%; (c) NaOH, THF/ethanol = 4:1, 4 h, 50 °C, 87%.</p></p></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/medium/jm9b01070_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Chemical structure of Davis oxaziridine. (B) Visualization of the sodium enolate substructure, indicating the different steric demands around the amide and lactam nitrogen, respectively; the pro-chiral center is indicated with an asterisk. (C) Transition state of asymmetric oxidation with an indication of steric clash of the chlorine with the substitution of the lactam nitrogen (bottom; <i>re</i> side attack) and the more favorable positioning of the chlorine close to the amide nitrogen when the reagent approaches the enolate from the <i>si</i> side.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01070/20191219/images/large/jm9b01070_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01070&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i106">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folkman, J.</span></span> <span> </span><span class="NLM_article-title">Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">1070</span>– <span class="NLM_lpage">1076</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(91)91529-L</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1016%2F0006-291X%2891%2991529-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1705118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADyaK3MXhvF2lsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=1991&pages=1070-1076&author=M.+Kusakaauthor=K.+Sudoauthor=T.+Fujitaauthor=S.+Maruiauthor=F.+Itohauthor=D.+Ingberauthor=J.+Folkman&title=Potent+anti-angiogenic+action+of+AGM-1470%3A+comparison+to+the+fumagillin+parent&doi=10.1016%2F0006-291X%2891%2991529-L"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Potent antiangiogenic action of AGM-1470: comparison with the fumagillin parent</span></div><div class="casAuthors">Kusaka, Masami; Sudo, Katsuichi; Fujita, Takeshi; Marui, Shogo; Itoh, Fumio; Ingber, Donald; Folkman, Judah</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1070-6</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The antiangiogenic activity of AGM-1470 (I), a new synthetic analog of fumagillin isolated from Aspergillus fumigatus, was extensively examd. both in vitro and in vivo using 4 different types of assay and compared to that of fumagillin.  Locally administered I inhibited angiogenesis in the chick embryo chorioallantoic membrane assay and the rat corneal assay.  In the rat sponge implantation assay, systemically administered I inhibited angiogenesis induced by basic fibroblast growth factor.  Furthermore, in the rat blood vessel organ culture assay, I (1-1,000 ng/mL) was found to inhibit selectively the capillary-like tube formation of endothelial cells with a minimal effect on the non-endothelial cell growth.  I showed more potent antiangiogenic activity and less toxicity than the fumagillin parent.  Therefore, I is more active than the fumagillin parent as an antiangiogenic compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4mFTU7gDP_rVg90H21EOLACvtfcHk0linpeb3VlQ0qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhvF2lsL4%253D&md5=5de7ce6f7523ce14abde38a91a93c24d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2891%2991529-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252891%252991529-L%26sid%3Dliteratum%253Aachs%26aulast%3DKusaka%26aufirst%3DM.%26aulast%3DSudo%26aufirst%3DK.%26aulast%3DFujita%26aufirst%3DT.%26aulast%3DMarui%26aufirst%3DS.%26aulast%3DItoh%26aufirst%3DF.%26aulast%3DIngber%26aufirst%3DD.%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DPotent%2520anti-angiogenic%2520action%2520of%2520AGM-1470%253A%2520comparison%2520to%2520the%2520fumagillin%2520parent%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1991%26volume%3D174%26spage%3D1070%26epage%3D1076%26doi%3D10.1016%2F0006-291X%2891%2991529-L" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagoya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, S.</span></span> <span> </span><span class="NLM_article-title">TNP-470 suppresses the tumorigenicity of HT1080 fibrosarcoma tumor through the inhibition of VEGF secretion from the tumor cells</span>. <i>Sarcoma</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1080/13577140120099182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1080%2F13577140120099182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=18521314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD38XovV2luw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2001&pages=197-202&author=M.+Kayaauthor=T.+Wadaauthor=S.+Nagoyaauthor=S.+Kawaguchiauthor=T.+Yamashitaauthor=N.+Yamamotoauthor=M.+Yoshimotoauthor=F.+Okadaauthor=S.+Ishii&title=TNP-470+suppresses+the+tumorigenicity+of+HT1080+fibrosarcoma+tumor+through+the+inhibition+of+VEGF+secretion+from+the+tumor+cells&doi=10.1080%2F13577140120099182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">TNP-470 suppresses the tumorigenicity of HT1080 fibrosarcoma tumor through the inhibition of VEGF secretion from the tumor cells</span></div><div class="casAuthors">Kaya, Mitsunori; Wada, Takuro; Nagoya, Satoshi; Kawaguchi, Satoshi; Yamashita, Toshihiko; Yamamoto, Nobuyuki; Yoshimoto, Mitsunori; Okada, Futoshi; Ishii, Seiichi</div><div class="citationInfo"><span class="NLM_cas:title">Sarcoma</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">197-202</span>CODEN:
                <span class="NLM_cas:coden">SARCFO</span>;
        ISSN:<span class="NLM_cas:issn">1357-714X</span>.
    
            (<span class="NLM_cas:orgname">Carfax Publishing</span>)
        </div><div class="casAbstract">The effects of the fumagillin analog TNP-470 (an angiogenesis inhibitor) on human fibrosarcoma cells were assessed in vivo (in mice implanted with the cells) and in vitro.  TNP-470 suppressed the tumorigenicity of HT1080 fibrosarcoma.  The conditioned medium from HT1080 fibrosarcoma cells treated with TNP-470 inhibited the proliferation and migration of the human endothelial cell lines HUVEC and ECV304.  The concn. of vascular endothelial growth factor (VEGF) in the conditioned medium from HT1080 cells treated with TNP-470 was lower than that in the medium of cells without TNP-470 treatment, indicating that TNP-470 downregulates the secretion of VEGF from HT1080 cells.  These findings strongly suggest that the direct action of TNP-470 on sarcoma cells inhibits angiogenesis through the downregulation of VEGF secretion and that this angiogenesis suppression resulted in the inhibition of tumorigenicity of HT1080 fibrosarcoma tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo83pPc7cn2P7Vg90H21EOLACvtfcHk0linpeb3VlQ0qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovV2luw%253D%253D&md5=da26c6e09e82c93c8e0a0a465b3a4276</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1080%2F13577140120099182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13577140120099182%26sid%3Dliteratum%253Aachs%26aulast%3DKaya%26aufirst%3DM.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DNagoya%26aufirst%3DS.%26aulast%3DKawaguchi%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DYoshimoto%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DF.%26aulast%3DIshii%26aufirst%3DS.%26atitle%3DTNP-470%2520suppresses%2520the%2520tumorigenicity%2520of%2520HT1080%2520fibrosarcoma%2520tumor%2520through%2520the%2520inhibition%2520of%2520VEGF%2520secretion%2520from%2520the%2520tumor%2520cells%26jtitle%3DSarcoma%26date%3D2001%26volume%3D5%26spage%3D197%26epage%3D202%26doi%3D10.1080%2F13577140120099182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, J. P.</span></span> <span> </span><span class="NLM_article-title">Antiangiogenic drug design: Multiple pathways targeting tumor vasculature</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">849</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.2174/092986706776361085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.2174%2F092986706776361085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=16611071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD28XislygsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=849-862&author=H.+Zhongauthor=J.+P.+Bowen&title=Antiangiogenic+drug+design%3A+Multiple+pathways+targeting+tumor+vasculature&doi=10.2174%2F092986706776361085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenesis drug design: multiple pathways targeting tumor vasculature</span></div><div class="casAuthors">Zhong, Haizhen; Bowen, J. Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">849-862</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The initiation, growth, and development of new blood vessels through angiogenesis are essential for tumor growth.  Tumor masses require access to blood vessels for a sufficient supply of oxygen and nutrients to maintain growth and metastasis.  Inhibiting tumor blood vessel formation as proposed by Judah Folkman in the early 1970s, therefore, offers promising therapeutic approaches for treating tumor-afflicted patients.  The blood vessel growth in normal tissues is regulated though a delicate and complex balance between the collective action of proangiogenic factors (e.g., vascular endothelial growth factor, VEGF) and the collective action of angiogenic inhibitors (e.g., thrombospondin-1).  In pathol. angiogenesis, the angiogenic switch is shifted toward the proangiogenic factors, and if the imbalance continues, irregular tumor vessel growth is the result.  Despite intense research, the mechanism of the angiogenic switch is not fully understood.  Many factors, however, have been shown to be involved in regulating the equil. between angiogenic stimulants and inhibitors.  VEGFR tyrosine kinase, methionine aminopeptidase-2 (MetAP-2), p53, tubulin, cyclooxygenase-2 (COX-2), and matrix metalloproteinases (MMPs) all directly and(or) indirectly influence the angiogenic switch.  This review describes some of the advances in inhibitor design and the mechanisms of action for the aforementioned factors (targets) involved in angiogenesis regulation.  The discussion reveals that a diaryl group sepd. by various connecting modules is one of the most common features for antiangiogenesis drug design.  This idea has been a working pharmacophore hypothesis for the authors' own antiangiogenic drug design endeavors over the years.  The recent advances of combination therapy (angiogenesis inhibitors with other chemotherapy/radiation) are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtcsYwFJZe2bVg90H21EOLACvtfcHk0linpeb3VlQ0qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislygsLc%253D&md5=c4ffce6ecc6ba18ea160ef93c7b542f1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F092986706776361085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706776361085%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DBowen%26aufirst%3DJ.%2BP.%26atitle%3DAntiangiogenic%2520drug%2520design%253A%2520Multiple%2520pathways%2520targeting%2520tumor%2520vasculature%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D849%26epage%3D862%26doi%3D10.2174%2F092986706776361085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-P.</span></span> <span> </span><span class="NLM_article-title">The development of MetAP-2 inhibitors in Cancer Treatment</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1021</span>– <span class="NLM_lpage">1035</span>, <span class="refDoi"> DOI: 10.2174/092986712799320709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.2174%2F092986712799320709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=22229417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1021-1035&author=S.-Q.+Yinauthor=J.-J.+Wangauthor=C.-M.+Zhangauthor=Z.-P.+Liu&title=The+development+of+MetAP-2+inhibitors+in+Cancer+Treatment&doi=10.2174%2F092986712799320709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The development of MetAP-2 inhibitors in cancer treatment</span></div><div class="casAuthors">Yin, S.-Q.; Wang, J.-J.; Zhang, C.-M.; Liu, Z.-P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1021-1035</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Methionine aminopeptidases (MetAPs), which remove methionine residue from newly synthesized polypeptide chains, are a class of metalloproteases ubiquitously distributed in both eukaryotes and prokaryotes.  MetAP-2 inhibition can induce G1 cell cycle arrest, cytostasis in tumor cells in vitro and inhibition of tumor growth in vivo.  The discovery of fumagillin with potent antiangiogenic and antiproliferative activities promoted the development of fumagillin analogs as a novel class of anticancer agents.  Early drug discovery efforts have focused on analogs of fumagillin, which irreversibly inhibit MetAP-2 through covalent modification of an epoxide.  Several fumagillin analogs, like CKD-732, TNP-470, and PPI-2458, were found to be potent selective inhibitors of MetAP-2 (proteolytic activity) and endothelial cell proliferation.  Further, they have entered in clin. trials for the treatment of different types of tumors.  Recently, attention was paid to reversible human MetAP-2 inhibitors, such as bengamides, 2-hydroxy-3-aminoamides, anthranilic acid sulfonamides, and triazole analogs, which have demonstrated their potential to inhibit angiogenesis and tumor growth in vivo as well.  This review article mainly discussed the development of MetAP-2 inhibitors in cancer therapy and also summarized their structure-activity relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9_jcycw6lErVg90H21EOLACvtfcHk0liCn8rr9meKzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSqtro%253D&md5=6bd1db81df9913ecd2b4cf14f3567677</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F092986712799320709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712799320709%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DS.-Q.%26aulast%3DWang%26aufirst%3DJ.-J.%26aulast%3DZhang%26aufirst%3DC.-M.%26aulast%3DLiu%26aufirst%3DZ.-P.%26atitle%3DThe%2520development%2520of%2520MetAP-2%2520inhibitors%2520in%2520Cancer%2520Treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D1021%26epage%3D1035%26doi%3D10.2174%2F092986712799320709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, F. D.</span></span> <span> </span><span class="NLM_article-title">TNP-470: An angiogenesis inhibitor in clinical development for cancer</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1383</span>– <span class="NLM_lpage">1396</span>, <span class="refDoi"> DOI: 10.1517/13543784.9.6.1383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1517%2F13543784.9.6.1383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=11060750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktFWjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=1383-1396&author=E.+A.+Krugerauthor=F.+D.+Figg&title=TNP-470%3A+An+angiogenesis+inhibitor+in+clinical+development+for+cancer&doi=10.1517%2F13543784.9.6.1383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">TNP-470: an angiogenesis inhibitor in clinical development for cancer</span></div><div class="casAuthors">Kruger, Erwin A.; Figg, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1383-1396</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 100 refs.  TNP-470, an analog of fumagillin, has been shown to inhibit angiogenesis in vitro and in vivo.  In 1992, TNP-470 entered clin. development for cancer as an anti-angiogenic agent.  It is currently in Phase I/II trials in Kaposi's sarcoma, renal cell carcinoma, brain cancer, breast cancer, cervical cancer and prostate cancer.  Terminal half-life values are short and have shown intermittent and intrapatient variation (range: 0.05 - 1.07 h).  Recently, mechanistic studies have identified cell cycle mediators and the protein methionine aminopeptidase-2 (MetAP-2) as mol. targets of TNP-470 and fumagillin.  In early clin. reports, TNP-470 is tolerated up to 177 mg/m2 with neurotoxic effects (fatigue, vertigo, ataxia, and loss of concn.) being the principal dose limiting toxicity (DLT).  Animal studies confirm some toxic effects on normal angiogenic processes such as the female reproductive system and wound healing, which will require caution and close monitoring in the clinic.  TNP-470 is one of the first anti-angiogenic compds. to enter clin. trials, making it a valuable prototype for future trials of angiogenesis inhibitors in oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6wwOg1czqDbVg90H21EOLACvtfcHk0liCn8rr9meKzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktFWjsb4%253D&md5=9963aa3a5d14aaccbbb22a8c4bfdd85f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543784.9.6.1383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.9.6.1383%26sid%3Dliteratum%253Aachs%26aulast%3DKruger%26aufirst%3DE.%2BA.%26aulast%3DFigg%26aufirst%3DF.%2BD.%26atitle%3DTNP-470%253A%2520An%2520angiogenesis%2520inhibitor%2520in%2520clinical%2520development%2520for%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2000%26volume%3D9%26spage%3D1383%26epage%3D1396%26doi%3D10.1517%2F13543784.9.6.1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BaMaung, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker-Garia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morowitz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shusterman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maris, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniewski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span> <span> </span><span class="NLM_article-title">Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">7861</span>– <span class="NLM_lpage">7869</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7861-7869&author=J.+Wangauthor=G.+S.+Sheppardauthor=P.+Louauthor=M.+Kawaiauthor=N.+BaMaungauthor=S.+A.+Ericksonauthor=L.+Tucker-Gariaauthor=C.+Parkauthor=J.+Bouskaauthor=Y.+C.+Wangauthor=D.+Frostauthor=P.+Tapangauthor=D.+H.+Albertauthor=S.+J.+Morganauthor=M.+Morowitzauthor=S.+Shustermanauthor=J.+M.+Marisauthor=R.+Lesniewskiauthor=J.+Henkin&title=Tumor+suppression+by+a+rationally+designed+reversible+inhibitor+of+methionine+aminopeptidase-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DBaMaung%26aufirst%3DN.%26aulast%3DErickson%26aufirst%3DS.%2BA.%26aulast%3DTucker-Garia%26aufirst%3DL.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DBouska%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DFrost%26aufirst%3DD.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DMorgan%26aufirst%3DS.%2BJ.%26aulast%3DMorowitz%26aufirst%3DM.%26aulast%3DShusterman%26aufirst%3DS.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DLesniewski%26aufirst%3DR.%26aulast%3DHenkin%26aufirst%3DJ.%26atitle%3DTumor%2520suppression%2520by%2520a%2520rationally%2520designed%2520reversible%2520inhibitor%2520of%2520methionine%2520aminopeptidase-2%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D22%26spage%3D7861%26epage%3D7869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenney, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, P.</span></span> <span> </span><span class="NLM_article-title">The bengamides: A mini-review of natural sources, analogues, biological properties, biosynthetic origins, and future prospects</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">740</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.6b00970</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.6b00970" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlGksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=740-755&author=K.+N.+Whiteauthor=K.+Tenneyauthor=P.+Crews&title=The+bengamides%3A+A+mini-review+of+natural+sources%2C+analogues%2C+biological+properties%2C+biosynthetic+origins%2C+and+future+prospects&doi=10.1021%2Facs.jnatprod.6b00970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Bengamides: A Mini-Review of Natural Sources, Analogues, Biological Properties, Biosynthetic Origins, and Future Prospects</span></div><div class="casAuthors">White, Kimberly N.; Tenney, Karen; Crews, Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">740-755</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  This review focuses entirely on the natural bengamides and selected synthetic analogs that have inspired decades of research.  Bengamide A was first reported in 1986 from the sponge Jaspis cf. coriacea, and bengamide-contg. sponges have been gathered from many biogeog. sites.  In 2005, a terrestrial Gram-neg. bacterium, Myxococcus virescens, was added as a source for bengamides.  Biol. activity data using varying bengamide-based scaffolds has enabled fine-tuning of structure-activity relationships.  Mol. target finding contributed to the creation of a synthetic "lead" compd., LAF389, that was the subject of a phase I anticancer clin. trial.  Despite clin. trial termination, the bengamide compd. class is still attracting worldwide attention.  Future breakthroughs based on the bengamide scaffold are possible and could build on their nanomolar in vitro and pos. in vivo antiproliferative and antiangiogenic properties.  Bengamide mol. targets include methionine aminopeptidases (MetAP1 and MetAP2) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB).  A mixed PKS/NRPS biosynthetic gene cluster appears to be responsible for creation of the bengamides.  This review highlights that the bengamides have driven inspirational studies and that they will remain relevant for future research, even 30 years after the discovery of the first structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo05ZANtPfNc7Vg90H21EOLACvtfcHk0liCn8rr9meKzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlGksLY%253D&md5=99921eaff0fdbd23dcba1d9289856c4c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.6b00970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.6b00970%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DK.%2BN.%26aulast%3DTenney%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DP.%26atitle%3DThe%2520bengamides%253A%2520A%2520mini-review%2520of%2520natural%2520sources%252C%2520analogues%252C%2520biological%2520properties%252C%2520biosynthetic%2520origins%252C%2520and%2520future%2520prospects%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2017%26volume%3D80%26spage%3D740%26epage%3D755%26doi%3D10.1021%2Facs.jnatprod.6b00970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidanze, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BaMaung, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedrow, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolaczkowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantei, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palazzo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker-Garcia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniewski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidsen, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. L.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: A structural basis for the reduction of albumin binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3832</span>– <span class="NLM_lpage">3849</span>, <span class="refDoi"> DOI: 10.1021/jm0601001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0601001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFent74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3832-3849&author=G.+S.+Sheppardauthor=J.+Wangauthor=M.+Kawaiauthor=S.+D.+Fidanzeauthor=N.+Y.+BaMaungauthor=S.+A.+Ericksonauthor=D.+M.+Barnesauthor=J.+S.+Tedrowauthor=L.+Kolaczkowskiauthor=A.+Vasudevanauthor=D.+C.+Parkauthor=G.+T.+Wangauthor=W.+J.+Sandersauthor=R.+A.+Manteiauthor=F.+Palazzoauthor=L.+Tucker-Garciaauthor=P.+Louauthor=Q.+Zhangauthor=C.+H.+Parkauthor=K.+H.+Kimauthor=A.+Petrosauthor=E.+Olejniczakauthor=D.+Nettesheimauthor=P.+Hajdukauthor=J.+Henkinauthor=R.+Lesniewskiauthor=S.+K.+Davidsenauthor=R.+L.+Bell&title=Discovery+and+optimization+of+anthranilic+acid+sulfonamides+as+inhibitors+of+methionine+aminopeptidase-2%3A+A+structural+basis+for+the+reduction+of+albumin+binding&doi=10.1021%2Fjm0601001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Anthranilic Acid Sulfonamides as Inhibitors of Methionine Aminopeptidase-2: A Structural Basis for the Reduction of Albumin Binding</span></div><div class="casAuthors">Sheppard, George S.; Wang, Jieyi; Kawai, Megumi; Fidanze, Steve D.; BaMaung, Nwe Y.; Erickson, Scott A.; Barnes, David M.; Tedrow, Jason S.; Kolaczkowski, Lawrence; Vasudevan, Anil; Park, David C.; Wang, Gary T.; Sanders, William J.; Mantei, Robert A.; Palazzo, Fabio; Tucker-Garcia, Lora; Lou, Pingping; Zhang, Qian; Park, Chang H.; Kim, Ki H.; Petros, Andrew; Olejniczak, Edward; Nettesheim, David; Hajduk, Phillip; Henkin, Jack; Lesniewski, Richard; Davidsen, Steven K.; Bell, Randy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3832-3849</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methionine aminopeptidase-2 (MetAP2) is a novel target for cancer therapy.  As part of an effort to discover orally active reversible inhibitors of MetAP2, a series of anthranilic acid sulfonamides with micromolar affinities for human MetAP2 were identified using affinity selection by mass spectrometry (ASMS) screening.  These micromolar hits were rapidly improved to nanomolar leads on the basis of insights from protein crystallog.; however, the compds. displayed extensive binding to human serum albumin and had limited activity in cellular assays.  Modifications based on structural information on the binding of lead compds. to both MetAP2 and domain III of albumin allowed the identification of compds. with significant improvements in both parameters, which showed good cellular activity in both proliferation and methionine processing assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogG0eQ-sDeVrVg90H21EOLACvtfcHk0lhY1QWfAhffkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFent74%253D&md5=3d1a68c7397d9483647b0e099f3885cc</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm0601001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601001%26sid%3Dliteratum%253Aachs%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26aulast%3DBaMaung%26aufirst%3DN.%2BY.%26aulast%3DErickson%26aufirst%3DS.%2BA.%26aulast%3DBarnes%26aufirst%3DD.%2BM.%26aulast%3DTedrow%26aufirst%3DJ.%2BS.%26aulast%3DKolaczkowski%26aufirst%3DL.%26aulast%3DVasudevan%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DG.%2BT.%26aulast%3DSanders%26aufirst%3DW.%2BJ.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DPalazzo%26aufirst%3DF.%26aulast%3DTucker-Garcia%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DPetros%26aufirst%3DA.%26aulast%3DOlejniczak%26aufirst%3DE.%26aulast%3DNettesheim%26aufirst%3DD.%26aulast%3DHajduk%26aufirst%3DP.%26aulast%3DHenkin%26aufirst%3DJ.%26aulast%3DLesniewski%26aufirst%3DR.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DBell%26aufirst%3DR.%2BL.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520anthranilic%2520acid%2520sulfonamides%2520as%2520inhibitors%2520of%2520methionine%2520aminopeptidase-2%253A%2520A%2520structural%2520basis%2520for%2520the%2520reduction%2520of%2520albumin%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3832%26epage%3D3849%26doi%3D10.1021%2Fjm0601001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marino, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattern, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomazek, T. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S. K.</span></span> <span> </span><span class="NLM_article-title">Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3777</span>– <span class="NLM_lpage">3785</span>, <span class="refDoi"> DOI: 10.1021/jm061182w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061182w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslGqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3777-3785&author=J.+P.+Marinoauthor=P.+W.+Fisherauthor=G.+A.+Hofmannauthor=R.+B.+Kirkpatrickauthor=C.+A.+Jansonauthor=R.+K.+Johnsonauthor=C.+Maauthor=M.+Matternauthor=T.+D.+Meekauthor=M.+D.+Ryanauthor=C.+Schulzauthor=W.+W.+Smithauthor=D.+G.+Tewauthor=T.+A.+Tomazekauthor=D.+F.+Veberauthor=W.+C.+Xiongauthor=Y.+Yamamotoauthor=K.+Yamashitaauthor=G.+Yangauthor=S.+K.+Thompson&title=Highly+potent+inhibitors+of+methionine+aminopeptidase-2+based+on+a+1%2C2%2C4-triazole+pharmacophore&doi=10.1021%2Fjm061182w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent Inhibitors of Methionine Aminopeptidase-2 Based on a 1,2,4-Triazole Pharmacophore</span></div><div class="casAuthors">Marino, Joseph P., Jr.; Fisher, Paul W.; Hofmann, Glenn A.; Kirkpatrick, Robert B.; Janson, Cheryl A.; Johnson, Randall K.; Ma, Chun; Mattern, Michael; Meek, Thomas D.; Ryan, M. Dominic; Schulz, Christina; Smith, Ward W.; Tew, David G.; Tomazek, Thaddeus A., Jr.; Veber, Daniel F.; Xiong, Wenfang C.; Yamamoto, Yuuichi; Yamashita, Keizo; Yang, Guang; Thompson, Scott K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3777-3785</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High-throughput screening for inhibitors of the human metalloprotease, methionine aminopeptidase-2 (MetAP2), identified a potent class of 3-anilino-5-benzylthio-1,2,4-triazole compds.  Efficient array and interative synthesis of triazoles led to rapid SAR development around the aniline, benzylthio, and triazole moieties.  Evaluation of these analogs in a human MetAP2 enzyme assay led to the identification of several inhibitors with potencies in the 50-100 picomolar range.  The deleterious effects on inhibitor potency by methylation of the anilino-triazole nitrogens, as well as the X-ray crystal structure of triazole I bound in the active site of MetAP2, confirm the key interactions between the triazole nitrogens, the active site cobalt atoms, and the His-231 side-chain.  The structure has also provided a rationale for interpreting SAR within the triazole series.  Key aniline (2-isopropylphenyl) and sulfur substituents (furanylmethyl) identified in the SAR studies led to the identification of potent inhibitors (II and III) of endothelial cell proliferation.  Triazoles II and III also exhibited dose-dependent activity in an aortic ring tissue model of angiogenesis highlighting the potential utility of MetAP2 inhibitors as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ4trPzfxMH7Vg90H21EOLACvtfcHk0lhY1QWfAhffkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslGqt7Y%253D&md5=4a598306bdc2c1f4d78f813029a6f557</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm061182w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061182w%26sid%3Dliteratum%253Aachs%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DFisher%26aufirst%3DP.%2BW.%26aulast%3DHofmann%26aufirst%3DG.%2BA.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DR.%2BK.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DMattern%26aufirst%3DM.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DRyan%26aufirst%3DM.%2BD.%26aulast%3DSchulz%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DTomazek%26aufirst%3DT.%2BA.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DXiong%26aufirst%3DW.%2BC.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DThompson%26aufirst%3DS.%2BK.%26atitle%3DHighly%2520potent%2520inhibitors%2520of%2520methionine%2520aminopeptidase-2%2520based%2520on%2520a%25201%252C2%252C4-triazole%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3777%26epage%3D3785%26doi%3D10.1021%2Fjm061182w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cezanne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bomke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friese-Hamim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knochel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, F.</span></span> <span> </span><span class="NLM_article-title">Novel reversible methionine aminopeptidase-2 (MetAP-2) inhibitors based on purine and related bicyclic templates</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1016%2Fj.bmcl.2016.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=27998678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFamtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=551-556&author=T.+Heinrichauthor=H.-P.+Buchstallerauthor=B.+Cezanneauthor=F.+Rohdichauthor=J.+Bomkeauthor=M.+Friese-Hamimauthor=M.+Krierauthor=T.+Knochelauthor=D.+Musilauthor=B.+Leuthnerauthor=F.+Zenke&title=Novel+reversible+methionine+aminopeptidase-2+%28MetAP-2%29+inhibitors+based+on+purine+and+related+bicyclic+templates&doi=10.1016%2Fj.bmcl.2016.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Novel reversible methionine aminopeptidase-2 (MetAP-2) inhibitors based on purine and related bicyclic templates</span></div><div class="casAuthors">Heinrich, Timo; Buchstaller, Hans-Peter; Cezanne, Bertram; Rohdich, Felix; Bomke, Joerg; Friese-Hamim, Manja; Krier, Mireille; Knoechel, Thorsten; Musil, Djordje; Leuthner, Birgitta; Zenke, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">551-556</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The natural product fumagillin 1 and derivs. like TNP-470 2 or beloranib 3 bind to methionine aminopeptidase 2 (MetAP-2) irreversibly.  This enzyme is crit. for protein maturation and plays a key role in angiogenesis.  In this paper we describe the synthesis, MetAP-2 binding affinity and structural anal. of reversible MetAP-2 inhibitors.  Optimization of enzymic activity of screening hit 10 (IC50: 1 μM) led to the most potent compd. 27 (IC50: 0.038 μM), with a concomitant improvement in LLE from 2.1 to 4.2.  Structural anal. of these MetAP-2 inhibitors revealed an unprecedented conformation of the His339 side-chain imidazole ring being co-planar sandwiched between the imidazole of His331 and the aryl-ether moiety, which is bound to the purine scaffold.  Systematic alteration and redn. of H-bonding capability of this metal binding moiety induced an unexpected 180° flip for the triazolo[1,5-a]pyrimdine bicyclic template.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_0XQ7H4uUXLVg90H21EOLACvtfcHk0liZHDe23W5dng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFamtLrN&md5=fb10c549d94343a4cc37da474b609b65</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DBuchstaller%26aufirst%3DH.-P.%26aulast%3DCezanne%26aufirst%3DB.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DBomke%26aufirst%3DJ.%26aulast%3DFriese-Hamim%26aufirst%3DM.%26aulast%3DKrier%26aufirst%3DM.%26aulast%3DKnochel%26aufirst%3DT.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DZenke%26aufirst%3DF.%26atitle%3DNovel%2520reversible%2520methionine%2520aminopeptidase-2%2520%2528MetAP-2%2529%2520inhibitors%2520based%2520on%2520purine%2520and%2520related%2520bicyclic%2520templates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D551%26epage%3D556%26doi%3D10.1016%2Fj.bmcl.2016.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniewski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span> <span> </span><span class="NLM_article-title">Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">5035</span>– <span class="NLM_lpage">5042</span>, <span class="refDoi"> DOI: 10.1021/bi020670c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi020670c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislSitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=5035-5042&author=J.+Wangauthor=G.+S.+Sheppardauthor=P.+Louauthor=M.+Kawaiauthor=C.+Parkauthor=D.+A.+Eganauthor=A.+Schneiderauthor=J.+Bouskaauthor=R.+Lesniewskiauthor=J.+Henkin&title=Physiologically+relevant+metal+cofactor+for+methionine+aminopeptidase-2+is+manganese&doi=10.1021%2Fbi020670c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Physiologically Relevant Metal Cofactor for Methionine Aminopeptidase-2 Is Manganese</span></div><div class="casAuthors">Wang, Jieyi; Sheppard, George S.; Lou, Pingping; Kawai, Megumi; Park, Chang; Egan, David A.; Schneider, Andrew; Bouska, Jennifer; Lesniewski, Rick; Henkin, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5035-5042</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identity of the physiol. metal cofactor for human methionine aminopeptidase-2 (MetAP2) has not been established.  To examine this question, we first investigated the effect of eight divalent metal ions, including Ca2+, Co2+, Cu2+, Fe2+, Mg2+, Mn2+, Ni2+, and Zn2+, on recombinant human methionine aminopeptidase apoenzymes in releasing N-terminal methionine from three peptide substrates: MAS, MGAQFSKT, and 3H-MASK(biotin)G.  The activity of MetAP2 on either MAS or MGAQFSKT was enhanced 15-25-fold by Co2+ or Mn2+ metal ions in a broad concn. range (1-1000 μM).  In the presence of reduced glutathione to mimic the cellular environment, Co2+ and Mn2+ were also the best stimulators (∼30-fold) for MetAP2 enzyme activity.  To det. which metal ion is physiol. relevant, we then tested inhibition of intracellular MetAP2 with synthetic inhibitors selective for MetAP2 with different metal cofactors.  A-310840 below 10 μM did not inhibit the activity of MetAP2-Mn2+ but was very potent against MetAP2 with other metal ions including Co2+, Fe2+, Ni2+, and Zn2+ in the in vitro enzyme assays.  In contrast, A-311263 inhibited MetAP2 with Mn2+, as well as Co2+, Fe2+, Ni2+, and Zn2+.  In cell culture assays, A-310840 did not inhibit intracellular MetAP2 enzyme activity and did not inhibit cell proliferation despite its ability to permeate and accumulate in cytosol, while A-311263 inhibited both intracellular MetAP2 and proliferation in a similar concn. range, indicating cellular MetAP2 is functioning as a manganese enzyme but not as a cobalt, zinc, iron, or nickel enzyme.  We conclude that MetAP2 is a manganese enzyme and that therapeutic MetAP2 inhibitors should inhibit MetAP2-Mn2+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnOVJL9uJhw7Vg90H21EOLACvtfcHk0liZHDe23W5dng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislSitrY%253D&md5=cb8ddc7017dc11f1327a0d83fcb2d417</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi020670c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi020670c%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DEgan%26aufirst%3DD.%2BA.%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DBouska%26aufirst%3DJ.%26aulast%3DLesniewski%26aufirst%3DR.%26aulast%3DHenkin%26aufirst%3DJ.%26atitle%3DPhysiologically%2520relevant%2520metal%2520cofactor%2520for%2520methionine%2520aminopeptidase-2%2520is%2520manganese%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26spage%3D5035%26epage%3D5042%26doi%3D10.1021%2Fbi020670c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seenisamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blume, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bomke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friese-Hamim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, T. F.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-based optimization of next generation reversible methionine aminopeptidase-2 (MetAP-2) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5025</span>– <span class="NLM_lpage">5039</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00041</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC1MXms1aiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5025-5039&author=T.+Heinrichauthor=J.+Seenisamyauthor=B.+Blumeauthor=J.+Bomkeauthor=M.+Calderiniauthor=U.+Eckertauthor=M.+Friese-Hamimauthor=M.+Lehmannauthor=B.+Leuthnerauthor=D.+Musilauthor=F.+Rohdichauthor=T.+F.+Zenke&title=Discovery+and+structure-based+optimization+of+next+generation+reversible+methionine+aminopeptidase-2+%28MetAP-2%29+inhibitors&doi=10.1021%2Facs.jmedchem.9b00041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors</span></div><div class="casAuthors">Heinrich, Timo; Seenisamy, Jeyaprakashnarayanan; Blume, Beatrix; Bomke, Joerg; Calderini, Michel; Eckert, Uwe; Friese-Hamim, Manja; Kohl, Rainer; Lehmann, Martin; Leuthner, Birgitta; Musil, Djordje; Rohdich, Felix; Zenke, Frank T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5025-5039</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Co- and posttranslational processing are crucial maturation steps to generate functional proteins.  MetAP-2 plays an important role in this process and inhibition of its proteolytic activity has been shown to be important for angiogenesis and tumor growth suggesting that small mol. inhibitors of MetAP-2 may be promising options for the treatment of cancer.  This work describes the discovery and structure-based hit optimization of a novel MetAP-2 inhibitory scaffold.  Of crit. importance, a cyclic tartronic diamide coordinates the MetAP-2 metal ion in the active site while addnl. side chains of the mol. were designed to occupy the liphophilic methionine side chain recognition pocket as well as the shallow cavity at the opening of the active site.  The racemic screening hit from a HTS campaign I was discovered with an enzymic IC50 of 150 nM.  The resynthesized eutomer confirmed this activity and inhibited HUVEC proliferation with an IC50 of 1.9 μM.  Its structural anal. revealed a sophisticated interaction pattern of polar and lipophilic contacts that were used to improve cellular potency to an IC50 of 15 nM.  In parallel, the mol. properties were optimized on plasma exposure and antitumor efficacy which led to the identification of advanced lead II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsd8oNNAZALLVg90H21EOLACvtfcHk0liZHDe23W5dng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXms1aiu7c%253D&md5=d3841fb334e4d75cc5050936c882fa2b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00041%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DSeenisamy%26aufirst%3DJ.%26aulast%3DBlume%26aufirst%3DB.%26aulast%3DBomke%26aufirst%3DJ.%26aulast%3DCalderini%26aufirst%3DM.%26aulast%3DEckert%26aufirst%3DU.%26aulast%3DFriese-Hamim%26aufirst%3DM.%26aulast%3DLehmann%26aufirst%3DM.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DZenke%26aufirst%3DT.%2BF.%26atitle%3DDiscovery%2520and%2520structure-based%2520optimization%2520of%2520next%2520generation%2520reversible%2520methionine%2520aminopeptidase-2%2520%2528MetAP-2%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5025%26epage%3D5039%26doi%3D10.1021%2Facs.jmedchem.9b00041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Exner, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeckler, F. M.</span></span> <span> </span><span class="NLM_article-title">Using surface scans for the evaluation of halogen bonds toward the side chains of aspartate, asparagine, glutamate, and glutamine</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1373</span>– <span class="NLM_lpage">1383</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.6b00075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.6b00075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSrtLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2016&pages=1373-1383&author=M.+O.+Zimmermannauthor=A.+Langeauthor=S.+Zahnauthor=T.+E.+Exnerauthor=F.+M.+Boeckler&title=Using+surface+scans+for+the+evaluation+of+halogen+bonds+toward+the+side+chains+of+aspartate%2C+asparagine%2C+glutamate%2C+and+glutamine&doi=10.1021%2Facs.jcim.6b00075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Using surface scans for the evaluation of halogen bonds toward the side chains of aspartate, asparagine, glutamate, and glutamine</span></div><div class="casAuthors">Zimmermann, Markus O.; Lange, Andreas; Zahn, Stefan; Exner, Thomas E.; Boeckler, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1373-1383</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using halogen-specific Connolly type mol. surfaces, we herein invented a new type of surface-based interaction anal. employed for the study of halogen bonding toward model systems of biol. relevant carboxylates (ASP/GLU) and carboxamides (ASN/GLN).  Database mining and statistical assessment of the PDB revealed that such interactions are widely underrepresented at the moment.  We obsd. important distance-dependent adaptation of the binding modes of halobenzenes from a preferential oxygen-directed to a bifurcated interaction geometry of the carboxylate.  In addn., halogen···π contacts perpendicular to the nitrogen atom of the carboxamide become increasingly important for the lighter halogens.  Our anal. on a MP2/TZVPP level of theory is backed by CCSD(T)/CBS ref. calcns.  To put the vast interaction energies into perspective, we also performed COSMO-RS calcns. of the solvation free energy.  Facilitating the visualization of our results mapped onto any binding site of choice, we aim to inspire more design studies showcasing these underrepresented interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5NarrHjH8HrVg90H21EOLACvtfcHk0lgx9Sp_XYrfxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSrtLbI&md5=a0b63faead8bbb541ae0344223c10869</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.6b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.6b00075%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DM.%2BO.%26aulast%3DLange%26aufirst%3DA.%26aulast%3DZahn%26aufirst%3DS.%26aulast%3DExner%26aufirst%3DT.%2BE.%26aulast%3DBoeckler%26aufirst%3DF.%2BM.%26atitle%3DUsing%2520surface%2520scans%2520for%2520the%2520evaluation%2520of%2520halogen%2520bonds%2520toward%2520the%2520side%2520chains%2520of%2520aspartate%252C%2520asparagine%252C%2520glutamate%252C%2520and%2520glutamine%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2016%26volume%3D56%26spage%3D1373%26epage%3D1383%26doi%3D10.1021%2Facs.jcim.6b00075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabelli, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacev, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenney, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span> <span> </span><span class="NLM_article-title">Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3996</span>– <span class="NLM_lpage">4016</span>, <span class="refDoi"> DOI: 10.1021/jm400227z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400227z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVyhu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3996-4016&author=F.+Zhangauthor=S.+Bhatauthor=S.+B.+Gabelliauthor=X.+Chenauthor=M.+S.+Millerauthor=B.+A.+Nacevauthor=Y.+L.+Chengauthor=D.+J.+Meyersauthor=K.+Tenneyauthor=J.+S.+Shimauthor=P.+Crewsauthor=L.+M.+Amzelauthor=D.+Maauthor=J.+O.+Liu&title=Pyridinylquinazolines+selectively+inhibit+human+methionine+aminopeptidase-1+in+cells&doi=10.1021%2Fjm400227z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridinylquinazolines Selectively Inhibit Human Methionine Aminopeptidase-1 in Cells</span></div><div class="casAuthors">Zhang, Feiran; Bhat, Shridhar; Gabelli, Sandra B.; Chen, Xiaochun; Miller, Michelle S.; Nacev, Benjamin A.; Cheng, Yim Ling; Meyers, David J.; Tenney, Karen; Shim, Joong Sup; Crews, Phillip; Amzel, L. Mario; Ma, Dawei; Liu, Jun O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3996-4016</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methionine aminopeptidases (MetAPs), which remove the initiator methionine from nascent peptides, are essential in all organisms.  While MetAP2 has been demonstrated to be a therapeutic target for inhibiting angiogenesis in mammals, MetAP1 seems to be vital for cell proliferation.  The authors' earlier efforts identified two structural classes of human MetAP1 (HsMetAP1)-selective inhibitors, but all of them failed to inhibit cellular HsMetAP1.  Using Mn(II) or Zn(II) to activate HsMetAP1, the authors found that select inhibitors could only effectively inhibit purified HsMetAP1 in the presence of physiol. unachievable concns. of Co(II).  In an effort to seek Co(II)-independent inhibitors, a novel structural class contg. a 2-(pyridin-2-yl)quinazoline core has been discovered.  Many compds. in this class potently and selectively inhibited HsMetAP1 without Co(II).  Subsequently, the authors demonstrated 4-[4-(4-Methoxyphenyl)piperazin-1-yl]-2-(pyridin-2-yl)-quinazoline, an auxiliary metal-dependent inhibitor, effectively inhibited HsMetAP1 in primary cells.  This is the first report that an HsMetAP1-selective inhibitor is effective against its target in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmoPt5R9K8a7Vg90H21EOLACvtfcHk0lgx9Sp_XYrfxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVyhu74%253D&md5=0409345988d6f77f2ba5fa51193e9bc1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm400227z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400227z%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DBhat%26aufirst%3DS.%26aulast%3DGabelli%26aufirst%3DS.%2BB.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DMiller%26aufirst%3DM.%2BS.%26aulast%3DNacev%26aufirst%3DB.%2BA.%26aulast%3DCheng%26aufirst%3DY.%2BL.%26aulast%3DMeyers%26aufirst%3DD.%2BJ.%26aulast%3DTenney%26aufirst%3DK.%26aulast%3DShim%26aufirst%3DJ.%2BS.%26aulast%3DCrews%26aufirst%3DP.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26atitle%3DPyridinylquinazolines%2520selectively%2520inhibit%2520human%2520methionine%2520aminopeptidase-1%2520in%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3996%26epage%3D4016%26doi%3D10.1021%2Fjm400227z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y. H.</span></span> <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">12357</span>– <span class="NLM_lpage">12361</span>, <span class="refDoi"> DOI: 10.1073/pnas.92.26.12357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1073%2Fpnas.92.26.12357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=8618900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADyaK28Xhtl2muw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Li%2C+X.%3B+Chang%2C+Y.+H.+Proc.+Natl.+Acad.+Sci.+U.+S.+A.+1995%2C+92%2C+12357%E2%80%9312361%2C+10.1073%2Fpnas.92.26.12357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases</span></div><div class="casAuthors">Li, Xuan; Chang, Yie-Hwa</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">12357-61</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We previously characterized a methionine aminopeptidase (EC 3.4.11.18; Met-AP1; also called peptidase M) in Saccharomyces cerevisiae, which differs from its prokaryotic homologs in that it (i) contains an N-terminal zinc-finger domain and (ii) does not produce lethality when disrupted, although it does slow growth dramatically; it is encoded by a gene called MAP1.  Here we describe a second methionine aminopeptidase (Met-AP2) in S. cerevisiae, encoded by MAP2, which was cloned as a suppressor of the slow-growth phenotype of the map1 null strain.  The DNA sequence of MAP2 encodes a protein of 421 amino acids that shows 22% identity with the sequence of yeast Met-AP1.  Surprisingly, comparison with sequences in the GenBank data base showed that the product of MAP2 has even greater homol. (55% identity) with rat p67, which was characterized as an initiation factor 2-assocd. protein but not yet shown to have Met-AP activity.  Transformants of map1 null cells expressing MAP2 in a high-copy-no. plasmid contained 3- to 12-fold increases in Met-AP activity on different peptide substrates.  The epitope-tagged suppressor gene product was purified by immunoaffinity chromatog. and shown to contain Met-AP activity.  To evaluate the physiol. significance of Met-AP2, the MAP2 gene was deleted from wild-type and map1 null yeast strains.  The map2 null strain, like the map1 null strain, is viable but with a slower growth rate.  The map1, map2 double-null strains are nonviable.  Thus, removal of N-terminal methionine is an essential function in yeast, as in prokaryotes, but yeast require two methionine aminopeptidases to provide the essential function which can only be partially provided by Met-AP1 or Met-AP2 alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTth2TLXouprVg90H21EOLACvtfcHk0lgx9Sp_XYrfxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xhtl2muw%253D%253D&md5=e73add916a407e1e626356ff0b178be2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.26.12357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.26.12357%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DY.%2BH.%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D12357%26epage%3D12361%26doi%3D10.1073%2Fpnas.92.26.12357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antoine, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannus, S.</span></span> <span> </span><span class="NLM_article-title">Homogeneous time-resolved G protein-coupled receptor-ligand binding assay based on fluorescence cross-correlation spectroscopy</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>502</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2016.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1016%2Fj.ab.2016.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=26954998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVWmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=502&publication_year=2016&pages=24-35&author=T.+Antoineauthor=D.+Ottauthor=K.+Ebellauthor=K.+Hansenauthor=L.+Henryauthor=F.+Beckerauthor=S.+Hannus&title=Homogeneous+time-resolved+G+protein-coupled+receptor-ligand+binding+assay+based+on+fluorescence+cross-correlation+spectroscopy&doi=10.1016%2Fj.ab.2016.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Homogeneous time-resolved G protein-coupled receptor-ligand binding assay based on fluorescence cross-correlation spectroscopy</span></div><div class="casAuthors">Antoine, Thomas; Ott, David; Ebell, Katharina; Hansen, Kerrin; Henry, Luc; Becker, Frank; Hannus, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">502</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-35</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) mediate many important physiol. functions and are considered as one of the most successful therapeutic target classes for a wide spectrum of diseases.  Drug discovery projects generally benefit from a broad range of exptl. approaches for screening compd. libraries and for the characterization of binding modes of drug candidates.  Owing to the difficulties in solubilizing and purifying GPCRs, assay formats have been so far mainly limited to cell-based functional assays and radioligand binding assays.  In this study, we used fluorescence cross-correlation spectroscopy (FCCS) to analyze the interaction of detergent-solubilized receptors to various types of GPCR ligands: endogenous peptides, small mols., and a large surrogate antagonist represented by a blocking monoclonal antibody.  Our work demonstrates the suitability of the homogeneous and time-resolved FCCS assay format for a robust, high-throughput detn. of receptor-ligand binding affinities and kinetic rate consts. for various therapeutically relevant GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOYce-xGzJ67Vg90H21EOLACvtfcHk0lgx9Sp_XYrfxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVWmsrk%253D&md5=7035221d68a3e982e4b665ea7a70e858</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2016.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2016.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DAntoine%26aufirst%3DT.%26aulast%3DOtt%26aufirst%3DD.%26aulast%3DEbell%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DHenry%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DF.%26aulast%3DHannus%26aufirst%3DS.%26atitle%3DHomogeneous%2520time-resolved%2520G%2520protein-coupled%2520receptor-ligand%2520binding%2520assay%2520based%2520on%2520fluorescence%2520cross-correlation%2520spectroscopy%26jtitle%3DAnal.%2520Biochem.%26date%3D2016%26volume%3D502%26spage%3D24%26epage%3D35%26doi%3D10.1016%2Fj.ab.2016.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung-Chi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (IC<sub>50</sub>) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=4202581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=C.+Yung-Chiauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28K1%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28IC50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DYung-Chi%26aufirst%3DC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528K1%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528IC50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hannus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beitzinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelmann, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weickert, M.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, G.</span></span> <span> </span><span class="NLM_article-title">siPools: highly complex but accurately defined siRNA pools eliminate off-target effects</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">8049</span>– <span class="NLM_lpage">8061</span>, <span class="refDoi"> DOI: 10.1093/nar/gku480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1093%2Fnar%2Fgku480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=24875475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCqsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=8049-8061&author=M.+Hannusauthor=M.+Beitzingerauthor=J.+C.+Engelmannauthor=M.-T.+Weickertauthor=R.+Spangauthor=S.+Hannusauthor=G.+Meister&title=siPools%3A+highly+complex+but+accurately+defined+siRNA+pools+eliminate+off-target+effects&doi=10.1093%2Fnar%2Fgku480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">siPools: highly complex but accurately defined siRNA pools eliminate off-target effects</span></div><div class="casAuthors">Hannus, Michael; Beitzinger, Michaela; Engelmann, Julia C.; Weickert, Marie-Theresa; Spang, Rainer; Hannus, Stefan; Meister, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8049-8061</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Short interfering RNAs (siRNAs) are widely used as tool for gene inactivation in basic research and therapeutic applications.  One of the major shortcomings of siRNA expts. are sequence-specific off-target effects.  Such effects are largely unpredictable because siRNAs can affect partially complementary sequences and function like microRNAs (miRNAs), which inhibit gene expression on mRNA stability or translational levels.  Here we demonstrate that novel, enzymically generated siRNA pools-referred to as siPools-contg. up to 60 accurately defined siRNAs eliminate off-target effects.  This is achieved by the low concn. of each individual siRNA dilg. sequence-specific off-target effects below detection limits.  In fact, whole transcriptome analyses reveal that single siRNA transfections can severely affect global gene expression.  However, when complex siRNA pools are transfected, almost no transcriptome alterations are obsd.  Taken together, we present enzymically produced complex but accurately defined siRNA pools with potent on-target silencing but without detectable off-target effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHBEMb-YiZK7Vg90H21EOLACvtfcHk0lgStOy9YT_BHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCqsrjL&md5=b5306bf86eb8d896cff94bb42b162d5f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgku480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgku480%26sid%3Dliteratum%253Aachs%26aulast%3DHannus%26aufirst%3DM.%26aulast%3DBeitzinger%26aufirst%3DM.%26aulast%3DEngelmann%26aufirst%3DJ.%2BC.%26aulast%3DWeickert%26aufirst%3DM.-T.%26aulast%3DSpang%26aufirst%3DR.%26aulast%3DHannus%26aufirst%3DS.%26aulast%3DMeister%26aufirst%3DG.%26atitle%3DsiPools%253A%2520highly%2520complex%2520but%2520accurately%2520defined%2520siRNA%2520pools%2520eliminate%2520off-target%2520effects%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26spage%3D8049%26epage%3D8061%26doi%3D10.1093%2Fnar%2Fgku480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="note"><p class="first last">AUC free @ 1 mg/kg iv [nM  h] = AUC/MW × fub.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last"><i>C</i><sub>ave</sub>, free @ 1 mg/kg iv [nM] = AUC free @ 1 mpk/24.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">IC<sub>50</sub>, cell free [nM] = HUVEC IC<sub>50</sub> × fub (5% fetal calf serum).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rager, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kardos, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, I. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1016/j.ijpharm.2004.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1016%2Fj.ijpharm.2004.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=15620875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGhurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2005&pages=349-359&author=Q.+Wangauthor=J.+D.+Ragerauthor=K.+Weinsteinauthor=P.+S.+Kardosauthor=G.+L.+Dobsonauthor=J.+Liauthor=I.+J.+Hidalgo&title=Evaluation+of+the+MDR-MDCK+cell+line+as+a+permeability+screen+for+the+blood-brain+barrier&doi=10.1016%2Fj.ijpharm.2004.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier</span></div><div class="casAuthors">Wang, Qing; Rager, Joseph D.; Weinstein, Kathryn; Kardos, Paula S.; Dobson, Glenn L.; Li, Jibin; Hidalgo, Ismael J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">349-359</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The objectives of this study were to (1) characterize MDR-MDCK monolayers as an in vitro model to predict brain uptake potential; (2) examine the ability of MDR-MDCK monolayers to identify the brain uptake potential of compds. that interact with P-glycoprotein (P-gp).  The study measured the bi-directional transport of 28 compds. across MDR-MDCK monolayers.  The brain uptake of a subset of the compds. was detd. in the rat brain perfusion model.  Drug concns. were analyzed by LC-MS-MS.  CNS-pos. drugs exhibited absorptive permeability coeffs. (Papp, A-B) values ranging from 3.4 × 10-6 to 20.2 × 10-6 cm/s; whereas CNS-neg. drugs showed Papp (A-B) ranging from 0.03 × 10-6 to 0.83 × 10-6 cm/s.  Inhibition of P-gp by cyclosporin A (CsA) significantly reduced secretory flux of compds. known to be P-pg substrates, but only enhanced the absorptive flux of compds. with high efflux ratio (>100).  In vitro results were confirmed by brain perfusion studies on selected compds.  MDR-MDCK monolayers can be used to classify compds. into CNS-pos. or CNS-neg. based on the permeability coeffs. (Papp, A-B).  Under the authors' exptl. conditions, compds. with Papp (A-B) >3 × 10-6 cm/s have high brain uptake potential; compds. with Papp (A-B) < 1 × 10-6 cm/s are unable to penetrate the blood-brain barrier (BBB); the brain uptake of compds. with Papp (A-B) < 1 × 10-6 cm/s and a P-gp-mediated efflux ratio of >100 may be enhanced by inhibiting P-gp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvF-zoLte8trVg90H21EOLACvtfcHk0lgStOy9YT_BHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGhurvE&md5=7d2cb9e13b2767b337bf808e73141ae1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2004.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2004.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DRager%26aufirst%3DJ.%2BD.%26aulast%3DWeinstein%26aufirst%3DK.%26aulast%3DKardos%26aufirst%3DP.%2BS.%26aulast%3DDobson%26aufirst%3DG.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHidalgo%26aufirst%3DI.%2BJ.%26atitle%3DEvaluation%2520of%2520the%2520MDR-MDCK%2520cell%2520line%2520as%2520a%2520permeability%2520screen%2520for%2520the%2520blood-brain%2520barrier%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2005%26volume%3D288%26spage%3D349%26epage%3D359%26doi%3D10.1016%2Fj.ijpharm.2004.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rzepa, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hii, K. K. M.</span></span> <span> </span><span class="NLM_article-title">Delineating origins of stereocontrol in asymmetric Pd-catalyzed a-hydroxylation of 1,3-ketoesters</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">3085</span>– <span class="NLM_lpage">3096</span>, <span class="refDoi"> DOI: 10.1021/jo1002906</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo1002906" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFeqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=3085-3096&author=A.+M.+R.+Smithauthor=H.+S.+Rzepaauthor=A.+J.+P.+Whiteauthor=D.+Billenauthor=K.+K.+M.+Hii&title=Delineating+origins+of+stereocontrol+in+asymmetric+Pd-catalyzed+a-hydroxylation+of+1%2C3-ketoesters&doi=10.1021%2Fjo1002906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Delineating Origins of Stereocontrol in Asymmetric Pd-Catalyzed α-Hydroxylation of 1,3-Ketoesters</span></div><div class="casAuthors">Smith, AlexanderM. R.; Rzepa, Henry S.; White, Andrew J. P.; Billen, Denis; Hii, King Kuok</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3085-3096</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Systematic studies of reaction conditions and subsequent optimization led to the identification of important parameters for stereoselectivity in the asym. α-hydroxylation reaction of 1,3-ketoesters.  Enantioselectivities of up to 98% can be achieved for cyclic substrates and 88% for acyclic ketoesters.  Subsequently, the combination of cyclic/acyclic ketoester, catalyst, and oxidant was found to have a profound effect on reaction rates and turnover-limiting steps.  The stereochem. of the reaction contradicts that obsd. for other similar electrophilic substitution reactions.  This was rationalized by transition-state modeling, which revealed a no. of cooperative weak interactions between oxidant, ligand, and counterion, together with C-H/π interactions that cumulatively account for the unusual stereoselectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOop3BMKBWxLVg90H21EOLACvtfcHk0lhsikEBVUnEqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFeqs7g%253D&md5=1d9305fa8479204590fdc1367bfa2141</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjo1002906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo1002906%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DA.%2BM.%2BR.%26aulast%3DRzepa%26aufirst%3DH.%2BS.%26aulast%3DWhite%26aufirst%3DA.%2BJ.%2BP.%26aulast%3DBillen%26aufirst%3DD.%26aulast%3DHii%26aufirst%3DK.%2BK.%2BM.%26atitle%3DDelineating%2520origins%2520of%2520stereocontrol%2520in%2520asymmetric%2520Pd-catalyzed%2520a-hydroxylation%2520of%25201%252C3-ketoesters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D3085%26epage%3D3096%26doi%3D10.1021%2Fjo1002906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. C.</span></span> <span> </span><span class="NLM_article-title">Asymmetric hydroxylation of enolates with N-sulfonyloxaziridines</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1021/cr00013a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr00013a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADyaK38XkvV2mtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1992&pages=919-934&author=F.+A.+Davisauthor=B.+C.+Chen&title=Asymmetric+hydroxylation+of+enolates+with+N-sulfonyloxaziridines&doi=10.1021%2Fcr00013a008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric hydroxylation of enolates with N-sulfonyloxaziridines</span></div><div class="casAuthors">Davis, Franklin A.; Chen, Bang Chi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">919-34</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    </div><div class="casAbstract">A review with 81 refs. on enantioselective synthesis of α-hydroxy carbonyl compds. by asym. hydroxylation of enolates using N-sulfonyloxaziridines, with particular emphasis on application in natural product synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt3Zc-tltJcbVg90H21EOLACvtfcHk0lhsikEBVUnEqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XkvV2mtbg%253D&md5=1db2ac18a11cd57a142aed7a0e75aac2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fcr00013a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00013a008%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DF.%2BA.%26aulast%3DChen%26aufirst%3DB.%2BC.%26atitle%3DAsymmetric%2520hydroxylation%2520of%2520enolates%2520with%2520N-sulfonyloxaziridines%26jtitle%3DChem.%2520Rev.%26date%3D1992%26volume%3D92%26spage%3D919%26epage%3D934%26doi%3D10.1021%2Fcr00013a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span> <span> </span><span class="NLM_article-title">Oxidation of 1,3-dicarbonyl compounds using (camphorylsulfonyl)oxaziridines</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">10481</span>– <span class="NLM_lpage">10492</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(98)00500-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1016%2FS0040-4020%2898%2900500-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVClsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=10481-10492&author=F.+A.+Davisauthor=H.+Liuauthor=B.-C.+Chenauthor=P.+Zhou&title=Oxidation+of+1%2C3-dicarbonyl+compounds+using+%28camphorylsulfonyl%29oxaziridines&doi=10.1016%2FS0040-4020%2898%2900500-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of 1,3-dicarbonyl compounds using (camphorylsulfonyl)oxaziridines</span></div><div class="casAuthors">Davis, Franklin A.; Liu, Hu; Chen, Bang-Chi; Zhou, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10481-10492</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The oxidn. of 1,3-dicarbonyl compds. with (camphorylsulfonyl)oxaziridines was studied in both cyclic and acyclic systems.  Two reaction pathways were identified: enolate α-hydroxylation and a novel Baeyer-Villiger type oxidn.  The Baeyer-Villiger oxidn. product was obsd. only for the ketones and arises via rearrangement of an alkoxy epoxide.  Synthetically useful ee's (82-95%) were obsd. only for enolates of β-ketoesters where the keto group is part of a 6-membered ring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE0-O-IH3x6bVg90H21EOLACvtfcHk0lhsikEBVUnEqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVClsbw%253D&md5=b8cffba5bbfdafa4825cd21b510f1688</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2898%2900500-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252898%252900500-6%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DF.%2BA.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DZhou%26aufirst%3DP.%26atitle%3DOxidation%2520of%25201%252C3-dicarbonyl%2520compounds%2520using%2520%2528camphorylsulfonyl%2529oxaziridines%26jtitle%3DTetrahedron%26date%3D1998%26volume%3D54%26spage%3D10481%26epage%3D10492%26doi%3D10.1016%2FS0040-4020%2898%2900500-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candela-Lena, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Fernandez, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J. E.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis of N, O, O, O-tetra-acetyl D-lyxophytosphingosine, jaspine B (pachastrissamine) and its C(2)-epimer</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2510</span>– <span class="NLM_lpage">2513</span>, <span class="refDoi"> DOI: 10.1016/j.tetasy.2007.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1016%2Fj.tetasy.2007.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=2510-2513&author=E.+Abrahamauthor=J.+I.+Candela-Lenaauthor=S.+G.+Daviesauthor=M.+Georgiouauthor=R.+L.+Nicholsonauthor=P.+M.+Robertsauthor=A.+J.+Russellauthor=E.+M.+Sanchez-Fernandezauthor=A.+D.+Smithauthor=J.+E.+Thomson&title=Asymmetric+synthesis+of+N%2C+O%2C+O%2C+O-tetra-acetyl+D-lyxophytosphingosine%2C+jaspine+B+%28pachastrissamine%29+and+its+C%282%29-epimer&doi=10.1016%2Fj.tetasy.2007.10.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric synthesis of N,O,O,O-tetra-acetyl D-lyxo-phytosphingosine, jaspine B (pachastrissamine) and its C(2)-epimer</span></div><div class="casAuthors">Abraham, Elin; Candela-Lena, Jose I.; Davies, Stephen G.; Georgiou, Matthew; Nicholson, Rebecca L.; Roberts, Paul M.; Russell, Angela J.; Sanchez-Fernandez, Elena M.; Smith, Andrew D.; Thomson, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2510-2513</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The highly diastereoselective conjugate addn. of lithium (S)-N-benzyl-N-(α-methylbenzyl)amide to a γ-silyloxy-α,β-unsatd. ester and in situ enolate oxidn. with (+)-(camphorsulfonyl)oxaziridine has been used as the key step in the asym. synthesis of N,O,O,O-tetra-acetyl D-lyxo-phytosphingosine I, jaspine B (pachastrissamine) II and its C(2)-epimer III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1hqKOTHxZMbVg90H21EOLACvtfcHk0lhsikEBVUnEqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7fK&md5=891ec081de4105f8318bd2ed7045acdd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2007.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2007.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DE.%26aulast%3DCandela-Lena%26aufirst%3DJ.%2BI.%26aulast%3DDavies%26aufirst%3DS.%2BG.%26aulast%3DGeorgiou%26aufirst%3DM.%26aulast%3DNicholson%26aufirst%3DR.%2BL.%26aulast%3DRoberts%26aufirst%3DP.%2BM.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DSanchez-Fernandez%26aufirst%3DE.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BD.%26aulast%3DThomson%26aufirst%3DJ.%2BE.%26atitle%3DAsymmetric%2520synthesis%2520of%2520N%252C%2520O%252C%2520O%252C%2520O-tetra-acetyl%2520D-lyxophytosphingosine%252C%2520jaspine%2520B%2520%2528pachastrissamine%2529%2520and%2520its%2520C%25282%2529-epimer%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2007%26volume%3D18%26spage%3D2510%26epage%3D2513%26doi%3D10.1016%2Fj.tetasy.2007.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shevchenko, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pupo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">List, B.</span></span> <span> </span><span class="NLM_article-title">Direct asymmetric S-hydroxylation of cyclic --branched ketones through enol catalysis</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1055/s-0037-1611084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1055%2Fs-0037-1611084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ChsbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=49-53&author=G.+A.+Shevchenkoauthor=G.+Pupoauthor=B.+List&title=Direct+asymmetric+S-hydroxylation+of+cyclic+%2D%2Dbranched+ketones+through+enol+catalysis&doi=10.1055%2Fs-0037-1611084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Asymmetric α-Hydroxylation of Cyclic α-Branched Ketones through Enol Catalysis</span></div><div class="casAuthors">Shevchenko, Grigory A.; Pupo, Gabriele; List, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Synlett</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-53</span>CODEN:
                <span class="NLM_cas:coden">SYNLES</span>;
        ISSN:<span class="NLM_cas:issn">0936-5214</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Enantiopure α-hydroxy carbonyl compds. are common scaffolds in natural products and pharmaceuticals.  Although indirect approaches towards their synthesis are known, direct asym. methodologies are scarce.  Herein, we report the first direct asym. α-hydroxylation of α-branched ketones through enol catalysis, enabling a facile access to valuable α-keto tertiary alcs.  The transformation, characterized by the use of nitrosobenzene as the oxidant and a new chiral phosphoric acid as the catalyst, delivers a good scope and excellent enantioselectivities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh1imlwX1aNLVg90H21EOLACvtfcHk0liehl0QgtL80g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ChsbjP&md5=75ab4da4cdffaf14421d0c35c2555325</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1055%2Fs-0037-1611084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0037-1611084%26sid%3Dliteratum%253Aachs%26aulast%3DShevchenko%26aufirst%3DG.%2BA.%26aulast%3DPupo%26aufirst%3DG.%26aulast%3DList%26aufirst%3DB.%26atitle%3DDirect%2520asymmetric%2520S-hydroxylation%2520of%2520cyclic%2520--branched%2520ketones%2520through%2520enol%2520catalysis%26jtitle%3DSynlett%26date%3D2019%26volume%3D30%26spage%3D49%26epage%3D53%26doi%3D10.1055%2Fs-0037-1611084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baidya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span> <span> </span><span class="NLM_article-title">Catalytic enantioselective O-nitrosocarbonyl aldol reaction of B-dicarbonyl compounds</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">18566</span>– <span class="NLM_lpage">18569</span>, <span class="refDoi"> DOI: 10.1021/ja309311z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja309311z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFygtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=18566-18569&author=M.+Baidyaauthor=K.+A.+Griffinauthor=H.+Yamamoto&title=Catalytic+enantioselective+O-nitrosocarbonyl+aldol+reaction+of+B-dicarbonyl+compounds&doi=10.1021%2Fja309311z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic Enantioselective O-Nitrosocarbonyl Aldol Reaction of β-Dicarbonyl Compounds</span></div><div class="casAuthors">Baidya, Mahiuddin; Griffin, Kimberly A.; Yamamoto, Hisashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18566-18569</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first example of a Cu-catalyzed asym. O-nitrosocarbonyl aldol reaction is described.  This novel protocol allows convenient access to highly enantioenriched α-hydroxy-β-ketoesters including the antibacterial natural product kjellmanianone (up to 99% ee).  MnO2 was introduced as a mild efficient oxidant for the in situ generation of nitrosocarbonyl species from hydroxamic acid derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq62nAT9ohxYrVg90H21EOLACvtfcHk0liehl0QgtL80g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFygtL3F&md5=1aab01cb5e995e06cf887daebcf39203</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja309311z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja309311z%26sid%3Dliteratum%253Aachs%26aulast%3DBaidya%26aufirst%3DM.%26aulast%3DGriffin%26aufirst%3DK.%2BA.%26aulast%3DYamamoto%26aufirst%3DH.%26atitle%3DCatalytic%2520enantioselective%2520O-nitrosocarbonyl%2520aldol%2520reaction%2520of%2520B-dicarbonyl%2520compounds%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D18566%26epage%3D18569%26doi%3D10.1021%2Fja309311z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-4644(20000601)77:3<465::AID-JCB11>3.0.CO;2-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10.1002%2F%28SICI%291097-4644%2820000601%2977%3A3%3C465%3A%3AAID-JCB11%3E3.0.CO%3B2-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=10760954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivFWju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2000&pages=465-473&author=J.+Wangauthor=P.+Louauthor=J.+Henkin&title=Selective+inhibition+of+endothelial+cell+proliferation+by+fumagillin+is+not+due+to+differential+expression+of+methionine+aminopeptidases&doi=10.1002%2F%28SICI%291097-4644%2820000601%2977%3A3%3C465%3A%3AAID-JCB11%3E3.0.CO%3B2-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases</span></div><div class="casAuthors">Wang, Jieyi; Lou, Pingping; Henkin, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">465-473</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The angiogenesis inhibitors fumagillin and TNP-470 selectively inhibit the proliferation of endothelial cells, as compared with most other cell types.  The mechanism of this selective inhibition remains uncertain, although methionine aminopeptidase-2 (MetAP2) has recently been found to be a target for fumagillin or TNP-470, which inactivates MetAP2 enzyme activity through covalent modification.  Primary cultures of human endothelial cells and six other non-endothelial cell types were treated with fumagillin to det. its effect on cell proliferation.  Only the growth of endothelial cells was completely inhibited at low concns. of fumagillin.  MetAP1 and MetAP2 levels in these cells were investigated to det. whether differential enzyme expression plays a role in the selective action of fumagillin.  Western blot anal. and RT-PCR data showed that MetAP1 and MetAP2 were both expressed in these different types of cells, thus, ruling out differential expression of MetAP1 and MetAP2 as an explanation for the cell specificity of fumagillin.  Expression of MetAP2, but not of MetAP1, is regulated.  Treatment of human microvascular endothelial cells (HMVEC) with fumagillin resulted in threefold increases of MetAP2 protein in the cells, while MetAP1 remained const.  Similar upregulation of MetAP2 by exposure to fumagillin was also obsd. in non-endothelial cells, eliminating this response as an explanation for cell specificity.  Taken together, these results indicate that while MetAP2 plays a crit. role in the effect of fumagillin on endothelial cell proliferation, differential endogenous expression or fumagillin-induced upregulation of methionine aminopeptidases is not responsible for this obsd. selective inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnEHBXHmConLVg90H21EOLACvtfcHk0liehl0QgtL80g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivFWju7k%253D&md5=f05de66bc107cb486c48ee6a81991234</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-4644%2820000601%2977%3A3%3C465%3A%3AAID-JCB11%3E3.0.CO%3B2-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-4644%252820000601%252977%253A3%253C465%253A%253AAID-JCB11%253E3.0.CO%253B2-M%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DHenkin%26aufirst%3DJ.%26atitle%3DSelective%2520inhibition%2520of%2520endothelial%2520cell%2520proliferation%2520by%2520fumagillin%2520is%2520not%2520due%2520to%2520differential%2520expression%2520of%2520methionine%2520aminopeptidases%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2000%26volume%3D77%26spage%3D465%26epage%3D473%26doi%3D10.1002%2F%28SICI%291097-4644%2820000601%2977%3A3%3C465%3A%3AAID-JCB11%3E3.0.CO%3B2-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Motulsky, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahan, L. C.</span></span> <span> </span><span class="NLM_article-title">The kinetics of competitive radioligand binding predicted by the law of mass action</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=6708928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;key=1%3ACAS%3A280%3ADyaL2c7mslOmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1984&pages=1-9&author=H.+J.+Motulskyauthor=L.+C.+Mahan&title=The+kinetics+of+competitive+radioligand+binding+predicted+by+the+law+of+mass+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetics of competitive radioligand binding predicted by the law of mass action</span></div><div class="casAuthors">Motulsky H J; Mahan L C</div><div class="citationInfo"><span class="NLM_cas:title">Molecular pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Although equilibrium competitive radioligand binding studies are often used to characterize hormone and neurotransmitter receptors, the kinetics of such experiments have not been extensively explored.  The interactions of the radioligand and competitor with the receptors can be described by two differential equations which can be solved to yield a single equation describing the binding of the radioligand as a function of time.  This equation has several applications: First, it can be used to simulate competitive binding reactions under defined conditions.  Second, fitting experimental data to this equation allows one to determine the association and dissociation rate constants of the competing ligand, parameters that cannot be derived from equilibrium experiments.  Furthermore, this method can be used to determine the KI of the competing drug from data acquired before equilibrium is reached.  Third, mathematical analysis of the binding equation allowed us to answer two specific questions regarding the kinetics of competitive radioligand binding: how long such an incubation takes to equilibrate, and how the IC50 varies over time.  The answers to these questions depended, to a large extent, on the relative values of the dissociation rate constants of the radioligand and competitor, which can be determined as noted above.  When the competitor dissociates from the receptors more rapidly than the radioligand, the IC50 first decreases and then increases, but never has a value less than the KI.  At low radioligand concentrations, equilibrium is reached in the same amount of time required of the radioligand to dissociate completely from the receptors as determined in an "off-rate experiment." At higher concentrations of radioligand this time is halved.  When the competitor dissociates from the receptor more slowly than does the radioligand, then the time required to equilibrate depends only on the dissociation rate constant of the competitor, and the IC50 decreases over time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCXDwvoK7MbN1QT_1O5WBYfW6udTcc2ebIEngNuhy0f7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c7mslOmtQ%253D%253D&md5=f0c09a16d7f8947fe0d72c256e2e4914</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMotulsky%26aufirst%3DH.%2BJ.%26aulast%3DMahan%26aufirst%3DL.%2BC.%26atitle%3DThe%2520kinetics%2520of%2520competitive%2520radioligand%2520binding%2520predicted%2520by%2520the%2520law%2520of%2520mass%2520action%26jtitle%3DMol.%2520Pharmacol.%26date%3D1984%26volume%3D25%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QED" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QED','PDB','6QED'); return false;">PDB: 6QED</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i102"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01070">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_41866"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01070?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01070</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HPLC traces for all described compounds; measured HUVEC proliferation inhibition IC<sub>50</sub>, protein binding and with protein binding corrected IC<sub>50</sub>; FCCS experimental details and further results; Western blot analysis of cell lysates; FCS-based target occupancy assays discriminate MetAP-2 inhibitors in cells; pulse-chase experiment of <b>M8891</b> in HCT116 cells; additional information for the in vivo experiments (tumor volume of individual tumor bearing mice at the end of the study; U87-MG and Cacki-1 models; body weight changes during the 36 days of treatment in the Caki-1 model) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01070/suppl_file/jm9b01070_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01070/suppl_file/jm9b01070_si_009.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01070/suppl_file/jm9b01070_si_001.pdf">jm9b01070_si_001.pdf (2.22 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01070/suppl_file/jm9b01070_si_009.csv">jm9b01070_si_009.csv (2.1 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code for <b>1a</b>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QED">6QED</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01070&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-24%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01070" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01070" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b85e4fab32c1","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
